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Summary of thesis 
This thesis addressed the sensory functions of the gastrointestinal (GI) tract with an 
emphasis on the interaction between afferents nerves and other cell types such as 
enterochromaffin (EC) cells and mast cells, and also investigated the influence of 
ageing on these interactions. 
 
Studies on mice focused on TRPA1, a central molecule in nociception and 
inflammation. TRPA1 signaling induced by allyl isothiocyanate (AITC) comprised 
direct activation of TRPA1 on extrinsic afferents, indirect activation of 5-HT3 
receptors on extrinsic afferents following 5-HT release form EC cells and indirect 
signals evoked by contractions. TRPA1 signaling was attenuated with advanced age. 
This could be attributed to reduced primary afferent innervation and decreased gene 
expression of 5-HT3 in the gut wall. 
 
Sensory functions of human GI tract were investigated morphologically and 
functionally. Some changes were identified in aged human bowel, including 
increased EC cells, mast cells, decreased sensory innervation and enhanced mast 
cell-afferent associations. Afferent activities were recorded from isolated human 
bowel using a novel in vitro model, allowing direct characterization of the 
mechanical and chemical sensitivities of human gastrointestinal afferents.    
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Abbreviation
4-HNE      4-hydroxy-2-nonenal  
4-ONE      4-oxononenal  
5-HIAA    5-hydroxyindoleacetic acid  
5-HT       5-hydroxytryptamine 
5-HTP       5-hydroxy-L-tryptophan 
15d-PGJ2  15-deoxy-prostaglandin J2  
AITC       allyl isothiocyanate  
ASIC       acid-sensing ion channel  
B2       bradykinin receptor 2  
CgA       chromogranin A  
CNS       central nervous system 
DDC       amino acid decarboxylase  
DRG       dorsal root ganglia 
EC       enterochromaffin cell  
ENS       enteric nervous system 
FITC       fluorescein isothiocyanate  
GAPDH    Glyceraldehyde 3-phosphate  
     dehydrogenase  
GI       gastrointestinal 
GPCRs     G protein-coupled receptors 
HBSS       Hank’s Balanced Salt Solution  
HT       high threshold 
IBS       Irritable Bowel Syndrome  
IGLE       intraganglionic laminar ending  
IL       interleukin 
IMAs     intramuscular arrays  
LT     low threshold  
mMCP    mouse mast cell protease 
NG     nodose ganglia 
NK1    neurokinin 1  
NMDA    N-methyl-D-aspartate  
NPY     neuropeptide Y  
OCT     optimal cutting temperature  
P2X     purinergic receptor 2X  
PAR2-AP protease-activated receptor-  
                activating peptide 
PKA     protein kinase A 
PLC     phospholipase C  
PYY     peptide YY  
ROS     reactive oxygen species  
SERT     serotonin reuptake transporter  
SP     Substance P  
SynCAM synaptic cell adhesion molecule  
TNBS  2,4,6-trinitrobenzene sulfonic acid  
TNF     tumor necrosis factor   
TPH     tryptophan hydroxylase  
TRP     transient receptor potential  
VIP    vasoactive intestinal polypeptide 
WDR    wide dynamic range 
?
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1.1 Anatomy and function of the GI tract 
The gastrointestinal (GI) tract, also known as the digestive tract or the alimentary 
canal, a continuous, muscular digestive tube winding through the body, performs the 
function of digesting food and absorbing nutrients through its lining into the blood 
(Marieb, 2004). It is divided into the upper and lower GI tract by the Ligament of 
Treitz which suspends the duodenum from the diaphragm. The upper GI tract is 
composed of the esophagus, stomach and duodenum, while the lower GI tract 
consists of jejunum, ileum, caecum, colon and rectum (figure 1.1). 
 
Each region of the GI tract is endowed with specialized structure to perform distinct 
function. The esophagus is a conduit that guides the chewed food from the mouth 
down to the stomach where it is stored. The stomach is not only a storage space, but 
also a secretory organ that produces gastric acid for digestion. The small intestine is 
divided into duodenum, jejunum and ileum. Enzymes from the pancreas and bile 
from the liver enter the duodenum to breakdown the food. The jejunum continues the 
digestive process and absorbs the majority of fatty acids, glucose, amino acids, 
vitamin, sodium and water into the bloodstream. The ileum is the final section of the 
small intestine where the remaining nutrients are absorbed, such as some amino acids, 
vitamin B-12 and most of bile salts. The lining of the small intestine is characterized 
by a large number of folds called plicae circulares as well as smaller finger-like 
projections called villi, which greatly increase the absorptive areas. Waste products 
of the digestive process are passed to the colon; by that time, most nutrients and 90% 
of the water have been absorbed. In humans, the colon is divided into four sections: 
ascending colon, transverse colon, descending colon and sigmoid colon. While the 
watery waste is moving forward along the colon, the excess water is gradually 
absorbed. When moving into the descending colon, the stools are solidified and 
stored as feces. Finally, fecal matter is evacuated through the rectum and the anal 
canal. 
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Figure 1.1 Representative graph showing the anatomy of human gastrointestinal 
system (Cawthray et al., 2012). 
 
 
In association with accessory organs, all parts of the GI tract are well coordinated to 
perform the digestion and absorption effectively. Below the organ level, different 
types of tissues join in a structural unit and work collectively to implement specific 
functions. Typical gut wall can be divided into distinct layers in the following order: 
mucosa, submucosa, muscularis externa and serosa (figure 1.2).  
 
The mucosa is the innermost layer of the GI tract, composed of epithelium, lamina 
propria and muscularis mucosae. Epithelium, lining the surface of mucosa, is a single 
layer of distinct types of epithelial cells, such as enterocytes, goblet cells, paneth 
cells, columnar cells and enteroendocrine cells, which contribute to the secretion and 
absorption. As epithelium is in direct contact with intraluminal contents, epithelial 
cells are joined together by tight junctions to form a barrier to harmful materials from 
the lumen. The laminar propria is a layer of loose connective tissue, lining beneath 
the epithelium. It contains capillaries and a central lacteal (lymph vessel), and is rich 
in immune cells. The muscularis mucosae is a thin layer of smooth muscle that 
separates laminar propria from the submucosa. In the small intestine, the mucosal 
surface protrudes into the lumen to form a number of finger-like projections called 
Chapter 1 
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villi to increase absorptive area. Differently, the mucosa of the large intestine appears 
smooth because there are no villi. Instead, numerous straight, tubular glands extend 
downward from the surface to the muscularis mucosae. 
 
The submucosa is a layer of loose connective tissue that supports the mucosa and 
joins the mucosa to the underlying smooth muscle. Numerous blood vessels, 
lymphatic vessels and nerves are running through here. 
 
 
Figure 1.2 Diagram showing different layers of the small intestine (Wilkin and 
Brainard, 2012). 
 
The muscularis externa is composed of an inner circular muscle layer and an outer 
longitudinal layer. The contraction and relaxation of these muscles are responsible 
for the segmentation and movement of intraluminal contents. 
 
The serosa is a thin serous membrane covering the muscularis externa. In the small 
and large intestine, serosa is part of visceral peritoneum, which contains mesentery 
and mesocolon to attach intestines to the rear of the abdominal wall.  
Mucosa 
Muscularis 
externa 
 Submucosa 
 Serosa 
Villi 
Epithelium 
Capillary 
Muscularis mucosae 
Lacteal 
Circular muscle 
Longitudinal 
muscle 
Laminar propria 
Crypt 
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1.2 Sensory innervation of the GI tract 
All the GI functions are controlled and coordinated by the autonomic nervous system. 
In addition to digestion and absorption, the GI tract must protect itself from potential 
harmful antigens and pathogens in the lumen. Essential to these functions is the 
ability to sense the stimuli in the lumen and gut wall in order to initiate appropriate 
responses. Consequently, the GI tract is endowed with an extensive sensory 
innervation, composed of intrinsic neurons of the enteric nervous system (ENS) and 
extrinsic nerves from the central nervous system (CNS) (figure 1.3).  
 
Figure 1.3 Schematic representation of the sensory innervation of the gut wall (Beyak 
et al., 2006). CM, circular muscle; DRG, dorsal root ganglia; IFAN, intestinofugal afferent 
neuron; IML, intermediolateral column; IPAN, intrinsic primary afferent neuron; NG, 
nodose ganglia; NTS, nucleus tracti, solitarii; PVG, prevertebral ganglia; RS, rectospinal; S, 
serosa; SC, spinal cord; SM, submucosa. 
and artemin, signaling through a receptor complex composed
of a common receptor Ret tyrosine kinase and coreceptor
subunit, GFR-α. GNDF, NTN, and artemin have high binding
affinity to GFR-α family members GFR-α1, GFR-α2, and
GFR-α3, respectively. Although there has been little study
to date regarding the role of specific NGFs in targeting and
survival of sensory axons projecting to the GI tract, a
number of observations are relevant. The first is that NGF is
required for survival of most nodose neurons early in devel-
opment, although a small number of nodose neurons survive
in NGF−/− mice. Interestingly, NGF dependence and tyrosine
kinase A (trkA) expression are lost in later development and
in the early postnatal period in most nodose neurons (20). 
In spinal afferents, NGF is crucial for survival of small,
unmyelinated, peptidergic, “nociceptor-like” fibers (21). This
is of particular interest in the GI tract, given that nearly all
adult spinal afferents (~80%) contain CGRP and express the
high-affinity NGF receptor trkA (22,23).
Besides NGF, the mediators BDNF, NT-3, and NT-4 have
been implicated as the key survival-promoting factors for
the cranial sensory neurons during the early embryonic stages
of target field innervation (20,24–26). For example, BDNF
null mice have few nodose neurons, and loss of BDNF
results in defective baroreceptor innervation, indicating an
important role in targeting of visceral afferents (24). BDNF
also is transported to the central terminals, suggesting a role
in development of central terminal connections by this ante-
grade signaling mechanism. NT-4 is also likely important in
visceral afferent development, especially in the development
of specialized IGLE-like endings, because mice with NT-4
gene deletion have an almost complete loss of IGLEs (27).
In the GI tract, few spinal afferents are isolectin B4 (IB4)
positive and express the GDNF receptor, whereas the major-
ity express TrkA (22,23). This observation likely provides 
a clue as to the targeting of extrinsic spinal sensory neurons
to the GI tract and viscera.
With regard to the GDNF family of neurotrophins, this
pathway is clearly important in targeting of enteric neurons
to the GI tract, and disruptions in this pathway are implicated
in the genesis of Hirschsprung’s disease (28). In the nodose
ganglion, GDNF deletion results in an almost complete loss
of neurons in the nodose ganglion (29), and GDNF depen-
dence of most nodose neurons is retained into adulthood.
What role this family of growth factors has in targeting of
vagal axons to the gut remains to be demonstrated.
ANATOMY OF EXTRINSIC 
AFFERENT FIBERS
Peripheral Projections
Vagal Afferent Fibers
Vagal afferent fibers project distally from the inferior
nodose and superior jugular ganglia, located bilaterally prox-
imal to the carotid bifurcation, and innervate the digestive
tract from the pharynx to the proximal colon (Fig. 25-1).
Sequentially, the vagus gives rise to pharyngeal, superior
laryngeal, recurrent laryngeal, and esophageal branches,
which innervate the pharynx, larynx, and esophagus (30,31).
On penetrating the diaphragm, the vagus emerges as dorsal
and ventral trunks, continuous with the right and left cervical
vagi, respectively. The ventral trunk divides into three branches
the hepatic, accessory celiac, and gastric branches, whereas
the dorsal trunk divides into celiac and gastric branches (32,
33). The stomach is predominantly innervated by the gastric
branches, with additional innervation to the fundus, antrum,
and pylorus from the hepatic branch of the vagus (34–36).
EXTRINSIC SENSORY AFFERENT NERVES INNERVATING THE GASTROINTESTINAL TRACT / 687
S
LM
MP
CM
SM
M
PVG
DRGNG
NTS SC
IML
IPAN
IPAN
IFAN
RS
Vagal 
afferent
fiber
spinal
afferent
fiber
FIG. 25-1. Schematic illustration of the different types of
afferent neurons innervating the gastrointestinal tract. Vagal
and spinal extrinsic primary afferent neurons possess cell
bodies that lie o tside the gut wall, in respective nodose/
jugular and dorsal root ganglia, and provide neuronal
connection between the gut and central nervous system.
Viscerofugal neuronal cell bodies lie within the myenteric
ganglia and project outside the gut to synapse within the
prevertebral ganglia (intestinofugal afferent neurons) or the
spinal cord (rectospinal neurons). Intrinsic primary afferent
neuronal cell bodies are found in the myenteric and submu-
cosal plexuses and possess afferent fibers, which are
contained within the gastrointestinal tract. CM, circular muscle;
DRG, dorsal root ganglia; IFAN, intestinofugal afferent neuron;
IML, intermediolateral column; IPAN intrinsic primary afferent
neuron; LM, longitudinal muscle; M, mucosa; MP; myenteric
plexus; NG, nodose ganglia; NTS, nucleus tracti solitarii; PVG,
prevertebral ganglia; RS, rectospinal; S, serosa; SC, spinal
cord; SM, submucosa.
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Enteric nervous system 
The neurons of the ENS are distributed throughout the entire GI tract in two types of 
ganglia: myenteric plexuses located between the circular and longitudinal muscle 
layers and submucosal plexuses located in the submucosa. They play an important 
role in the control of gut motility including segmentation and peristalsis, regulation 
of local blood flow, fluid exchange and secretion. 
 
The ENS has been described as a second brain for several reasons (Gershon, 1999). 
It is capable of coordinating reflexes independently of the brain and the spinal cord. 
The ENS comprises primary sensory neurons sensitive to mechanical and chemical 
stimuli, interneurons that form a connection between other neurons and motor 
neurons targeting on different effectors including smooth muscle, pacemaker cells, 
blood vessels, epithelia and mucosal glands (Costa et al., 2000). 
 
 
Extrinsic sensory innervation of the GI tract    
Although enteric neurons perform complex reflexes independently, the extrinsic 
sensory nerves convey signals of noxious and non-noxious events to the CNS, 
allowing the CNS to regulate crucial GI functions and enabling awareness of GI 
events. 
 
Origins and projections 
The extrinsic sensory nerves innervating the GI tract are derived from two sources: 
vagal and spinal nerves (figure 1.3). The vagal afferent nerves with their cell bodies 
located in jugular/nodose ganglia (NG), project centrally to the brainstem and 
peripherally to the visceral organs from the pharynx to the proximal colon. The cell 
bodies of spinal sensory neurons are located in the lower thoracic, lumbar and sacral 
segments of dorsal root ganglia (DRG), which relay sensory signals to the dorsal 
horn. The spinal afferents are divided into two subpopulations: splanchnic and pelvic. 
The splanchnic afferents innervate the entire length of the GI tract, whereas the 
pelvic afferents only supply the distal large intestine. These afferents run in mixed-
nerve bundles that contain both afferent and efferent nerves. Vagal afferents are 
predominant over efferent fibers, accounting for 90% of total vagal nerves; 
Chapter 1 
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conversely, spinal sensory afferent nerves occupy a much smaller proportion, about 
10~20% for the splanchnic nerve and 30~50% for the pelvic nerve. Furthermore, a 
greater proportion of afferent innervation of the GI tract is provided by the vagus 
nerve (Sengupta and Gebhart, 1994); however, this predomination diminishes 
rostrocaudally along the GI tract, especially in the distal colon and rectum where 
spinal afferents via pelvic nerve are predominant.  
 
   
 
Figure 1.4 Schematic representation of the vagal and spinal innervation of the GI tract 
(Beyak et al., 2006). CG, celiac ganglia; GSN, greater splanchnic nerve; HGN, hypogastric 
nerve; ICG, intermediate cervical ganglia; IMG, inferior mesenteric ganglia; IMN, 
intermesenteric nerve; LCN, lumbar colonic nerve; LSN, lumbar splanchnic nerve; MPG, 
major pelvic ganglia; NTS, nucleus tracti solitarii; PN, pelvic nerve; SCG, superior cervical 
ganglia; SG, stellate ganglia; SMG, superior mesenteric ganglia. 
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Distribution of peripheral afferent terminals 
Studies employing electrophysiologic and anatomic tracing techniques have 
demonstrated the presence of afferent nerve terminals within different layers of gut 
wall. 
 
In the rat mucosa, a network of vagal afferent fibers have been shown extending 
through the laminar propria, with some terminals close to the basal laminar but not 
extending through the epithelial cells (Berthoud et al., 1995). Morphological studies 
on spinal mucosa afferent are limited, although their response to mucosal stroking 
has been documented by a few functional studies in the rodent (Lynn and Blackshaw, 
1999; Brierley et al., 2004). 
 
Most rat vagal afferent terminals in the muscle layers consist of two types of 
specialized endings, intraganglionic laminar endings (IGLEs) and intramuscular 
arrays (IMAs) (Wang and Powley, 2000); conversely, most spinal afferents 
terminating within the muscle layers have been suggested to be bare nerve endings 
(Mazzia and Clerc, 1997; Blackshaw and Gebhart, 2002), although some studies 
have described a type of rectal IGLEs resembling vagal IGLEs supplied by pelvic 
nerve in the guinea pig (Lynn et al., 2003; Olsson et al., 2004). IGLEs comprise a 
distinctive cluster of terminal puncta derived from a single afferent fiber, which 
encapsulate a myenteric ganglion or pole of ganglia. IGLEs have been demonstrated 
to be mechano-transduction sites of vagal tension receptors in the guinea pig 
(Zagorodnyuk and Brookes, 2000; Zagorodnyuk et al., 2001). IMAs innervating both 
circular and longitudinal muscle layers are composed of arrays of parallel terminal 
processes running in close proximity to each other and to muscle fibers. The 
structural characteristics of IMAs imply their role as mechanoreceptors; however, 
further investigation is required to confirm this hypothesis. 
 
The sensory innervation of the serosa and mesentery is supplied by spinal afferents 
(Sengupta and Gebhart, 1994), and most of their endings are thought to be bare nerve 
endings. 
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Mechanosensitivity 
Sensory afferent nerves innervating the GI tract can be classified according to the 
locations of their receptive fields as mucosal, muscular, serosal and mesenteric 
afferents. This approach of classification is based on in vitro recording on rat flat-
sheet preparations and afferent responses to distinct mechanical stimulation 
including probing, stretch and mucosal stroking (Lynn and Blackshaw, 1999). 
 
All mechano-sensitive afferent subtypes are responsive to probing, allowing accurate 
location of their receptive fields. In addition to probing, mucosal afferents are 
sensitive to light stroking of the mucosa and insensitive to distension or compression. 
Muscular afferents are characterized by their ability to response to stretch. Serosal 
and mesenteric afferents show responses to probing only.    
  
Studies on mouse colonic spinal afferents have identified five different subtypes of 
afferents, three of which (mucosal, muscular and serosal) are conserved between 
splanchnic and pelvic nerves. Each pathway has a unique subtype: mesenteric 
afferent in the splanchnic nerve and muscular/mucosal in the pelvic nerve (Brierley 
et al., 2004). 
 
Another commonly used mechanical stimulation is distension of tubular preparations 
by balloon inflation or saline infusion. Afferents can also be classified based on their 
response threshold to distension and adaptability. Studies on mouse small intestine 
have characterized three functional types of afferents by discriminating their 
responses to distension using spike sorting analysis (Rong et al., 2004). The first type 
is low-threshold unit whose discharges reach a peak rapidly in the first few 
millimeters of Mercury increase in pressure, but without further increase when 
pressure rises up to 60 mmHg. The second subtype, named as wide dynamic range 
afferents, also have a low threshold, whereas their discharges increase continuously 
following the increase of pressure (figure 1.5). The third type has a threshold more 
than 20 mmHg and thus classified as high-threshold unit. It is widely accepted that 
low-threshold units might originate from both vagal and spinal afferents, whereas 
high-threshold units are exclusively of spinal origin (Ozaki and Gebhart, 2001; 
Booth et al., 2001). 
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The molecular identity of the ion channels responsible for mechanical transduction 
has not been fully understood. Increasing evidence based on mutant rodent has 
suggested voltage gated sodium channel Nav1.7 and Nav1.8 might be the 
mechanotransduction sites (Nassar et al., 2005; Schuelert and McDougall, 2012). A 
recent study suggested that Nav1.9 might be another candidate (Hockley et al., 2014). 
In addition, transient receptor potential (TRP) channels have been found to play an 
essential role in a number of mechanosensory systems. TRPV4 (Suzuki et al., 2003) 
and TRPA1 (Brierley et al., 2009) knockout mice appeared to have some deficits in 
the mechanical sensitivity. 
 
 
Figure 1.5 Example of multiunit mesenteric 
afferent response to ramp distension in 
mouse jejunum. The upper channel displays 
the overall afferent discharges in response to 
distension, whereas the lower diagram shows 
pressure-response relations of three functional 
classes of afferents. Reproduce from (Rong et 
al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemosensitivity 
Chemical sensitivity to nutrients, toxins and inflammatory mediators present in the 
lumen and gut wall are crucial functions of sensory afferents innervating the GI tract. 
Most of these actions are mediated by activation of ligand-gated ion channels and 
other membrane-bound receptors such as G protein-coupled receptors (GPCRs). 
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Ligand-gated ion channels, present on both vagal and spinal afferent, are gated by 
binding of various compounds, transmitters and protons. Some well-studied channels 
include 5-HT3, TRP, purinergic receptor 2X (P2X), N-methyl-D-aspartate (NMDA), 
acid-sensing ion channels (ASIC) and nicotinic receptors. For example, the TRP 
family of ion channels plays a primary role in chemosensitivity. TRPV1 is gated by 
capsaicin, the pungent ingredient in chili peppers, and TRPM8, a cold-sensitive 
channel, is the receptor of menthol (Jordt et al., 2003). In addition, TRPA1 is gated 
by pungent natural compounds in cinnamon oil, mustard oil, garlic, wintergreen oil, 
clove oil and ginger (Bandell et al., 2004). 
 
In addition to modulating afferent activity through ligand-gated ion channels, 
chemical stimuli may also act on plasma membrane protein receptors such as GPCRs 
that subsequently activate intracellular secondary signaling pathways. Increasing 
evidence has suggested an important role of GPCRs in regulating afferent signaling 
in response to nutrient-derived stimuli (Beyak et al., 2006), inflammatory mediators 
(Grundy, 2002) as well as mechanosensitivity (Page and Blackshaw, 1999). These 
modulations in concert with ligand-gated ion channels fine-tune afferent sensitivity 
to adapt with different conditions. 
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1.3 GI-related disorders 
GI disorders such as gastritis, ulcerative colitis, Crohn’s disease, irritable bowel 
syndrome (IBS) and diverticulosis are very common medical conditions. In the past 
decade, a large number of studies have addressed the pathogenesis of IBS. 
   
IBS is defined as a functional bowel disorder characterized by chronic abdominal 
pain, discomfort, bloating and alteration of bowel habits, which cannot be explained 
by a visible structural or biochemical abnormality. However, some genetic, cellular 
and biochemical abnormalities in IBS have been reported, suggesting it is no longer 
purely functional (Barbara et al., 2004a; Spiller et al., 2007). Based on the 
predominant symptoms, it is classified into three subtypes: constipation-predominant 
IBS (IBS-C), diarrhea predominant IBS (IBS-D) and alternative IBS (IBS-A). IBS is 
diagnosed using either the Manning or the Rome criteria. The most recent Rome III 
criteria includes recurrent abdominal pain or discomfort at least 3 days a month in 
the past 3 months in association with two or more of the following: improvement 
with defecation, onset associated with a change in frequency of stool or onset 
associated with a change in form of stool (Longstreth et al., 2006). 
 
Prevalence rates of IBS usually range from 5% to 20%, but vary markedly between 
countries and depend on the diagnostic criteria used (Spiller et al., 2007). An 
international survey shows that the overall prevalence of IBS is 11.5% in eight 
European countries (Hungin et al., 2003). This rate in the UK is 10.5%; furthermore, 
IBS accounts for 20~50% of referrals to gastroenterology clinics and thus is a 
substantial burden on primary healthcare services (Wilson et al., 2004). 
 
Despite the large unmet medical needs, the pathogenesis of IBS hasn’t been fully 
understood. One of the hypotheses is visceral hypersensitivity based on the 
observation that IBS patients have a lower pain threshold to colorectal distension or 
electrical stimuli (Ritchie, 1973; Whitehead et al., 1990; Sinhamahapatra et al., 2001; 
Verne et al., 2001; Dong et al., 2004). An abnormal bi-directional interaction 
between the immune system and nervous system is believed to be crucial in the 
pathophysiology of IBS. Increasing evidence has suggested an important role of mast 
cells and enterochromaffin cells (ECs) in IBS hypersensitivity. 
Chapter 1 
 19 
 
Increased mast cells, EC cells and T lymph cells are observed in the colonic biopsies 
from IBS patients (Lee et al., 2008). The severity of abdominal pain in IBS patients 
has been found positively correlated with serotonin release (Cremon et al., 2011) and 
anatomical mast cell-nerve association (Barbara et al., 2004b). 
 
2,4,6-trinitrobenzene sulfonic acid (TNBS) induced visceral hypersensitivity is 
abolished in mast cell deficient rats (Ohashi et al., 2008). Treatment with mast cell 
stabilizer, disodium cromoglycate, improves the symptoms in a large proportion of 
IBS-D patients (Leri et al., 1997). 
 
Upon stimulation, EC cells and mast cells release 5-HT, which is an important 
neurotransmitter involved in signal transduction of visceral stimuli (Grundy, 2008). 
The contribution of serotonin in the pathology of IBS is demonstrated by the 
therapeutic effect of 5-HT3 antagonists and 5-HT4 receptor agonists on many IBS 
symptoms (De Giorgio et al., 2007; Ford et al., 2009). Animal models of visceral 
hypersensitivity are associated with increased EC cells, enhanced serotonin release 
and impaired uptake (Linden et al., 2003; O'Hara et al., 2004). In addition, mucosal 
supernatants from IBS patients significantly increased afferent firing recorded from 
rat jejunal nerves (Barbara et al., 2007), which could be blunted by 5-HT3 receptor 
antagonist granisetron (Cremon et al., 2011). 
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1.4 Mast cells 
Mast cells are long-lived tissue resident cells, extensively distributed at sites where 
host tissue in contact with external allergens and microorganisms, such as upper 
dermis, the respiratory tract and the GI tract (Beil et al., 2000). They belong to the 
immune system and are best known for their role in allergy and anaphylaxis. The 
most striking morphological characteristic of mast cells is numerous cytoplasmic 
secretory granules filled with preformed mediators, such as histamine, serotonin, 
protease, heparin, proteoglycans and cathepsin; in addition, many cytokines, lipid 
mediators and growth factors are newly synthesized after activation (Buhner and 
Schemann, 2011). The prominent diversity of mediators released from mast cells 
indicates their broad involvements in a wide variety of physiological and 
pathological activities. 
 
Mast cells are derived from bone marrow and leave bone marrow as immature 
precursors. The sites where mast cells settle and mature largely determine their 
characteristics. Rodent mast cells can be divided based on their locations into 
mucosal mast cells and connective tissue mast cells. In humans, mast cells are 
classified by their protease profiles, one subtype expressing tryptase only and the 
other expressing both tryptase and chymase. 
 
Interaction between mast cells and nerves has been a hot topic in the past two 
decades for its potential involvement in the pathogenesis of functional bowel 
disorders. It is estimated that 70% of intestinal mucosal mast cells are in direct 
contact with nerves with another 20% within 2 µm (Stead et al., 1989; Stead, 1992). 
Furthermore, the severity of abdominal pain in IBS patients is positively correlated 
with anatomical mast cell-nerve association (Barbara et al., 2004b). In animal model 
of stress-induced hypersensitivity, the number of mast cells in close proximity to 
PGP 9.5 or CGRP-positive nerve fibers was increased in rat colon (Barreau et al., 
2008). This anatomical association has functional relevance as crosstalk between 
mast cells and nerves might modulate afferent sensitivity and alter mucosal 
homeostasis. 
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Based on animal experiments, upon stimulation mast cells release mediators that 
stimulate or sensitize afferent nerves, resulting in release of neuropeptides, which, in 
turn, further excite mast cells (Shanahan et al., 1985; Repke and Bienert, 1987; 
Purcell and Atterwill, 1995). As shown in figure 1.6, a number of signaling 
molecules and receptors involved in this crosstalk have been identified (Buhner and 
Schemann, 2011). This bidirectional communication forms a positive feedback loop, 
which might amplify inflammatory response within the GI tract. Imbalanced or 
exaggerated amplification is a likely mechanism contributing to visceral 
hypersensitivity. 
 
 
 
Figure 1.6 Schematic illustration of mast cell-nerve interactions in human gut and a 
summary of involved signaling pathways.  Smaller font indicates smaller contribution. 
Image from (Buhner and Schemann, 2011). 
identiﬁed on extrinsic neurons in the jejunum [88]. Recently, it was
shown that histamine or serotonin application to rat dorsal root
ganglion cells with projections to the viscera increased the Ca2+
responses to a TRPV4 (transient receptor potential cation channel
subfamily V member 4) agonist and enhanced the TRPV4 expression
[89]. TRPV4 is known to be involved in visceral hypersensitivity.
Sensitization of extrinsic afferent neurons by mast cell mediators
in particular histamine and proteases has been demonstrated in
animal models. Similar mechanisms may also be operative in the
human gut [90–92]. Application of an “inﬂammatory soup” composed
of PGE2, histamine, serotonin, ATP, adenosine and bradykinin
increased the spiking activity of afferents nerves [91].
Another group of mast cells mediators comprises the prostaglan-
dins (PGs) and leukotrienes (LTs) which are synthesized from the
precursor arachidonic acid by cyclooxygenase and lipoxygenase
enzymes, respectively. Among these substances PGD2 is the dominant
prostanoid and LTC4, LTD4, and LTE4 are the most prevalent
leukotrienes produced by human mast cells [19,93]. It was shown in
rodents that each of these mediators strongly stimulate intestinal
secretion [94]. These effects were partly mediated by direct actions on
enteric neurons. Intracellular recordings in guinea pig submucous
plexus revealed an activation of the neurons by all the mediators [95].
Whether similar mechanisms are active in humans is unclear. How-
ever, PGD2 receptors (DP) have been localized within the mucous-
secreting goblet cells of the human colon [96]. Recently an inducible
system for PGE2 generation in cultured human cord blood mast cells
was detected and described [97]. Since PGE2 plays amajor role in non-
allergic diseases similar studies in human enteric mast cells would be
interesting.
A variety of different cytokines, chemokines and growth factors
has been identiﬁed in human mast cells (Table 1). Most of them are
not stored preformed but synthesized de novo active mast cells.
There is evidence that IL-1β and TNFα, but not IFN-γ, IFN-α, IL-6 or
IL-8 exhibit prosecr tory effects in the human distal colon [98]. The
effects were TTX insensitive but could be blocked by indomethacine.
This indicates an additional effect of prostaglandins rather than an
involvement of the ENS in this mechanism. In guinea-pig submucous
and myenteric neurons IL-1β induced an indomethacine sensitive c-
Fos expression [94] suggesting an indirect effect on the ENS which
involves prostaglandins. Results from human submucous neurons
demonstrated a direct excitatory action of IL-1β on enteric neurons
[99]. Further knowledge on the inﬂuence of cytokines on enteric
neurons derives from studies in laboratory animals. Frequently
studied substances are IL-1β and IL-6. Both are reported to increase
excitability in submucous and myenteric neurons and to mediate
effects on cholinergic and non-cholinergic transmission [100–102]. IL-
1β also sensitizes extrinsic visceral afferents of cats to histamine or
excite them directly at higher doses [103].
It is generally believed and stated in many reviews that human
intestinal mast cells do not release serotonin. This would be supported
by our own results which show a consistent lack of serotonin
immunoreactivity in human intestinal mast cells (Fig. 1). Also
human isolated mast cells do not release serotonin in response to IgE
receptor cross linking (personal communication Prof. Stephan Bis-
choff, UniversityHohenheim). However, there is no original paper that
actually substantiates the assumption that human intestinal mast cells
cannot release serotonin. There are two publications that demonstrate
presence of serotonin in human intestinal mast cells. The ﬁrst paper
described the presence of serotonin immunoreactivity in about 30% of
mast cells in normal tissue from patients with rectal carcinoma [49].
Their number is increasedmore than threefold in the colon of patients
with UC. This study also showed an electronmicrograph of a serotonin
containingmast cell degranulating in the lumen of a gland. The second
paper reported that cultured human mast cells derived from CD34+
peripheral blood progenitors are able to release serotonin although the
serotonin levels were much smaller than those released from mouse
mast cells [104]. The same study also found that human mast cells
express the serotonin syn hesizing enzyme tryptophan hydroxylase.
Thus the jury is still out on the ability or inability of mast cells to
synthesize and release se otonin. In case it turns out that mast cells do
under certain conditions or in response to a particular stimulus release
serotonin, this serotonin may then act on nerves nearby. Human
Fig. 2. Schematic illustration of mast cell nerve interactions in the human gut based on staining patterns such as those shown in Fig. 1 and functional data. The diagram takes into
account themast cell gradient along the gut wall with the highest density in the epithelial/subepithelial layer. Mast cell mediators excite enteric neurons through the receptors listed.
Smaller fonts illustrate smaller contribution of the receptor. On the other hand, neurotransmitters released from enteric nerves or visceral afferents modulate mast cell mediator
release (↑ increase; ↓ decrease).
5S. Buhner, M. Schemann / Biochimica et Biophysica Acta xxx (2011) xxx–xxx
Please cite this article as: S. Buhner, M. Schemann, Mast cell–nerve axis with a focus on the human gut, Biochim. Biophys. Acta (2011),
doi:10.1016/j.bbadis.2011.06.004
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1.5 Enterochromaffin cells 
Enterochromaffin (EC) cells are a subtype of endocrine cells that reside in the 
epithelia lining of the GI tract. This name reflects their straining via a chromium salt 
reaction that they share with chromaffin cells in the adrenal medulla (Rindi et al., 
2010). EC cells have apical microvilli exposed to the intestinal lumen to monitor 
intraluminal contents, which might activate EC cells to release mediators like 
serotonin (5-HT) across the basolateral membrane into the lamina propria (Raybould, 
1999). 
 
Although 5-HT is present in the CNS and platelets, about 90% of the body’s 5-HT 
resides in the gut (Gershon and Tack, 2007), where it is synthesized by EC cells and 
to a lesser extent by serotonergic neurons within the myenteric plexus in the mouse 
(Gershon et al., 1965). It is generally believed that 5-HT is also present in murine 
mucosal mast cells but not in human, although some studies suggest a very low 
amount of 5-HT in human mast cells (Kushnir-Sukhov et al., 2007). 5-HT can be 
synthesized from L-tryptophan via 5-hydroxy-L-tryptophan (5-HTP) by a metabolic 
pathway composed of two enzymes: tryptophan hydroxylase (TPH) and amino acid 
decarboxylase (DDC). EC cells contain one form of enzyme for serotonin’s 
biosynthesis, tryptophan hydroxylse-1 (TPH-1), whereas enteric serotonergic 
neurons have a different enzyme TPH-2 (Cote et al., 2003). The impact of mucosal 
5-HT is terminated by a serotonin reuptake transporter (SERT) that transports 5-HT 
into epithelial cells.  
 
5-HT activates a group of G-protein-coupled receptors (5-HT1, 5-HT2, 5-HT4-7) and 
only one exceptional ligand-gated ion channel (5-HT3) to influence various 
biological and neurological processes. Many of these receptors are distributed in the 
GI tract. In terms of sensory signaling, most attention has focused on 5-HT3 and 5-
HT4. In particular, immuno-labeled 5-HT3 receptors are present on both NG and 
DRG neurons innervating rat GI tract (Hicks et al., 2002; Raybould et al., 2003), and 
5-HT3 expressions in the murine NG are much higher than DRG (Peeters et al., 
2006). 5-HT activates vagal afferents in the upper GI tract exclusively via 5-HT3 
receptors in the ferret (Blackshaw and Grundy, 1993), whereas it activates spinal 
afferents through both 5-HT3 and non-5-HT3 receptors in the rat (Hicks et al., 2002). 
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In rat small intestine, afferent discharges triggered by 5-HT are composed of a direct 
excitation through 5-HT3 and indirect actions through increased motility, which is 
likely to arise from 5-HT receptors on enteric neurons and muscles (Hillsley et al., 
1998).  
 
EC cells are thought to be an important interface between the hostile environment of 
the gut lumen and the afferent nerves that are unable to penetrate into the epithelium. 
They function as taste cells of the GI tract by releasing 5-HT in response to a variety 
of stimuli including mucosal stroking, nutrients (e.g., glucose), toxin (e.g., cholera 
toxin, chemotherapeutics) and adenosine (Racke and Schworer, 1991; Kellum et al., 
1999; Grundy, 2008). Under physiological conditions, released serotonin may 
interact with the closely apposed sensory nerves to orchestrate proper motor and 
secretion reflexes to facilitate the transition of luminal contents as well as digestion 
and absorption of nutrients. However, in pathophysiological state, 5-HT, in 
conjunction with other inflammatory mediators, may induce abnormal secretory and 
motor responses and result in nausea, vomiting, diarrhea, constipation or visceral 
pain. 5-HT has been demonstrated to be a major mediator of emetic and diarrhoea 
responses to luminal toxins; for example, intravenous cisplatin, a chemotherapeutic 
agent used in the treatment of tumors, (Andrews et al., 1990) and radiation (King et 
al., 1999)-induced emesis is significantly attenuated by 5-HT3 receptor antagonist. 
 
Increasing evidence has revealed the involvement of 5-HT bioavailability in GI 
inflammation and functional disorders. Increased EC cells, enhanced serotonin 
release and impaired SERT activity have been shown in clinical (Coleman et al., 
2006; Minderhoud et al., 2007) and animal models of inflammatory bowel diseases 
(Linden et al., 2003; Coates et al., 2004; O'Hara et al., 2004). Similarly, increased 
EC cells with enhanced spontaneous release of 5-HT have been reported in IBS 
patients (Spiller et al., 2000; Cremon et al., 2011). Furthermore, a positive 
correlation between 5-HT release and the severity of abdominal pain has been found 
in IBS patients (Cremon et al., 2011). These observations suggest a role of serotonin 
in the pathology of IBS. Indeed, 5-HT3 antagonists such as alosetron have been 
proved to relieve symptoms in female patients with non-constipated IBS, and 5-HT4 
receptor agonist tegaserod has been found effective in IBS-C (De Giorgio et al., 2007; 
Ford et al., 2009). 
Chapter 1 
 24 
1.6 Transient receptor potential ankyrin 1 (TRPA1)  
Transient receptor potential (TRP) channels are a superfamily of ion channels mostly 
located on the plasma membrane of numerous cell types and conserved across a wide 
range of species. TRP channels were initially discovered in a trp-mutant strain of 
Drosophila characterized by a transient response to steady light, and as such were 
subsequently named as “transient receptor potential”. Based on sequence homology, 
TRP channels are classified into seven subfamilies: TRPC (canonical), TRPV 
(vanilloid), TRPM (melastatin), TRPP (polycystin), TRPML (mucolipin), TRPA 
(ankyrin) and TRPN (NO mechanoreceptor potential C). Most TRP channels are 
composed of 6 transmembrane segments (S1-S6) with a pore loop between S5 and 
S6 and intracellular N- and C-terminal (Nilius and Owsianik, 2011). 
 
The fundamental goal toward understanding the mechanisms of sensation or 
nociception is to identify the molecules that are responsible for stimulus detection 
and excitation or sensitization of primary sensory nerves. TRP channels have 
attracted attention as some members serve as receptors for a variety of natural plant 
compounds that excite nociceptors to elicit pain and inflammation (Clapham, 2003; 
Wang and Woolf, 2005). For example, noxious heat-sensitive TRPV1 is the receptor 
for capsaicin, the pungent ingredient in chili peppers, and TRPM8, a cold-sensitive 
channel, can be activated by menthol. In the past decade, increasing evidence has 
suggested that TRPA1, the sole member of the TRPA subfamily, is another candidate 
essential for neurogenic inflammation and nociception.  
 
TRPA1, defined by the ankyrin repeats in the N-terminal, was first discovered in 
cultured fibroblasts by Jaquemar (1999) and coworkers.  Similar to most TRP 
channels, TRPA1 consists of 6 transmembrane domains with intracellular N- and C-
terminals (figure 1.7). Several cysteine residues in the N-terminal are implicated in 
TRPA1 activation by reactive agonists. 
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Figure 1.7 Schematic image showing the structures of TRPA1 (left) and TRPV1 (right) 
monomers. The intracellular N-terminal of TRPA1 has about 14 ankyrin repeats, containing 
some cysteine and lysine residues that are responsible for activation by agonists as well as a 
partial EF-hand domain involved in calcium-dependent gating. TRPV1 is gated by capsaicin 
binding to multiple intracellular regions, and also gated by protons interacting with acidic 
residues at the extracellular end of S5 and within the pore loop. N- and C-terminals have 
interaction sites for calmodulin (Cam) and ATP. Domains with positive charge in the C-
terminal of TRPA1 and TRPV1 may serve as interaction sites of phosphatidylinositol-4,5-
bisphosphate (PIP2), the substrate of phospholipase C. (Bessac and Jordt, 2008) 
 
 
Activation of TRPA1 
TRPA1 can be activated by pungent natural compounds in cinnamon oil, mustard oil, 
garlic, wintergreen oil, clove oil and ginger (figure 1.8), among which allyl 
isothiocyanate (AITC, mustard oil), cinnamaldehyde and allicin are specific to 
TRPA1 (Bandell et al., 2004; Jordt et al., 2004; Bautista et al., 2006). These 
compounds activate TRPA1 through covalent modification of reactive cysteine 
residues in the ankyrin repeat domains (Macpherson et al., 2007). Topical application 
of these agents has long been known to excite sensory nerve afferents and thus result 
in acute pain and neurogenic inflammation through release of neuropeptide, purines 
and other transmitters in the mouse (Bautista et al., 2006). 
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In addition to environmental irritants, a few endogenous TRPA1 agonist have been 
identified in the rodent, such as 4-hydroxy-2-nonenal (4-HNE) and 4-oxononenal (4-
ONE) produced through peroxidation of membrane phospholipids by reactive 
oxygen species in response to oxidative insults during tissue injury and inflammation 
(Trevisani et al., 2007; Graepel et al., 2011). Additionally, a cyclopentane PGD2 
metabolite, 15-deoxy-prostaglandin J2 (15d-PGJ2) (Cruz-Orengo et al., 2008) and 
nitrooleic acid (Taylor-Clark et al., 2009) produced by reactive nitrogen species acid 
also activate TRPA1.  
 
The role of TRPA1 as a direct transducer for noxious cold is controversial. It has 
been suggested that TRPA1 functions as a detector of noxious cold based on the 
observation that cells heterologously expressing TRPA1 could be activated by 
temperature below 17 °C (Story et al., 2003; Bandell et al., 2004). Conversely, other 
studies have shown that TRPA1 is not implicated in cold sensitivity (Jordt et al., 
2004; Bautista et al., 2006). A recent study has revealed that most cold sensitive 
DRGs from rat are responsive to AITC, whereas only a small proportion of mouse 
thermosensors respond to AITC (Teichert et al., 2014). Similarly, it is controversial 
if TRPA1 is required for mechanosensitivity (Bautista et al., 2006; Kwan et al., 2006; 
Brierley et al., 2009; Cattaruzza et al., 2010).  
 
Another mechanism of TRPA1 activation is modulation by G protein-coupled 
receptors through secondary messenger signaling. For example, bradykinin, a 
proalgesic and proinflammatory mediator, indirectly activates TRPA1 through the 
Gq and phospholipase C (PLC) coupled bradykinin receptor 2 (B2) (Bandell et al., 
2004; Bautista et al., 2006; Wang et al., 2008). 
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Figure 1.8 Schematic illustration of TRPA1 activation (Garrity, 2011).  
 
TRPA1 expression in the GI tract 
The GI tract is innervated by both intrinsic neurons and extrinsic nerves that 
originate from the NG and DRG. Combination of retrograde tracing and in situ 
hybridization has revealed TRPA1 expression in a high proportion of NG and DRG 
neurons specifically innervating mouse intestine (Brierley et al., 2009).  In addition 
to extrinsic neurons, TRPA1 mRNA has been detected in whole-thickness intestinal 
specimens (Penuelas et al., 2007), muscularis externa and mucosa (Poole et al., 2011) 
in the mouse. Furthermore, a study has demonstrated that TRPA1 is highly expressed 
in human and rat EC cells (Nozawa et al., 2009). 
 
Immunoreactivity for TRPA1 has been identified in a subset of mouse colonic DRG 
neurons containing sensory neuropeptide SP and CGRP (Cattaruzza et al., 2010). It 
is also found in peripheral nerve endings in different layers of mouse colon 
frequently colocalized with CGRP (Brierley et al., 2009). Another study has shown 
that TRPA1 immunoreactivity is prominently localized to myenteric and submucosal 
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ganglia and also present throughout the surface epithelial cells in the mucosa of 
mouse intestine (Poole et al., 2011). These inconsistent reports about TRPA1 
distribution patterns within the gut wall may be attributed to the lack of specific 
antibodies. 
 
TRPA1 in visceral pain and inflammation 
TRPA1 is expressed in sensory neurons that serve as polymodal nociceptors because 
they can be activated by pungent irritants, noxious cold and endogenous proalgesic 
mediators. Activation of TRPA1 elicits acute nociceptive behavior in mice, followed 
by neurogenic inflammation and marked hypersensitivity to thermal and mechanical 
stimuli, which is absent in TRPA1 knockout animals (Bandell et al., 2004; Bautista 
et al., 2006). In line with these behavior studies, introcolonic administration of 
TRPA1 agonists, mustard oil and 4-HNE, augments visceromotor responses to 
colorectal distention in the mouse (Cattaruzza et al., 2010). Similarly, TRPA1 
agonists ATIC and cinnamaldehyde as well as the inflammatory mediator bradykinin 
induce mechanical hypersensitivity to probing, which is absent in TRPA1 knockout 
mice (Brierley et al., 2009).  
 
In animal models of colitis, TNBS induces a TRPA1-dependent hypersensitivity to 
colorectal distention accompanied with an up-regulation of TRPA1 in DRG neurons 
innervating the colon; this hypersensitivity is suppressed either by knockout of 
TRPA1 (Cattaruzza et al., 2010) or reducing TRPA1 expression using antisense 
oligoxynucleotide (Yang et al., 2008). Another study on mosue has demonstrated 
that TNBS directly activates TRPA1 on colonic DRG neurons by modification of 
cysteine and lysine residues in the N-terminal, which induces massive release of 
CGRP and SP to promote neurogenic inflammation; these effects can be prevented 
by either knockout of TRPA1 or pretreatment with TRPA1 antagonist (Engel et al., 
2011). 
 
These observations suggest that TRPA1 plays a critical role in the sensation and 
modulation of abdominal pain and inflammation, and thus it is a very promising 
therapeutic target for many gastrointestinal diseases characterized by abdominal pain. 
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1.7 Ageing and the GI tract 
The world population is ageing at a very rapid rate, which boosts emerging concerns 
in age-related disorders. Comparing with cardiovascular, musculoskeletal and 
nervous system, the GI tract is generally less affected by ageing. However, a variety 
of gastrointestinal disorders have a major impact on the quality of life in the elderly, 
such as dysphagia, dyspepsia, anorexia, constipation and fecal incontinence 
(Johanson et al., 1989; Wald, 1990; Lindgren and Janzon, 1991; Morley, 1997; Firth 
and Prather, 2002). Most commonly, the incidence of motility or transit problems is 
increasing with age, including delays in gastric emptying and intestinal transit 
associated with fecal stasis (Jost, 1997; O'Mahony et al., 2002; Hays and Roberts, 
2006; Norton, 2006). The immune system within the GI tract is impaired with ageing, 
resulting in increased susceptibility to infections in the elderly (Ogra, 2010). These 
conditions, individually or collectively, contribute to malnutrition and thus increased 
frailty and vulnerability of elderly population. 
 
As part of the process of ageing, dramatic changes arise within most organs and 
tissues, and the GI-tract has no exception. These changes can help the understanding 
of the causes underlying the increased incidence of GI conditions with advanced age. 
Although motility problems are prevalent in the GI tract of the elder people, it is 
unknown whether this is due to impaired function of smooth muscles themselves or 
the neurons that regulate their activities. It has been demonstrated that smooth 
muscle contractility in response to electrical stimuli is not impaired in aged rat 
(Hoyle and Saffrey, 2012). However, some changes in the cellular level have been 
described. Isolated colonic smooth muscle cells from aged rat display a decrease in 
calcium channel currents and intracellular Ca2+ levels (Xiong et al., 1993). 
Abnormalities of mitochondrial structure and apoptosis of smooth muscle cells have 
been identified in the colon of aged animals. In addition, a reduction in the number 
and network of interstitial cells of Cajal has been reported in aged human stomach 
and colon (Gomez-Pinilla et al., 2011). 
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Table 1.1 Summary of age-related changes in gastrointestinal innervation 
 Species Findings Reference 
Intrinsic neural pathways 
Myenteric 
plexus 
Rat Reduced neurons (Santer and Baker, 1988; 
Phillips et al., 2003) 
Guinea 
pig 
Reduced neurons (Gabella, 1989; Peck et 
al., 2009) 
Mice Reduced neurons (El-Salhy et al., 1999) 
Human Reduced neurons (de Souza et al., 1993; 
Gomes et al., 1997; 
Bernard et al., 2009) 
Human Increased morphological abnormalities  (Hanani et al., 2004) 
Submucosal 
plexus 
Rat Reduced neurons (Phillips et al., 2007) 
Mouse Reduced neurons (El-Salhy et al., 1999) 
Human Reduced number of ganglion (Bernard et al., 2009) 
Extrinsic neural pathways 
Motor 
innervation 
Rat Deterioration such as swollen axons, 
decreased tyrosine hydroxylase  
(Phillips et al., 2007) 
Sensory 
innervation 
Human  Reduced primary sensory neurons (Nagashima and Oota, 
1974) 
Rat No change in the number of sensory 
neurons 
(Soltanpour et al., 1996; 
Bergman and Ulfhake, 
1998) 
Rat Dystrophic and regressive alterations in 
vagal afferents 
(Phillips et al., 2010) 
 
The myenteric plexus, the outer of the two ENS plexuses, is primarily involved in the 
control of smooth muscle motility. The reduction in myenteric neurons in aged small 
and large intestine was first described in rat (Santer and Baker, 1988), and verified in 
other species including guinea pig (Gabella, 1989; Peck et al., 2009), mice (El-Salhy 
et al., 1999) and human (de Souza et al., 1993; Gomes et al., 1997; Bernard et al., 
2009), suggesting this is a general phenomenon in aged intestine. Another study on 
human has revealed that myenteric ganglia abnormalities (cavities in ganglia) are 
augmented with advanced age (Hanani et al., 2004). The submucosal plexus, located 
in the submucosa between the muscle layers and mucosa, regulates secretion and 
absorption as well as motility. Similar to myenteric plexus, neuron loss in 
submucosal plexus with advanced age has been found in rat (Phillips et al., 2007) 
and mouse (El-Salhy et al., 1999). A study on human colon did not find any 
significant change in the density of neurons or neurons per ganglion in aged 
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submucosal plexus, although the number of ganglion per unit declined with age 
(Bernard et al., 2009). 
 
Multiple studies on rat have revealed that the neuronal loss starts in adulthood and 
progresses in a linear manner over the lifespan, with similar patterns in myenteric 
and submucosal plexuses (Phillips and Powley, 2001; Phillips et al., 2003; 
Thrasivoulou et al., 2006; Phillips et al., 2007; Phillips and Powley, 2007). 
Conversely, study on mouse has shown a significant decrease in the number of 
neurons per ganglion in 12-month-old mice, whereas no additional reduction was 
found in the 24-month group (El-Salhy et al., 1999). 
 
It has been thoroughly studied that different functional classes of enteric neurons can 
be classified based on their chemical coding (Furness, 2000). Neurons in the 
myenteric plexus are composed of two subpopulations: nitrergic neurons and 
cholinergic neurons (Mann et al., 1999; Nakajima et al., 2000; Phillips et al., 2003). 
Multiple studies have demonstrated that there is no loss of nitrergic neurons in aged 
rat myenteric plexus (Belai et al., 1995; Cowen et al., 2000; Phillips et al., 2003). On 
the contrary, cholinergic neurons are significantly reduced with advanced age in rat 
ileum (Cowen et al., 2000). In agreement with animal studies, a study on human 
colon confirmed the reduction of cholinergic neurons in aged myenteric plexus, 
accompanied with unchanged nitrergic neurons (Bernard et al., 2009). Selective age-
related loss of cholinergic neurons associated with sparing of nitrergic neurons might 
result in an accumulative augment of the proportion of inhibitory neurons, which 
might contribute to the motility dysfunction in the elderly. The reason why 
cholinergic neurons are more vulnerable in ageing process is not clear; however, 
Thrasivoulou (2006) proposed that this might be due to calcium dyshomeostasis in 
association with increased intra-neuronal level of reactive oxygen species (ROS). In 
addition, caloric restriction diet that reduces the accumulation of ROS has been 
demonstrated to rescue enteric neuron loss in aged rat (Cowen et al., 2000). 
 
In addition to intrinsic neurons, sympathetic innervations of the myenteric plexus and 
submucosa plexus in the rat deteriorate with advanced age, as indicated by the 
presence of observable swollen axons and decreased expression of tyrosine 
hydroxylase; similar swollen varicosities are observed in the sensory terminals of 
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vagal innervation, whereas spinal afferents are not dramatically affected by 
senescence (Phillips and Powley, 2007). Some studies have described decreases in 
the size or number of primary neurons in the mammalian nodose ganglia and DRGs 
(Vega et al., 1993), while other studies haven’t observed a significant change in the 
rat (Soltanpour et al., 1996; Bergman and Ulfhake, 1998). Although this neuronal 
loss with age is controversial, a number of evidences have revealed metabolic 
changes of these primary neuron cell bodies, such as reduced basophilic Nissl 
material, accumulated lipofuscin, translucent vacuoles, inclusions, granules, 
filamentous bodies, masses and tangles (Brizzee and Ordy, 1979; Koistinaho, 1986; 
Vega et al., 1993; Soltanpour et al., 1996). A study demonstrated that vagal afferent 
terminals innervating the rat GI tract displayed dystrophic and regressive alterations 
with ageing (Phillips et al., 2010). 
 
In addition to the changes in the GI innervation, some other alterations might also 
contribute to the GI conditions in the elderly. It has been proposed that ageing is a 
chronic inflammatory process with a shift toward a proinflammatory cytokine profile 
evidenced by increased circulating levels of IL-1, IL-6, TNF-α and IL-12, IFN- α/β, 
which promote a low-grade chronic systemic pro-inflammatory state in the elderly 
(Fagiolo et al., 1993; Franceschi et al., 1995; Bruunsgaard and Pedersen, 2003; 
Csiszar et al., 2003; Giunta, 2008). It is generally considered that ageing is 
associated with immunosenescence with deficient innate and adaptive immune 
response (Solana et al., 2006; Gomez et al., 2008). However, due to the complication 
of ageing process, the basic mechanisms underlying ageing remain poorly 
understood. 
 
The accurate relationship between the ages of the model animals compared with the 
ages of humans is still subject to controversy. There is no simple equation to convert 
animal age to human. At a rough estimate, 24 months in mice may be equivalent to 
70-75 years in humans (Horgan et al., 2007), and 24 months in rat is comparable 
with 60 years in humans (Andreollo et al., 2012). 
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1.8 General aims and objectives 
This thesis focused on the interactions between mast cells, EC cells and sensory 
innervation of the GI tract as well as the effect of ageing on these interactions. The 
objectives comprise:  
1) to examine age-related changes in the density of mast cells, EC cells and 
sensory nerves as well as anatomical association between mast cells and 
afferent nerves in human bowel; 
2) to characterize the mechanical and chemical sensitivity of human intestinal 
afferents using a recently established in vitro recording model; 
3) to investigate the involvement of mast cells and EC cells in TRPA1 signaling 
induced by TRPA1 agonists in mouse jejunum; 
4) to examine the influence of ageing on TRPA1 signaling and underlying 
mechanisms in mouse jejunum. 
 
 
Hypotheses:  
1) density of mast cell, EC cells and sensory nerves as well as anatomical 
association between mast cells and afferent nerves is altered in aged human 
bowel;  
2) a predominant subpopulation of human intestinal afferents is nociceptors 
responding to both noxious mechanical and chemical stimulation; 
3) mediators released from EC cells and mast cells amplify peripheral TRPA1 
signaling in mouse jejunum; 
4) peripheral TRPA1 signaling is attenuated in aged mouse jejunum. 
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2.1 Animals 
The majority of animal experiments were carried out in tissue or cells freshly 
obtained from 3-4 months (adult) or 24 months old (aged) male mice with a 
C57/BL6 background purchased from Charles River (Margate, UK). Studies on 
TRPV1 knockout mice (generated in GlaxoSmithKline, Harlow, UK) were compared 
to their wildtype littermates under the same maintenance conditions. All mice had 
free access to food and water before they were humanly killed by cervical dislocation 
in accordance with Schedule 1 procedures of UK Animals (Scientific Procedures) 
Act 1986.  
 
Once the mice were sacrificed, a midline incision of the abdomen was carried out to 
allow access to intestine specimens. The entire small intestines from duodenum to 
caecum were harvested in ice-cold Krebs solution (composition, in mM: NaCl 120, 
KCl 5.9, MgSO4 1.2, NaH2PO4 1.2, NaHCO3 15.4, glucose 11.5 and CaCl2 1.2). 
Following further dissections, jejunum segments were collected 5 cm distal to the 
stomach and 10 cm proximal to the caecum. 
 
 
2.2 Human bowel specimens 
All experimental procedures comply with ethical approval obtained from South 
Humber Research Ethics Committee. Human bowel specimens were non-diseased 
surplus tissue obtained from consented patients undergoing bowel resection for 
surgical treatment in Northern General Hospital, Sheffield. A pathologist consultant 
was present at the theatre to assure that the specimens that we were given were not 
proximal to the tumors and free of morphological abnormalities or inflammation. 
The specimens were transported from the theatre to the research lab in pre-
oxygenated ice-cold Krebs within less than an hour. Histological staining (H&E or 
toluidine blue) was performed to make sure that the morphology was normal. 
 
Information of patients was confidential and anonymous. Only age, gender and 
diagnosis of the patents were known (listed in table 2.1). Detail medical history or 
other possible gastrointestinal symptoms of the patients were unavailable. 59 
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specimens in total were obtained from 35 male and 24 female patients aged between 
24 and 88 with a median at 67. 
 
As the specimens obtained were morphologically normal, no criteria were made to 
exclude any specimen. Exceptionally, 5 specimens were excluded for afferent 
recording due to limited mesentery, as required by dissection of nerve bundles from 
mesentery. Roughly, specimens obtained in the first two years were used for 
immunohistochemistry and histological staining, and specimens in the second and 
third year were used for afferent recording. 
 
Table 2.1 List of human bowel specimens 
Date Age Gender Region Diagnose 
21.10.10 76 M Sigmoid colon Adenocarcinoma 
24.11.10 65 M Ascending colon Adenocarcinoma 
15.12.10 43 F Sigmoid colon Adenocarcinoma 
26.01.11 72 F Sigmoid colon Adenocarcinoma 
24.02.11 77 M Sigmoid colon Adenocarcinoma 
02.03.11 68 F Sigmoid colon Diverticular disease 
15.03.11 59 F Sigmoid colon Adenocarcinoma 
23.03.11 84 F Ascending colon Adenocarcinoma 
11.05.11 72 M Rectum Adenocarcinoma 
18.05.11 31 M Ascending colon Pseudomembranous colitis 
06.06.11 68 M Sigmoid colon Adenocarcinoma 
14.06.11 46 M Ileum Crohn’s disease 
21.06.11 87 F Ileum Endocrine carcinoma 
23.06.11 82 M Ileum Adenocarcinoma 
30.08.11 67 M Ascending colon Appendicitis perforated 
20.09.11 72 F Sigmoid colon Adenocarcinoma 
27.09.11 67 M Rectum Adenocarcinoma 
04.10.11 70 M Sigmoid colon Adenocarcinoma 
11.10.11 24 F Ileum Crohn’s and endometriosis 
15.11.11 70 M Sigmoid colon Adenocarcinoma 
29.11.11 77 M Ascending colon Tubullovillous adenoma 
06.12.11 49 M Sigmoid colon Diverticular disease 
20.12.11 55 F Ascending colon Adenocarcinoma 
10.01.12 80 M Descending colon Carcinoma  
17.01.12 50 F Ileum Crohn’s disease 
24.01.12 72 F Ascending colon Adenocarcinoma 
31.01.12 38 M Sigmoid colon Proctitis cystica profunda 
28.02.12 58 F Ileum Endocrine carcinoma 
06.03.12 62 F Ileum Adenocarcinoma and lymphocytic 
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lymphoma 
11.05.12 80 M Transverse colon Adenocarcinoma 
18.05.12 54 M Sigmoid colon Diverticular disease 
22.05.12 54 M  Sigmoid colon Adenocarcinoma 
29.05.12 48 F Sigmoid colon 
Diversion colitis, previous ulcerative 
colitis 
18.06.12 56 M Sigmoid colon Adenocarcinoma 
04.07.12 66 F Ileum Tubulovillous adenoma 
18.09.12 32 F Rectum Adenocarcinoma 
19.09.12 64 M Ileum Tubulovillous adenoma 
25.09.12 57 F Ileum Crohn's disease 
12.10.12 78 F Sigmoid colon Adenocarcinoma 
16.10.12 53 M Ileum Adenocarcinoma 
17.10.12 88 F Transverse colon Adenocarcinoma 
30.10.12 74 M Sigmoid colon Adenocarcinoma 
31.10.12 78 M Ileum Adenocarcinoma 
07.11.12 64 M Ileum Adenocarcinoma 
13.11.12 63 M Sigmoid colon Adenocarcinoma                 
19.02.13 67 M Descending colon Adenocarcinoma 
16.04.13 56 F Ileum Crohn’s disease 
23.04.13 66 M  Descending colon Adenocarcinoma 
24.04.13 62 M Descending colon Adenocarcinoma 
08.05.13 42 M Sigmoid colon Adenocarcinoma 
15.05.13 70 M Descending colon Adenocarcinoma 
04.06.13 51 F Sigmoid colon Adenocarcinoma 
05.06.13 72 M Ileum Tubulovillous adenoma 
10.06.13 68 F Ascending colon Adenocarcinoma                                                                
11.06.13 73 M Sigmoid colon  Adenocarcinoma 
25.06.13 72 M  Descending colon Adenocarcinoma 
26.06.13 71 F Ileum Adenocarcinoma 
02.07.13 49 M Descending colon Adenocarcinoma 
10.07.13 67 F Sigmoid colon Adenocarcinoma 
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2.3 Histological staining and immunohistochemistry  
All human (or mouse) specimens were only labeled with the date of harvest, so that 
the information that might lead to bias (such as age) was concealed. The codes were 
consistently labeled on corresponding tissue tubes, frozen blocks, slides and images. 
When acquiring images for immunohistochemistry, random fields were selected 
under DAPI filter so that the immunoreactivities were blinded. 
 
2.3.1 Fixation 
Different fixatives were used in different experiments.  Unless otherwise stated, the 
fixation time was either overnight at 4 °C or 2~3 hours at room temperature. After 
fixation, specimens were rinsed using phosphate buffer (0.01M PBS, made from 
tablet, Sigma P4417) for 3 times. 
 
Paraformaldehyde (PFA) 
To make 4% PFA, 4g PFA was added into 100 ml phosphate buffer. The solution 
was heated while stirring to 60 °C under the hood until transparent. If solution did 
not get clear, NaOH was added drop by drop. The pH of solution was 7.2-7.4. 
 
Carnoy’s fixative 
Carnoy’s fixative was composed of 60% ethanol, 30% chloroform and 10% glacial 
acetic acid. 
 
Zamboni’s Fixative 
125 ml PFA (from 16% stock solution) and 150 ml picric acid (saturated aqueous, 
Sigma, 239801) were combined and made up to 1 liter with 0.1 M phosphate buffer. 
The pH was adjusted to 7.3 using 10 M NaOH.  
 
2.3.2 Embedding and sectioning  
Prior to process of embedding, specimens were trimmed accordingly to fit the 
embedding mold used in different experiments.  
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JB4 resin embedding 
Fixed specimens were dehydrated in graded ethanol (70%, 90%, 100%, and dried 
100%), one hour for each concentration. Following removal of all ethanol, tissue was 
infiltrated in freshly made catalyzed JB4 solution A (JB4 solution A 100 ml 
combined with 0.9 gram Benzoyl Peroxide, Polysciences 00226-1) at least overnight. 
Infiltrated tissue was then embedded in molds filled with fresh catalyzed JB4 
solution A plus accelerator solution B (JB4 solution A 50ml, Benzoyl peroxide 0.45g 
and solution B 0.8ml) and mounted on an aluminum stub. The mold was kept in 
fridge overnight at the minimum. Once resin solution set, the resin blocks were taken 
out of the molds, rinsed with 70% alcohol to remove excess unpolymerised resin and 
left dry in a fume hood for a couple of hours. 
 
Microtome sectioning 
Resin blocks were sectioned at 2 µm using a LKB 2218 Historange microtome 
(LKB-Produkter, Bromma, Sweden) equipped with a glass knife. Sections were 
placed onto distilled water to expand, collected using a microscope slide and dried on 
a hotplate.   
 
Cryo-embedding 
Fixed tissue was incubated in 30% sucrose (Sigma-Aldrich, S5016) overnight at 4°C 
until tissue sank down to the bottom of container. Thereafter, specimens were placed 
into molds filled with optimal cutting temperature compound (OCT, Bright 
Instrument Company, 53581) and orientated appropriately. The molds were kept on 
dry ice until OCT was fully frozen. OCT block with tissue could be either sectioned 
directly or stored at -80°C. 
 
Cryo-sectioning 
OCT blocks containing specimen were sectioned in a cryostat (Bright Instrument, 
OTF5000, Huntingdon, UK) at 10 µm. The cryostat was set up at -20°C for specimen 
temperature and -15°C for the chamber. Sections were collected discontinuously to 
avoid repetition using pre-coated glass slides (Thermo Scientific MNJ-700) and 
stored at -20°C.  
 
                                                                                                          
                                                                                                                   Chapter 2 
 40 
2.3.3 Histological staining 
H&E staining 
Slides with sections were stained with GILLS II Haematoxylin (Surgipath, 01521E) 
for 5 minutes and rinsed within running water to remove excess dye. Sections were 
then counterstained in 1% Eosin Y /PBS for 1 minutes and washed in running water. 
After dried on a hotplate, sections were mounted with glass coverslips using DPX 
mounting medium. 
 
Toluidine blue staining 
Toluidine blue is one of the most commonly used metachromatic dyes for mast cells 
labeling in both clinic and research, based to its ability to stain acid 
mucopolysaccharide and glycoaminoglycans components within mast cell granules 
in red-purple (metachromatic staining) and the background in blue (orthochromatic 
staining). To make a stock solution, 1 gram toluidine blue O (Sigma, T-3260) was 
added into 100 ml 70% ethanol and mixed well. Stock solution was stable for 6 
months. Fresh working solution was diluted by 10 times from stock using 1% sodium 
chloride. 
 
Slides with sections were incubated within 0.1% toluidine blue for 3 minutes, rinsed 
in distilled water, dried on a hotplate and mounted with coverslips using DPX 
mounting medium. 
 
2.3.4 Immunohistochemistry and immunocytochemistry 
Slides with cryo-sections were placed in a closed humid box. Prior to application of 
primary antibodies, slides were washed with PBS for 5 minutes to remove OCT and 
blocking solution for 20 minutes to block unspecific binding. Treatment with 0.1% 
Triton X-100 (Sigma-aldrich, X100-100ML) was optional, depending on the location 
of epitope. Blocking solution was usually 5% normal serum from the same species in 
which the secondary antibodies were raised. After overnight incubation of primary 
antibodies at 4°C, slides were rinsed in PBS for three times, 5 minutes each. 
Following incubation of fluorophores conjugated secondary antibodies for 2 hours at 
room temperature and rinse with PBS, slides were mounted with coverslips using 
VECTASHIELD Mounting Medium with DAPI (Vector, H1200). Unless otherwise 
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stated, antibodies were diluted in corresponding blocking solution. Negative control 
was performed by omitting the primary antibodies. 
 
In terms of double staining, two primary antibodies raised in different species were 
mixed and diluted accordingly prior to application. Similarly, two secondary 
antibodies were applied as a mixture.  
 
For staining on cell culture, cells were seeded on coverslips pre-coated with 
polylysine (100 µl each) and left in incubator for 30 minutes. Prior to blocking using 
2% normal serum (from the same species as secondary antibodies), cells were fixed 
in 4% PFA for 20 minutes and rinsed with PBS thoroughly. Treatment with 0.1% 
Triton X-100 for 1 minute was optional for intracellular antigens. Cells were 
incubated with primary antibodies and secondary antibodies separately at room 
temperature, each for one hour and followed with PBS rinse. Finally, coverslips were 
mounted on microscope slides using VECTASHIELD Mounting Medium with DAPI.      
 
Table 2.2 Summary of primary antibodies used in this thesis 
Antigen Company Catalogue Source Species 
Target 
species Dilution 
CGRP PENINSULA LABORATORIES  T4239 Rabbit Human 1:1000 
CGRP Abcam ab47027 Rabbit Human, rat, Predict: mouse - 
Tryptase Santa Cruz sc-271095 Mouse Human, mouse & rat 
1:1000 IHC 
1:100 ICC 
Serotonin AbD serotec AHP522 Rabbit Human 1:50 
Substance P Abcam ab24126 Rabbit Human, Rat 1:50 
TRPA1 Abcam ab58844 Rabbit Mouse, Rat,  - 
TRPA1 Abcam ab62053 Rabbit Human, mouse - 
TRPA1 Abcam ab68847 Rabbit Mouse - 
TRPA1 Thermo PA1-46159 Rabbit Human, mouse - 
Tryptase Santa Cruz sc-32474 Goat Mouse 1:200 
Tryptase Santa Cruz sc-32889 Rabbit Mouse 1:200 
- indicates that antibody did not work convincingly. 
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Table 2.3 Summary of secondary antibodies used in this thesis 
Species 
 
Company 
 Catalogue Fluorophore 
Dilution 
 
Goat anti-rabbit Vector FI-1000 FITC 1:200-1:400 
Goat-anti-mouse Jackson ImmunoResearch 
115-166-003 
 Cy3 1:200-1:400 
Goat anti-rabbit Jackson ImmunoResearch 111-165-144 Cy3 1:200-1:400 
Fab Fragment 
Goat anti- Rabbit 
Jackson 
ImmunoResearch 111-297-003 
Rhodamine Red-
X 1:200-1:400 
 
 
2.3.5 Microscopy and image analysis 
Stained sections were observed under an Olympus BX51 microscope (Tokyo, Japan). 
Images were acquired using an Olympus ColorView II digital camera.  
 
Image analysis with ImageJ 
Image analysis was performed with ImageJ software (1.43u, National Institutes of 
Health, USA) if applicable. Prior to any measurement, pixel size was calibrated 
using a 1mm stage micrometer with 100 divisions. 
 
Area measurement  
The region of interest was selected using the Freehand Selection tool in the Startup 
toolbar. The area of selected region was measured using the Measure function in the 
Analyze menu. 
 
Distance measurement  
A straight line was drawn across the distance of interest using the Line tool in the 
Startup toolbar. The length of the line was measured using the Measure function in 
the Analyze menu. 
 
Particle analysis  
An intensity threshold was set up using the Adjust command in the Image menu to 
discriminate the immunoreactivities from the background. The range of particle size 
was set up in the Analyze Particles menu to exclude unspecific staining, and then the 
number of targeted particles and the area occupied by those particles was measured. 
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2.4 Extracellular recording of afferent activity  
2.4.1 Dissection, nerve preparation and afferent recording 
Mouse jejunum 
After removed from mice, intestine specimens were placed and maintained in ice-
cold Krebs solution bubbled with carbogen (95% O2 and 5% CO2). Following further 
dissection, a 2-3 cm jejunum segment with mesenteric neurovascular bundle in the 
middle was placed into recording chamber, which was constantly perfused with 
oxygenized Krebs solution and maintained at a stable temperature of 34°C. Two ends 
of the segment were cannulated and tied firmly. One end was connected to a 
perfusion pump (PERFUSOR®secura, Braun, Netherlands), allowing continual 
perfusion of Krebs through the lumen of jejunum at a rate of 10 ml per hour; the 
other side was attached to a pressure transducer (DTXPlusTM, BD, Singapore) 
through a three-way connecter catheter. By controlling this three-way tap, segments 
were allowed to be distended with intraluminal pressure monitored (usually up to 60 
mmHg). The neurovascular bundle was pinned onto a dissection platform made by 
sylgard (SYLGARD® 184 Silicone elastomer kit).  
 
Under a dissection microscope (Nikon, SMZ-1B, Japan), afferent nerves in the 
neurovascular bundle were identified and pulled out gently using fine forceps. After 
cleaning up fat and connective tissue around, a nerve bundle was sucked into a 
suction electrode attached to a Neorolog headstage (NL 100, Digitimer, Ltd, UK) 
and an AC amplifier (NL 104). Electronic signals were amplified by 10,000 times, 
filtered properly (NL 125, band pass filter) and recorded on a computer via a power 
1401 analogue-to-digital interface and Spike 2 software (Version 7.10, Cambridge 
Electronic Design, UK). Multi-unit afferent nerve activities were quantified by a 
spike processor (Digitimer D130) that counted the number of spikes over a pre-set 
threshold. The threshold was usually set at the peak of smallest identifiable action 
potentials.  
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Figure 2.1 A schematic in vitro model to monitor the afferent nerve activity and 
intraluminal pressure of mouse jejunum. A jejunum segment was connected to an 
infusion pump allowing perfusion of Krebs into the lumen and a pressure transducer, which 
monitored intraluminal pressure after closing the three-way tap between the segment and the 
transducer. Mesenteric nerve bundle was identified, dissected and sucked in a glass 
electrode. Action potentials from the afferents were amplified, filtered and recorded through 
corresponding equipment and software.  
 
Human bowel 
In comparison with mouse intestine, human bowel was much larger in size with 
thicker mesentery attachment. As such, recording chamber for human bowel (volume 
at about 100 ml) was markedly larger than that for mouse (10 ml). Specimens were 
cut open along the middle of mesentery and pinned flat on the bottom of the organ 
bath with mucosa uppermost (as shown in figure 2.2). The mesentery was also 
divided into two parts, so that nerve bundles could be identified from both sides of 
the preparation. As the nerve bundles were deeply embedded among dense adipose 
tissue and connective tissue, identification of them significantly consumed more time 
and efforts than mouse. In addition, more dissection was required to expose clean 
nerve fibers. Nerve activities were then recorded from the dissected fibers as 
described above. 
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Figure 2.2 Schematic representation of afferent recording setup of human bowel 
specimens. (A) Tubular human bowel tissue was cut open along the dash line. (B) Flat-sheet 
specimen was pinned onto the bottom of organ bath with mucosa side up. (C) Nerve bundle 
was identified from either side of mesentery, dissected clean and sucked into a glass 
electrode. Action potentials from the afferents were amplified, filtered and recorded through 
corresponding equipment and software.  
 
2.4.2 Experimental protocols 
Prior to application of any protocol, the preparation was left stabilized in the 
recording chamber for 30~60 minutes until the afferent activities were stable.  
 
Control distension 
Distension of the intestine preparations refers to an intraluminal infusion of Krebs at 
a rate of 10 ml/h. The outflow tap between preparation and pressure transducer was 
closed to allow the segment to be filled until the intraluminal pressure reached 60 
mmHg. Unless otherwise stated, the preparation was distended every 15-20 minutes. 
Chemical agents were not applied until three reproducible responses to distension 
achieved.   
 
Extraluminal application of agonist 
In most experiments, agonists or other chemical stimuli diluted in Krebs were 
constantly perfused into organ bath by a peristaltic pump (Gilson MINIPLUS 3, 
USA). In other cases, the drug was directed injected into the organ bath using a 
A C B 
 
Mesentery 
 Gut wall 
Lumen 
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pipette with the perfusion of Krebs closed. The volume of agonist solution and time 
interval between repeated applications varied in different groups of experiments. 
 
Intraluminal application of agonist 
Agonist or other chemical stimuli diluted in Krebs were continually applied into the 
lumen of preparations using a syringe driver (Genie Kent, mutil-phaserTM NE-1000, 
USA). The timespan of perfusion might vary in different sets of experiments. 
 
Extraluminal application of antagonist 
Antagonists diluted in Krebs were perfused into organ bath 10-15 minutes before the 
application of agonists, which were diluted in antagonist-Krebs solution to make sure 
the concentration of antagonist unaltered. After the response to agonist finished, 
antagonist solution was replaced by fresh Krebs. 
 
2.4.3 Analysis of data 
Data are presented as either frequency of afferent discharge (number of action 
potentials per second) or total number of spikes in certain period. All data are 
expressed as mean ± SEM from the N values, where N refers to the number of 
animals or human specimens. 
 
The response of afferent nerves to a pharmacological agent was analyzed in two 
ways, peak response and response profile against time. Peak response was quantified 
as maximum frequency in a 30-second bin subtracted by baseline activity using a 
script. Response profile showing the change of mean frequency over time was 
obtained from XY View measurements of Spike 2. 
 
The response to ramp distension was plotted as mean afferent discharge per second 
against increasing intraluminal pressure from 0 to 60 mmHg using a script. 
 
Statistical analysis 
All graphical and statistical analysis was performed using GraphPad Prism (Version 
6.0, San Diego, USA). Student paired & unpaired t-test, 1-way and 2-way ANOVA 
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were used as appropriate. P<0.05 was considered as significant between compared 
groups. * in a figure refers to P<0.05; **, P<0.01 and ***, P<0.001.?
 
Single unit analysis 
Single unit analysis was performed offline using the spike sorting function of Spike 2 
(version 7.10) to discriminate afferent nerve activities of individual units. Afferent 
activity was sampled at 20,000 Hz. A 2.5 millisecond period was used to construct a 
template that was composed of 50 data points, so that the whole profile of a spike 
was analyzed. Following generation of the first template, each new spike was 
compared against this template. Spikes that did not match the first template would 
create new templates. As such, spikes were classified into different single units 
according to their waveform. An example of this process is seen in figure 2.3, in 
which 4 different units were discriminated. 
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Figure 2.3 Diagrammatic representation of single unit analysis. (A) An example 
wavemark window of Spike 2 showing template generation and spike matching. (B) Output 
information about templates with setup parameters. (C) Example traces showing afferent 
response to distension. The wavemark trace reveals the activities of individual single units 
during the distension using the templates generated from figure A. 
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Principal component analysis was used to ensure that the single units identified by 
the wavemask analysis were different enough to be classified as distinct nerve fibers. 
It worked by disassociating the shapes of individual single units based on 
measurements on each spike shape, such as amplitude, latency, area and slope. These 
data were normalized, shifted and scaled in a 3-dimensional manner (figure 2.4A is a 
two-dimensional representation of this clustering). The amount of overlap between 
the clusters indicated the similarities of two units. For example, as shown in figure 
2.4 A, unit 01 (blue) and unit 04 (red) were well discriminated from others, 
convincingly suggesting that they were two distinct units. Whereas, some overlaps 
existed between unit 02 (green) and unit 03 (cyan), indicating that they shared some 
similar properties and might be generated by the same afferent fiber. However, in the 
raw trace of spikes (figure 2.4B), they appeared to be slightly different. In this 
equivocal case, their functional characteristics would be considered. If they showed 
similar patterns in response to the same mechanical or chemical stimulations, they 
were likely to be the same unit.  
 
This example exposed the limitations of single unit analysis. Since this recording 
technique detected and recorded the field potentials from the electrode, the profile of 
spikes would be largely influenced by the noise, which was the major source of 
variations in spike profile. If two distinct units generated action potentials with some 
tiny similarities, the addition of variations made it difficult to discriminate them. It 
was even worse if there were a large number of units in one nerve bundle, which 
usually showed a higher chance of similar and equivocal units. In addition, large 
number of units accompanied with high firing frequency resulted in frequent 
summations of spike profiles, which could not be discriminated. 
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Figure 2.4 Example of principle component analysis. (A) Representative graph showing 
the clusters of individual units sorted in figure 2.3. Each colour represents a template. 
Unit 01 (blue) and unit 04 (red) are well discriminated from the other units. Some overlaps 
exist between unit 02 (green) and unit 03 (cyan). (B) Wavemark and raw spike traces 
comparing unit (02) and unit (03). 
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2.5 Investigation of gene expression 
2.5.1 RNA extraction 
Mouse or human specimens used for gene expression studies were immediately 
placed in at least 10 volumes of RNAlater Stabilization Reagent (QIAGEN, 76106) 
after harvested and stored at -20°C. RNA purification was performed using RNeasy 
Mini Kit (QIAGEN 74104) according to manufacturer’s instructions. Up to 20 mg 
stabilized tissue was disrupted and homogenized in 1.5 mL Pestle and Microtube 
(VWR Labshop, 47747-366) using a Pestle Motor (VWR Labshop, 47747-370). 
Isolated RNA was eluted in RNase-free water and stored at -80°C. 
 
2.5.2 Reverse transcription (RT) 
Reverse transcription was performed using High Capacity cDNA Reverse 
Transcription Kit with RNase Inhibitor (Applied Biosystems, 4374966) according to 
manufacturer’s instructions. 2× Reverse Transcription Master Mix was prepared as 
shown in table 2.4 and distributed into PCR tubes, with 1 volume of total RNA 
added to create a 1× mix. RT reaction was performed in a thermal cycler (TECHNE 
TC-3000X, Stone, UK). A summary of RT programme was shown in table 2.5. 
 
              Table 2.4 Component of RT reaction mix (for 20 µl reaction) 
 
 
 
 
 
 
 
 
  
Component Volume/Reaction (µl) 
10× RT Buffer 2.0 
25× dNTP Mix (100 mM) 0.8 
10× RT Random Primers 2.0 
MultiScribeTM Reverse Transcriptase 1.0 
RNase Inhibitor 1.0 
Nuclease-free H2O 3.2 
Total RNA 10.0 
                                                                                                          
                                                                                                                   Chapter 2 
 52 
Table 2.5 RT reaction thermal cycle 
 Step 1 
 
Step 2 
 
Step 3 
 
Step 4 
 
Temperature (°C) 25 
 
37 
 
85 
 
4 
 Time 
 
10 min 
 
120 min 
 
5 min 
 
 
  
 
2.5.3 Quantitive real-time PCR 
All probes were predesigned and verified by mass spectrometry by Integrated DNA 
Technologies. Probes were diluted using IDTE buffer, containing 10mM TRIS 
(Melford Laboratories Ltd., B2005) and 0.1mM EDTA (Sigma-aldrich, E9984). 
 
Prior to use, the TaqMan Gene Expression Master Mix (Applied Biosystems 
4369016) was thoroughly mixed by swirling the bottle. The components for 20 µl 
reaction mix in Hard-Shell® Thin-Wall 96-Well Skirted PCR Plates (BIO-RAD, 
HSP-9665) were listed in table 2.6. Reactions for each sample were run in duplicate. 
 
Table 2.6 Component of q-PCR reaction mix (for 20 µl reaction) 
 
 
            
 
 
 
           
Prior to run reactions, the plates were covered with MicroAmpTM Optical Adhesive 
Film for 96-Well Plates (Applied Biosystems, 43111971) and centrifuged briefly to 
spin down the contents and eliminate any air bubbles from the solutions. PCR 
reactions were performed in BIO-RAD CFX96 TouchTM Real-time system (C1000 
TouchTM Thermal Cycler, Bio-Rad Laboratories Ltd. Hercules, USA) with the 
thermal cycling programme set up as follows:  
 
  
Component Volume/Reaction (µl) 
TaqMan Gene Expression Master Mix 10  
Probe mix 1   
cDNA 1   
RNAase-free water 8   
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Table 2.7 Summary of q-PCR cycles 
Step Temperature (°C) Duration Cycles 
UDG incubation 50 2 min HOLD 
AmpliTaq Gold®, 
UP Enzyme Activation 95 10 min HOLD 
Denature 95 15 sec 
40 
Anneal/Extend 60 1 min 
 
  
2.5.4 Analysis of data 
Data obtained from the PCR machine were Ct value, which referred to the cycle 
number where the PCR curve reached the threshold in the linear part of the curve. 
Higher Ct value indicates less mRNA detected. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), one of the most commonly used housekeeping gene, was 
used as endogenous reference, and thus expression of tested gene were normalized 
against GAPDH expression. ∆Ct referred to relative gene expression compared with 
GAPDH expression. 
∆Ct= Ct tested gene – Ct housekeeping gene 
To examine the change of gene expression between different samples, fold change 
was introduced and calculated as follows: 
∆Ct sample 1 =Ct tested gene in sample 1 – Ct housekeeping gene in sample 1  
∆Ct sample 2 = Ct tested gene in sample 2 – Ct housekeeping gene in sample 2 
 ∆∆Ct=∆Ct sample 1 -∆Ct sample 2 
Fold change=2
-∆∆Ct 
In ageing study,  
∆∆Ct=∆Ct aged samples -∆Ct control 
Fold change=2
-∆∆Ct 
Fold change indicated change of gene expression in aged samples compared to 
control group. For example, if ∆∆Ct was 1, fold change would be -2, suggesting this 
gene was down regulated by half in aged group; if ∆∆Ct was -1, fold change would 
be 2, indicating this gene expression doubled in aged group. Fold change >2 or <-2 
was considered as significant.   
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2.6 Calcium imaging 
2.6.1 Dissociation of DRG and nodose ganglion 
Culture media used for DRG and nodose neuron preparation was composed of 90% 
DMEM/F12 (Invitrogen, 31330-038), 10% fetal calf serum (Invitrogen, 10500-064) 
and 1% PenStrep (Sigma, P4333). Prior to cell plating, autoclaved coverslips were 
coated with matrigel (1:6 diluted in ice-cold culture media, 50 µl for each coverslip, 
BD Matrigel™ Basement Membrane Matrix, 356234) and left in incubator for 30 
minutes.  
 
Mice were sacrificed by decollation after anesthetization. T7-L2 DRG and nodose 
ganglion were quickly isolated under a dissecting microscope and collected into 
Hank’s Balanced Salt Solution (HBSS, Sigma-aldrich, H1641). The ganglions were 
incubated in HBSS containing 2.0 mg/ml papain (Sigma-aldrich, P4762) and 0.3 
mg/ml L-cysteine (Sigma-aldrich, C7352) at 37°C for 20 minutes. After gently 
removing all papain solution, 4.0 mg/ml collagenase (Sigma-aldrich, C0130) and 
4.7mg/ml dispase (Sigma-aldrich, D4693) were added into the tube. Prior to 
incubation in 37°C water bath for 20 minutes, the tube was flicked gently to agitate 
ganglia. Cells were then washed in culture media and plated on metrigel-coated 
coverslips (50 µl per coverslip). Following 2-hour incubation, cells were flooded 
with culture media (1 ml per well) and put back into incubator.   
 
2.6.2 Calcium imaging  
After overnight incubation, cells were loaded with Fura-2 AM (4µM, Life 
technologies, F1201) for 30 minutes. Coverslips with cells were then sealed on a 
chamber platform (Series 20, Warner Instruments, Hamden, CT, USA) and 
continuously perfused with HEPES buffer (in mM: NaCl 135, KCl 5, HEPES 10, 
glucose 10, MgCl2 1 and CaCl2 2) at room temperature. Excitation lights were 
generated by OptoLED light source (Cairn Research Limited, Kent, UK). 
Fluorescent intensity of Fura2 was monitored and recorded using a digital camera 
(C4742-95 Hamamatsu Corporation, Sewickley, PA, USA), a Hamamatsu camera 
controller and a computer with SimplePCI software (Version 6.6.0.0, Hamamatsu 
Corporation). 
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2.6.3 Protocol and analysis  
Prior to application of drug, 5-minute baseline intensity was recorded. Drug diluted 
in HEPES buffer was perfused into the recording chamber by gravity for 1 minute, 
followed by HEPES washout. At the end of each experiment, 5 µM ionomycin was 
applied as a positive control. 
 
Intracellular calcium concentration was indicated by the ratio of emission 
fluorescence under 340 nm and 380 nm excitation light. Changes of calcium 
concentration in response to a drug were calculated as the net difference between 
baseline 340/380 ratio and the peak ratio during drug application. Data were 
expressed as mean±SE. 
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CHAPTER 3 
 
Changes of EC cells, mast cells and 
afferent nerves in aged human bowel 
                                                                                                                       Chapter 3 
 57 
3.1 Introduction 
Ageing and GI innervation 
Ageing is associated with a variety of GI disorders, such as dysphagia, dyspepsia, 
anorexia, constipation and fecal incontinence (Johanson et al., 1989; Wald, 1990; 
Lindgren and Janzon, 1991; Morley, 1997; Firth and Prather, 2002). Most commonly, 
the incidence of motility or transit problems is increasing with age (Jost, 1997; 
O'Mahony et al., 2002; Hays and Roberts, 2006; Norton, 2006). Although the 
mechanisms underlying those GI disorders in the elderly remain poorly understood, 
the symptoms suggest that the causes might be the loss or functional alteration of the 
neural signaling in the gut that regulates the gastrointestinal functions. 
 
As introduced in chapter 1, a large number of studies on aged small or large intestine 
have described reductions in myenteric neurons (Santer and Baker, 1988; Gabella, 
1989; de Souza et al., 1993; Gomes et al., 1997; El-Salhy et al., 1999; Bernard et al., 
2009; Peck et al., 2009) and submucosal neurons (El-Salhy et al., 1999; Phillips et al., 
2007). In addition to intrinsic neurons, signs of deterioration with advanced age have 
been observed in sympathetic and vagal innervation, whereas spinal afferents are not 
dramatically affected by senescence (Phillips and Powley, 2007). Some studies have 
described decreases in the size or number of primary neurons in the nodose ganglia 
and DRGs (Vega et al., 1993), while other studies did not observe a significant 
change (Soltanpour et al., 1996; Bergman and Ulfhake, 1998). Despite this 
discrepancy, a number of evidences have revealed metabolic changes of these 
primary neuron cell bodies, such as reduced basophilic Nissl material, accumulated 
lipofuscin, translucent vacuoles, inclusions, granules, filamentous bodies, masses and 
tangles (Brizzee and Ordy, 1979; Koistinaho, 1986; Vega et al., 1993; Soltanpour et 
al., 1996). A study demonstrated age-related dystrophic and regressive alterations on 
vagal afferent terminals innervating the GI tract (Phillips et al., 2010). 
 
Neuropeptides transmit neuronal signal to neighboring cells to regulate physiological 
functions; therefore, they have been frequently used as markers for functional 
alterations in ageing studies. Some age-related changes in neuropeptide have been 
reported. Substance P (SP), vasoactive intestinal polypeptide (VIP) and somatostatin 
positive nerve fibers are decreased in the small intestine of senile rat in comparison 
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with young animals (Feher and Penzes, 1987). Concentrations of VIP, neuropeptide 
Y (NPY) and galanin in tissue extracts from mouse duodenum decrease in both 12 
and 24 months old animals compared with 3-month group, whereas SP and 
neurotensin decrease in 12-month-old mice but not in 24-month group; in mouse 
colon, peptide YY (PYY), soatostatin, VIP, galanin and neurotensin decrease in 12-
month-old animals, while SP increase in 24-month group (El-Salhy and Sandström, 
1999).   
 
SP is an important neuropeptide, participating a variety of physiological and 
pathological activities. Most importantly, SP has multiple proinflammatory effects 
on many different cell types including lymphocytes, monocytes, neutrophils, mast 
cells and eosinophils (Shanahan et al., 1985; Repke and Bienert, 1987; Haines et al., 
1993; Ho et al., 1996; O'Connor et al., 2004). In addition, NK1 (SP receptor) mutant 
mice showed significant reduced nociceptive response when the stimuli were 
moderate to intense, suggesting SP is involved in the transmission of pain signal to 
the CNS (De Felipe et al., 1998).  
 
Some studies have revealed age-related alterations in SP. Perivascular SP innervating 
rat aorta declined from 6 months old and disappeared after 12 months old (Connat et 
al., 2001).  Density of SP content in some areas of rat spinal cord significantly 
declined with age (Goettl et al., 1999; Ranson et al., 2005). Density of SP-positive 
nerve fibers was decreased in the circular muscle of aged guinea-pig colon (Peck et 
al., 2009). SP concentration in mouse tissue extracts decreased in aged antrum and 
duodenum, but increased in aged colon (El-Salhy and Sandström, 1999). 
 
Ageing and non-neuronal changes in the GI tract 
Apart from the changes in the GI innervation, some other alterations might 
contribute to the GI disorders in the elderly as well. Two studies have demonstrated a 
severe weakening of the lymphatic pump including diminished contraction amplitude 
and frequency in aged mesenteric lymphatic vessels, implying lowered ability to 
adapt the situations with increased volumetric loads which might occur during 
inflammation and local edema in the gut (Akl et al., 2011; Nagai et al., 2011). Some 
reports proposed that ageing is a chronic inflammatory process with a shift toward a 
proinflammatory cytokine profile in tissue that may account for numerous 
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deleterious vascular changes associated with ageing (Csiszar et al., 2003; 
Bruunsgaard and Pedersen, 2003; Giunta, 2008). Ageing has been thought to involve 
immunosenescence with deficient innate as well as adaptive immune response 
(Solana et al., 2006; Gomez et al., 2008) 
 
Interactions between nerves and other cell types like EC cells and mast cells not only 
regulate normal GI physiology but also contribute to some functional disorders, such 
as the hypersensitivity in IBS, as has been introduced previously. Extensive studies 
have testified to the close association between mast cells and nerves, whereas few 
have focused on sensory nerves specifically. A study on rat dura mater provided 
evidence that mast cells were in close apposition (less than 100 nm) to SP and CGRP 
positive nerve fibers (Dimitriadou et al., 1997). In addition, a large proportion of rat 
intestinal mucosal mast cells directly contact with nerves, some of which contain SP 
or CGRP (Stead et al., 1987; Pang et al., 1996). It has been documented that the 
contact values of SP and CGRP with mast cells increased in the developing lesions 
of psoriatic skin (Naukkarinen et al., 1996). However, limited information can be 
found from the literature about the effect of ageing on the anatomic relationship 
between mast cells and SP. 
 
Although the alterations of gastrointestinal innervation with advancing age have been 
extensively studied, it is poorly understood if the densities of EC cells and mast cells 
in the GI tract are changed in the elderly. 
 
EC cells are increased in rat stomach during ageing (Khomeriki, 1989). A study 
employing chromatographic analysis found an increase in the synthesis and release 
of serotonin in aged mouse distal ileum (Parmar et al., 2012). A study on human 
duodenum found that serotonin positive cells appeared to increase with age 
(Sandstrom and El-Salhy, 1999). Conversely, staining for somatostatin and 
chromogranin, markers for EC cells, did not reveal any change in aged rat colon 
(Sweet et al., 1996). 
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Table 3.1 Summary of age-related changes in the density of EC cells and mast cells 
Species Region Findings Reference 
EC cells 
Rat Stomach Increased EC cells and enhanced 
serotonin production 
(Khomeriki, 1989) 
Rat Colon No change (Sweet et al., 1996) 
Human Duodenum Increased EC cells from infant to adult, 
no further significant increase 
(Sandstrom and El-Salhy, 1999) 
Guinea pig Distal 
colon 
No change (Bertrand et al., 2010) 
Human Rectum No change (Dunlop et al., 2004) 
Mouse Ileum & 
colon 
Increased 5-HT release (Bertrand et al., 2010) 
Mouse Distal 
ileum 
Increased synthesis and release of 5-HT (Parmar et al., 2012) 
Mast cells 
Rat Mesentery Increased mast cells (Banerjee and Dasgupta, 1981; 
Chatterjee and Gashev, 2012) 
Rat Lung Increase (Migally et al., 1983) 
Human  Jejunum No change (Arranz et al., 1992) 
Mouse Tibial 
nerve 
Increase (Ceballos et al., 1999) 
Human Rectum Reduction (Dunlop et al., 2004) 
Human Dermis Increase (Gunin et al., 2011; Petrov et 
al., 2013) 
 
Some studies have demonstrated that the number of mast cell are increased with 
ageing in human dermis and suggested that mast cells could be potentially involved 
in tissue damage and ageing decay in the skin (Gunin et al., 2011; Petrov et al., 2013). 
Another study in rat lung has revealed a greater perivascular mast cell density in 
aged group, comparing with young control after exposure to and recovery from 
chronic hypoxia (Migally et al., 1983). 
 
Studies on mast cells in ageing have been limited to derma and lung in context of 
allergy or asthma. In the GI tract, two reports revealed increased mast cells in the 
mesenteric tissue of aged rat (Banerjee and Dasgupta, 1981; Chatterjee and Gashev, 
2012). A study quantified mast cells from jejunal biopsy and did not found dramatic 
difference between aged (>70) and adult group (20-50) (Arranz et al., 1992). 
Circulating monocyte chemoattractant protein-1, a chemoattractant for monocytes, T 
cells, mast cells and basophils, has been demonstrated positively correlated with 
advanced age in healthy humans (Inadera et al., 1999). In addition, production of 
stem cell factor that regulates mast cell formation is augmented with age (Hart et al., 
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1999). These independent lines of evidence might suggest increases in mast cells in 
the elderly. 
 
As introduced in chapter 1, transient receptor potential (TRP) channels play an 
important role in detecting and responding to a variety of stimulations. It has been 
shown that TRPV1, TRPA1, TRPM8, TRPC6, TRPM2 are involved in nociceptive 
visceral sensitivity (Boesmans et al., 2011). TRPM4 has been demonstrated to be a 
critical regulator of Ca2+ entry in mast cells (Vennekens et al., 2007). TRPC4 and 
TRPC6 are implicated in smooth muscle contractility (Walker et al., 2002; Boesmans 
et al., 2011). Potential alterations of these ion channels with advanced age might 
contribute to age-related dysfunctions; however, limited studies have addressed these 
potential changes. Expression level of TRPC6 was not changed in aged rat aorta 
(Erac et al., 2010). No change was found for TRPV1 expression in aged mice DRG 
(Wang et al., 2006). Changes in gene expression of TRP channels in aged human 
bowel are largely unknown. Similarly, effect of ageing on the expression of TPH1 
and chromogranin A (CgA), markers for EC cells, hasn’t been investigated in human 
bowel. 
 
 
Objectives 
This chapter examined intestinal specimens from patients at different ages using 
morphological and molecular techniques to evaluate possible age-related changes in: 
1) the density of EC cells;  
2) the density of mast cells; 
3) the density of sensory afferents nerves; 
4) the anatomical relationship between mast cells and afferent nerves; 
5) the gene expression of selected TRP channels and EC cell markers 
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3.2 Experimental protocol and analysis 
Quantification of EC cells density in human bowel mucosa 
Human bowel specimens were fixed in 4% PFA, embedded in OCT and sectioned in 
a cryostat as described in section 2.3. EC cells were labeled by a polyclonal rabbit 
anti serotonin antibody (1:50, AbD Serotec, AHP522) and visualized by a goat anti-
rabbit secondary antibody conjugated with Cyanine 3 (Cy3, 1:400, Jakson 
ImmunoResearch, 111-165-144). 
 
10 random images were acquired from one specimen under 20 times objective for 
offline quantification. EC cells density was calculated as number of EC cells divided 
by the area of mucosa. EC cells were counted blindly, and area of mucosa was 
measured using ImageJ software.  
 
Quantification of mast cells density in human bowel 
Previous studies showed a critical influence of the fixative on the number of mast 
cells identified by staining, and Carnoy’s fixative was recommended as the best one 
to evaluate human intestinal mucosal mast cells (Strobel et al., 1981). We did a brief 
test using human bowel specimens to compare Carnoy’s fixative with PFA, and no 
significant difference was found in the densities of toluidine blue stained mast cells. 
As such, for mast cells quantification, all specimens were fixed in 4% PFA, 
embedded in resin, sectioned using a microtome and stained in toluidine blue as 
described in section 2.3. 
 
Three populations of mast cells (mucosa, submucosa and serosa) were blindly 
quantified under 20 times objective of an Olympus BX51 light microscope using an 
eyepiece graticule (area= 0.35mm*0.35mm= 0.1225mm2). As shown in figure 3.1, 
the eyepiece graticule was orientated along the muscularis mucosa or muscle layer at 
the left edge of sections to select the first field and then moved horizontally to select 
the remaining fields. Ten random microscope fields in mucosa and serosa 
respectively as well as 20 random fields in submucosa were counted for each section. 
The average density of a sample was calculated from 5 sections. Data were expressed 
as number of mast cells per square millimeter.    
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Figure 3.1 Schematic representation of the counting method for mast cells in human 
bowel. Prior to counting mast cells in the mucosa, one edge of the eyepiece graticule was 
orientated along the muscularis mucosa. By moving the graticule in parallel, ten random 
microscope fields in the mucosa were selected and counted. Similarly, 10 random fields in 
the serosa and 20 random fields in the submucosa were quantified. Area of graticule= 
0.35mm×0.35mm= 0.1225mm2. 
 
 
Quantification of Substance P (SP) density in human bowel 
Specimens were fixed in 4% PFA, embedded in OCT and sectioned in a cryostat as 
described in section 2.3. SP positive varicosities were labeled by a polyclonal rabbit 
anti SP antibody (1:50, Abcam, ab24126) and visualized by a goat anti-rabbit 
secondary antibody conjugated with fluorescein isothiocyanate (FITC, 1:400, Vector, 
FI-1000). 
 
Images were acquired under a 20 times objective from 5 random fields for each 
specimen. Areas occupied by SP immunoreactivities and total areas of mucosa were 
measured using ImageJ software. SP density was expressed as percentage of SP 
occupied area in total area of mucosa. 
 
Anatomical relationship between mast cells and afferent nerves  
Specimens were fixed in 4% PFA, embedded in OCT and sectioned in a cryostat as 
described in section 2.3. Double immunostaining was performed by applying a 
mixture of monoclonal mouse anti mast cell tryptase antibody (1:1000, Santa Cruz, 
sc-271095) and polyclonal rabbit anti SP antibody (1:50, Abcam, ab24126). Staining 
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was revealed by a mixture of goat anti-mouse (Cy3, 1:400, Jackson ImmunoResearch, 
115-166-003) and goat anti-rabbit secondary antibody (FITC, 1:400, Vector, FI-1000). 
 
Images of double staining were acquired under a 20 times objective from 5 random 
areas for each specimen. The distance between a mast cell and its nearest SP 
varicosity was measured using ImageJ software. Considering the fact that the 
thickness of the cryo-section was 10 µm, if the distance between mast cell and SP 
was more than 10 µm, it was unclear whether there would be a closer SP varicosity 
in adjacent sections. As such, distances over 10 µm were excluded for distribution 
analysis. 
 
Data analysis 
Linear regression was used to evaluate the potential associations between age and EC 
cells, mast cells, SP and mast cell-SP relationship. The value of r2 reflects the 
goodness-of-fit of linear regression. P value indicates the probability that randomly 
selected points would result in a regression line if there were no linear relationship 
between X and Y. P<0.05 was taken as significant. The solid line in a linear 
regression figure is the best-fit line and the dotted lines represent 95% confidence 
intervals. 
 
Gene expression in human bowel mucosa 
Up to 20 mg mucosa tissue dissected from human bowel specimens was immediately 
placed in at least 10 volumes of RNAlater Stabilization Reagent (QIAGEN, 76106) 
after harvested and stored at -20°C. RNA isolation, reverse transcription and 
quantitive real-time PCR were performed as described in section 2.5. Fluorescent 
probes used in RT-PCR were listed in table 3.2. 
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Table 3.2 Summary of probe sequences used in RT-PCR 
All probes were against Homo sapiens genes. 
Genes Accession No.  Sequence  
Expected 
Size (bp) 
TRPA1 NM_007332 Forward 5' GCCACTGAGATTGTTAAACTGATG 3' 129 
  Reverse 5' GTCTGCTAGCTCATGGTGAT 3'  
TRPC4 NM_016179 Forward 5' CGTCGAGTGGATGATATTACCG 3' 117 
  Reverse 5' ACAAAGTCCATTAGATTCCACCA 3'  
TRPC6 NM_004621 Forward 5' AGGACTATCTGCTCATGGACT 3' 113 
  Reverse 5' GTGAGCCAGTCTGTTGTCAG 3'  
TRPM2 NM_003307 Forward 5' TCCTCCTACTCTGCCTCTAC 3' 111 
  Reverse 5' AAATCTGGTCCGTGTGCTC 3'  
TRPM4 NM_001195227 Forward 5' CAGTGACTTCCCAAGTATCCTG 3' 111 
  Reverse 5' CAGTTGCTGTGCTCCATGA 3'  
TRPM8 NM_024080 Forward 5' GCTGGCTAATGAGTACGAGAC 3' 126 
  Reverse 5' TCCAGACAGTTGCTTCCAC 3'  
TRPV1 NM_080705 Forward 5' TCCTGCTCAACATGCTCATC 3' 132 
  Reverse 5' AGCTCTTCTCCGTGTCCA 3'  
TPH1 NM_004179 Forward 5' CCATTGTGCCAACAGAGTTC 3' 115 
  Reverse 5' GTTCATAGCCAAGTCCGCAA 3'  
CgA NM_001275 Forward 5' GATCCTTTCCATTCTGAGACATCA 3' 128 
  Reverse 5' GAACCTCTGAGAGTTCATCTTCA 3'  
GAPDH NM_002046 Forward 5' ACATCGCTCAGACACCATG 3' 143 
  Reverse 5' TGTAGTTGAGGTCAATGAAGGG 3'  
 
Figure 3.2 GAPDH expression levels in human bowel were not affected by age or 
region. Quantitive RT-PCR of GAPDH was performed with the same amount of starting 
RNA. Ct value indicated the expression level of GAPDH. (A) No significant difference was 
found between aged group (>65) and non-aged group (<65). P=0.75, unpaired t-test, N=9 for 
non-aged, N=10 for aged. (B) Expression levels of GAPDH in the ileum were comparable to 
that in the colon. P=0.75, unpaired t-test, N=5 for ileum, N=14 for colon. 
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GAPDH was used as endogenous reference gene after evaluating the influence of age 
and region on its expression. As shown in figure 3.2, no significant age or region-
related change was found in GAPDH gene expression. To examine the changes of 
gene expression with advanced age, two analysis methods were employed. One 
method was linear regression to assess the relationship between relative gene 
expression (1/2ΔCt) and age. The other was fold change analysis, as introduced in 
section 2.5. As such, specimens were classified into two groups based on the age of 
patients, aged (≥65) and non-aged (<65). Fold change >2 or <-2 was considered as 
significant.  
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3.3 Age-related changes in EC cell density of human bowel 
EC cells, labeled by an anti-serotonin antibody, were distributed throughout the 
epithelia lining of mucosa in both ileum and colon. Figure 3.3 (A) and (B) showed 
the lateral view and apical view of serotonin immunoreactivities respectively. This 
conical distribution indicated that serotonin was concentrated at the base of EC cells, 
facing the laminar propria of the mucosa. 
Figure 3.3 Representative images of human EC cells labeled by an anti-serotonin 
antibody. (A) Lateral view of an EC cell in the epithelium of a villus. (B) Apical view of 
colonic mucosa. Several EC cells were found in the epithelium surrounding a pit (crypt). (C) 
and (D) showed two examples of EC cell staining in the ileum from a 50-year-old patient (C) 
and a 87-year-old patient (D) respectively. (E) and (F) were two sample images of EC cells 
in the colon from two patients at age 49 (E) and 80 (F). E: epithelium, L: lumen, LP: laminar 
propria. Scale bar = 20 µm in A and B; 50 µm in C-F. 
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IHC was performed on 26 bowel specimens from patients of different ages, ranging 
form 38 to 87. The densities of EC cells were blindly quantified. EC cell density was 
increased with advancing age in human ileum (P<0.05, r2=0.528, linear regression, 
N=10); conversely, such a correlation was not found in the colon (figure 3.4A&B). 
Furthermore, if male and female patients were separately analyzed, EC cells in the 
male ileum, female ileum and female colon tended to increase with age; only male 
colon showed no alteration with age (figure 3.4C-F).  
 
The distribution patterns of EC cells throughout the lower GI tract were compared 
between both genders (figure 3.5). In specimens from male patients, EC cell density 
was augmented in a rostral-caudal direction (P<0.05, one-way ANOVA). On the 
contrary, in female specimens, EC cell density did not show any significant alteration 
across different regions. 
 
These data indicated that EC cell distribution pattern along the GI tract was both 
region and gender related. To sum up, male patients had a marked higher density of 
EC cell in their colon compared with ileum, and that density in the colon was not 
increased with advanced age like ileum. In female patients, EC cell density did not 
show any regional difference, and was increased with age in both ileum and colon. 
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Figure 3.4 Changes of EC cell density with age in human ileum and colon. (A) 
EC cells density was increased with age in the ileum. P<0.05, r2=0.528, linear 
regression, N=10. (B) EC cell density in the colon was not changed with age. 
P=0.848, r2=0.003, N=16. (C, E and F) showed the relationship between EC cells and 
age in male ileum (C, P=0.083, r2=0.841, N=4), female ileum (E, P=0.175, r2=0.405, 
N=6) and female colon (F, P<0.01, r2=0.940, N=5). (D) In male colon, EC cell 
density was not altered by ageing, P=0.208, r2=0.170, N=11. EC cell density was 
expressed as number of EC cells per square millimeter of mucosa. 
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Figure 3.5 Distribution of EC cells throughout human intestine. (A) EC cell density was 
graded from ileum to distal colon in specimens from male patients. P<0.05, one-way 
ANOVA. N=4 for ileum, 2 for proximal colon and 9 for distal colon. (B) In female patients, 
no significant difference was found throughout the intestine. N=6 for ileum, 2 for proximal 
colon and 3 for distal colon. Proximal colon was defined as ascending colon and transverse 
colon; distal colon included descending colon and sigmoid colon. * P<0.05. 
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3.4 Age-related changes of mast cell density in human bowel 
Due to containing granules rich in heparin and histamine, mast cells were stained 
red-purple (metachromatic staining) in the cytoplasm and blue (orthochromatic 
staining) in the nuclei by toluidine blue (as illustrated in figure 3.6A). Based on their 
location, three populations of mast cells were quantified, i.e., mucosal, submucosal 
and serosal mast cell.  
Figure 3.6 Sample images of human intestinal mast cells labeled by toluidine blue. (A) 
A high magnification image of mast cell stained in red-purple. (B-D) Sample staining of 
mast cells in the mucosa (B), submucosa (C) and serosa (D). (E-F) were two sample images 
of mucosal mast cells in the colon from two patients at age 43 (E) and 84 (F) respectively. M: 
mucosa, MM: muscularis mucosae, S: serosa, SM: submucosa. Scale bar = 10 µm in A; 20 
µm in B-F. 
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Although mast cells could be detected throughout the gut wall from mucosa lamina 
propria to serosa/mesentery in human bowel, they were extensively distributed next 
to the muscularis mucosa, indicating their role in innate immune defense. Mucosa, as 
the innermost layer that directly contacts with the external environment, contained 
the largest density of mast cells (figure 3.7) in both small and large intestine. Mast 
cells were very occasionally found in the muscle layer, or to be accurate, in the 
connective tissue and blood vessels running through muscle layer.  
 
Mast cell densities in different locations were plotted against the ages of patients 
(figure 3.8). Mucosal mast cell densities were significantly increased with advancing 
age in both ileum (P<0.05, r2=0.606, linear regression, N=8) and colon (P<0.05, 
r2=0.413, N=14). Such a relationship was not found in the submucosa and serosa. 
 
 
 
Figure 3.7 Distribution of mast cells throughout the gut wall of human small and large 
intestine. (A) Mast cell density in the mucosa was significantly greater than that in 
submucosa and serosa in small intestine. P<0.001, one-way ANOVA. Mucosa vs. 
submucosa, P<0.01; mucosa vs. serosa, P<0.001, N=9. (B) Similarly, in the large intestine, 
mucosa contained more mast cells than submucosa and serosa. P<0.0001, one-way ANOVA. 
Mucosa vs. submucosa, P<0.0001; mucosa vs. serosa, P<0.0001, N=15. *** P<0.001, **** 
P<0.0001. 
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Figure 3.8 Changes of mast cell density with age in human ileum and colon. Mucosal 
mast cell densities were increased with age in both ileum (A, P<0.05, r2=0.606) and colon (B, 
P<0.05, r2=0.413). No significant correlation was found in ileal submucosa (C, P=0.697, 
r2=0.027), ileal serosa (E, P=0.166, r2=0.293), colonic submucosa (D, P=0.458, r2=0.047) 
and colonic serosa (F, P=0.914, r2=0.001). N=8 for ileum, 14 for colon, linear regression. 
Mast cell density was calculated as number of mast cells per square millimeter of mucosa. 
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Our data revealed a positive significant correlation between EC cell density and 
mucosal mast cell density in the ileum but not colon. This observation was not 
contrary to the age related changes in the densities of EC cells and mast cells. In the 
ileum, both EC cells and mucosal mast cells were increased with advanced age, 
whereas in the colon, EC cells were not changed with ageing.  
 
 
 
Figure 3.9 Relationship between EC cells density and mucosal mast cell density. A 
significant linear relationship was found between EC cell density and mucosal mast cell 
density in the ileum (A, P<0.05, r2=0.818, linear regression, N=6) but not colon (B, P=0.226, 
r2=0.201, linear regression, N=9).  
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3.5 Age-related changes of SP density in human colon 
Vesicle-like SP positive immunoreactivities could be detected in myenteric plexuses, 
submucosa plexuses, nerve terminals and blood vessels. Very short SP positive nerve 
fibers were occasionally found in the submucosa and muscle layers, while 
continuous fibers were extensively distributed in the lamina propria of mucosa. This 
might be resulted from the angle between nerve pathway and sectioning direction. 
Another reason might be that SP contained vesicles were not visible at this 
magnification unless they formed varicosities close to the nerve terminals.  
 
Diameter of SP positive varicosities was about 1~2 µm. Areas occupied by these 
varicosities in colonic mucosa were measured using ImageJ software. SP density 
tended to reduce with advanced age, although this was not statistically significant 
(figure 3.10C, P=0.058, r2=0.344, N=11). This suggests a possible neurodegeneration 
of sensory innervation in aged human colon. 
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Figure 3.10 Changes of SP positive varicosities in aged human colonic mucosa. A and B 
illustrated SP positive nerve fibers running through the laminar propria of colonic mucosa in 
specimens obtained from two patients at age 54 (A) and 80 (B) respectively. L: lumen, LP: 
laminar propria, MM: muscularis mucosae. Scale bar = 20 µm. (C) SP density in colonic 
mucosa tended to reduce with advanced age, P=0.058, r2=0.344, linear regression, N=11. 
Relative SP density was calculated as the percentage of areas occupied by SP 
immunoreactivities in the areas of mucosa. 
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3.6 Age-related changes of anatomical relationship between 
mast cells and afferent nerves in human colon 
To examine the anatomical relationship between mast cells and sensory afferent 
nerves, double immunostaining of mast cell tryptase and SP was performed. A 
number of mast cells (stained in red) were closely associated with SP-positive 
varicosities (stained in green) (figure 3.11A&B). To quantify this relationship, the 
distance between mast cell and its closest SP varicosity was measured using ImageJ 
software. The distribution pattern of the distances between mast cells and SP was 
shown by a histogram (figure 3.11C). More than 50% of mast cells were located 
within only 1 µm away from SP-positive nerve fibers. The percent of mast cells 
within 2 µm (1~2 µm) from SP was about 14%, and this percentage reduced 
gradually with the distance increasing.  
 
Two representative distribution patterns of this anatomic relationship from adult and 
aged patients respectively were shown in figure 3.11D. The distribution pattern in 
aged specimen shifted to the left remarkably, suggesting more mast cells in close 
apposition with SP. A significant positive linear relationship was found between the 
percent of mast cells within 1 µm from SP with advanced age (figure 3.11E, P<0.05, 
r2=0.508). From 4 µm, the percentage tended to reduced with age, although only 8 
µm (P<0.05) and 9 µm (P<0.01) groups reached significant level.    
 
To examine whether this close association between mast cells and SP was random, a 
flipped control was perform. Prior to superimposing red channel (mast cell staining) 
and green channel (SP staining) together, one of the channels was flipped over 
horizontally (figure 3.12). Measurement of mast cells-SP distances and distribution 
analysis was performed consistently. As a result, the distribution pattern was 
completely broken in the flipped image, suggesting that the close associations that 
we observed were not accidental. 
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Figure 3.11 Changes of the anatomical relationship between mast cells and sensory 
nerves in aged human colonic mucosa. (A) Double immunostaining revealed the spatial 
relationship between mast cells (in red) and SP (in green) in colonic mucosa. (B) An 
amplified image showing the close association between mast cells and SP positive nerve 
fibers. (C) A histogram showing the distribution pattern of the mast cell (MC)-SP distances. 
Relative frequency indicated the percentage of mast cells located within certain distance. 
N=10. (D) Two sample distribution patterns of the MC-SP distance obtained from two 
patients at age 54 and 80 respectively. (E) The percentage of mast cells within 1µm from SP 
was increased with age, P<0.05, r2=0.508, linear regression, N=10. (F) Percent of mast cells 
within 2 µm (1-2µm) from SP showed an increasing tendency, but not significant, P=0.205, 
r2=0.192. For 3 µm group, no obvious tendency was found, r2=0.008. From 4 µm to 10 µm, 
the percentages tended to reduce, r2=0.120, 0.079, 0.350, 0.084, 0.453, 0.589 and 0.336 
respectively; among these groups, a significant relationship was found only in 8 µm (P<0.05) 
and 9 µm (P<0.01) groups, linear regression, N=10. LP: laminar propria, MM: muscularis 
mucosae. Scale bar = 50 µm in A, 10 µm in B. 
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Figure 3.12 A flip control demonstrating that the close association observed above was 
not random. (A) A normal superimposed image showing the spatial relationship between 
mast cells (in red) and SP (in green) in colonic mucosa. (B) With the same image in (A), 
prior to merging red channel (mast cell staining) and green channel (SP staining), red 
channel was flipped over horizontally. Comparing with a control distribution in (C), the 
distribution pattern in flipped image was completely broken.  Scale bar =50 µm. 
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3.7 Gene expression in human bowel mucosa 
Quantitive RT-PCR was performed on total RNA isolated from the mucosa of human 
bowel specimens. All the examined genes were present in the mucosa of both ileum 
and colon, as confirmed by gel electrophoresis (figure 3.13A&B). Among these 
genes, TRPA1, TRPM4 and CgA were highly expressed, comparing with others 
(figure 3.13C&D).  
 
Comparison of gene expression was made between ileum and colon. Based on t-test 
of relative gene expression (1/2ΔCt), colonic mucosa showed a significant lower 
expression in TRPA1 (P<0.05) and TRPV1 (P<0.01) than ileum (figure 3.13C, N=5 for 
ileum, N=15 for colon).  Fold changes were calculated as described in methods 
section of this chapter. Significant differences could be detected for TRPA1 (-
2.19±0.26), TRPC4 (2.64±0.37), TRPC6 (2.00±0.30), TRPM2 (-2.62±0.39), and 
TRPV1 (-2.76±0.25) (figure 3.13E).  
 
Ileum and colon specimens were classified into aged group (≥65, N=11) and non-
aged group (<65, N=9). Unpaired t-test of the relative gene expression (1/2ΔCt) did 
not reveal any significant differences (figure 3.13D) between the aged and the non-
aged. Fold changes (aged vs. non-aged, figure 3.13F) revealed that only TRPC4 
showed a significant up-regulation in the aged bowel with a fold change more than 2 
(2.01±0.40).  
 
The age-related comparison above was based on 5 ileum specimens and 15 colon 
specimens. Based on colon only, a similar significant increase of gene expression 
was detected for TRPC4 (figure 3.14A, fold change 2.40±0.30). However, there was 
no significant linear relationship between the relative gene expression (1/2ΔCt) and 
age for TRPC4 (figure 3.14B) and all the other genes. 
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Figure 3.13 Gene expression in the mucosa of human ileum and colon. (A and B) Two 
electrophoresis images showing the presence of PCR products for examined genes in ileum 
(A) and colon (B). Bands from left to right were GAPDH, TRPA1, TRPC4, TRPC6, TRPM2, 
TRPM4, TRPM8, TRPV1, TPH1 and CgA.  (C) Relative gene expression (1/2ΔCt) in human 
ileum and colon. Comparing with ileum, colon showed a significant lower expression of TRPA1 
(P<0.05) and TRPV1 (P<0.01), unpaired t-test, N=5 for ileum, N=15 for colon. (D) Relative 
gene expression (1/2ΔCt) in aged and non-aged human bowel. Unpaired t-test did not reveal any 
significant differences, N=9 for non-aged group (3 ileum and 6 colon), N=11 for aged group (2 
ileum, 9 colon). (E) Fold change of gene expression in the colon vs. ileum. Fold change = -
2.19±0.26 for TRPA1, 2.64±0.37 for TRPC4, 2.00±0.30 for TRPC6, -2.62±0.39 for TRPM2, -
1.49±0.19 for TRPM4, 1.47±0.35 for TRPM8, -2.76±0.25 for TRPV1, 1.08±0.35 for TPH1 and -
-1.38±0.38 for CgA. (F) Fold change of gene expression in aged group against non-aged group. 
Fold change= -1.04±0.34 for TRPA1, 2.01±0.40 for TRPC4, 1.15±0.34 for TRPC6, -1.06±0.46 
for TRPM2, 1.36±0.23 for TRPM4, 1.18±0.47 for TRPM8, 1.07±0.39 for TRPV1, -1.13±0.37 
for TPH1 and -1.99±0.49 for CgA.  
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Figure 3.14 Gene expression in the mucosa of human colon. (A) Fold change of gene 
expression in aged colonic mucosa compared with non-aged group. Fold change= 1.08±0.38 for 
TRPA1, 2.40±0.30 for TRPC4, 1.21±0.35 for TRPC6, 1.12±0.52 for TRPM2, -1.05±0.27 for 
TRPM4, 1.86±0.52 for TRPM8, -1.03±0.32 for TRPV1, -1.14±0.45 for TPH1 and -1.85±0.56 for 
CgA. Only TRPC4 showed a significant up-regulation. N=9 for aged group, N=6 for non-aged 
group. (B) No significant linear relationship was found between relative gene expression (1/2ΔCt) 
and age for TRPC4 and all the other examined genes in colonic mucosa. TRPA1, r2=0.038, 
TRPC4, r2 =0.027, TRPC6, r2=0.093, TRPM2, r2=0.006, TRPM4, r2=0.019, TRPM8, r2=0.162, 
TRPV1, r2= 0.009, TPH1, r2=0.114 and CgA, r2=0.216, linear regression, N=14. 
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3.8 Discussion 
This chapter evaluated the effects of ageing on the density of EC cell, mast cell, SP, 
the anatomical relationship between mast cells and SP as well as gene expression of 
selected TRP channels in human bowel. 
 
Effects of ageing on EC cell density in human bowel 
The distribution of EC cells in the epithelium of the gut wall facilitates their function 
as the sensors of the luminal contents. Serotonin released from EC cells activates 
intrinsic and extrinsic sensory nerve terminals to initiate peristaltic and secretory 
reflexes as well as to transmit signals to the CNS; furthermore, inhibition of 5-HT3 
receptor has been shown to attenuate visceral afferent sensitivity and blunt 
abdominal pain in IBS patients (Prior and Read, 1993; Delvaux et al., 1998; De Ponti, 
2004; Tonini, 2005; De Giorgio et al., 2007; Gershon and Tack, 2007; Spiller, 2007; 
Ford et al., 2009).  
 
Our data suggest that EC cell density is increased with advanced age in human ileum 
but not in the colon.  Further analysis demonstrated that this difference was because 
EC cells density in male colon was not changed with age.  
 
In line with the EC cell distribution pattern observed in male patients, 
immunohistochemical studies on mouse have revealed that serotonin positive cells 
increase from small intestine to colon (Lee et al., 2010; Wheatcroft et al., 2005). 
Moreover, it has been demonstrated that mucosal serotonin concentrations in the 
lower GI tract of both IBS patients and healthy control display an ascending rostral-
caudal gradient (Miwa et al., 2001). These studies prove a regional difference for EC 
cell distribution and serotonin availability; however these mixed-gender studies 
might largely reflect the pattern of the male, since the female shows an even 
distribution that might be masked by the male.   
 
A study that revealed increased 5-HT positive EC cells in IBS patients compared 
with healthy control did not find any gender related differences in both groups 
(Cremon et al., 2011), although their data appeared to show a higher EC cell density 
in female control than male (0.42±0.19% vs. 0.3±0.1%, P=0.279). The difference 
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between their data and ours may be due to that they collected biopsies from the 
proximal descending colon, where the gender related difference is not as prominent 
as distal colon. Another conflicting report on rectal biopsy from healthy volunteers 
did not find any gender differences in EC cells distribution (Dunlop et al., 2004). It 
has been demonstrated that expression of 5-HT3 receptor in the colon of 
ovariectomized rats is significantly augmented, supporting a gender-related 
difference in serotonergic signaling (Li et al., 2004). 
 
In addition to region and gender, our data suggest an age-related increase of EC cell 
in the ileum but not colon, or to be accurate, male colon. A chromatographic assay 
revealed elevated synthesis and release of serotonin in aged mouse ileum and 
suggested that was due to enhancement of the activity or expression of the enzyme 
L-amino acid decarboxylase, based on a significant increase in the ratio of 5-HT: 5-
HTP (Parmar et al., 2012). In agreement with our data, a study on aged rat colon did 
not find any change in staining for somatostatin and chromogranin, markers for EC 
cells (Sweet et al., 1996). In addition, human rectal biopsy did not show any age-
related alteration in EC cell density (Dunlop et al., 2004).  
 
A study has reported a positive correlation between 5-HT release and mucosal mast 
cell infiltration in IBS colon and suggested that immune activation could drive 5-HT 
release (Cremon et al., 2011). Although this is reasonable inference, there is no 
sufficient evidence to rule out the possibility that 5-HT release drives mast cell 
infiltration or possibly both 5-HT release and mast cell infiltration are consequence 
of other factors.  Our data revealed a positive correlation between EC cell density 
and mast cell infiltration in the ileum but not in the colon (figure 3.9). This may be 
not contrary to previous report, as EC cell density may not accurately reflect the 
release of serotonin. Alternatively, our data might suggest that some other 
mechanisms instead of mast cell infiltration accounted for the increase of EC cells, as 
the density of EC cells in the colon maintained at a high level across the age 
spectrum, despite increased mast cells with advanced age.    
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Effects of ageing on mast cell density in human bowel 
Mast cells are classified into mucosal mast cells and connective tissue mast cells 
based on their locations. Our data suggest that mucosal mast cells predominate in 
human small and large intestine. Furthermore, densities of mucosal mast cell are 
augmented with advanced age in both ileum and colon. No significant alteration was 
detected in the densities of submucosal and serosal mast cells.  
 
A study has reported a 27% increase in the total number of mast cells and 400% 
increase in the number of activated mast cells in aged rat mesenteric tissue and 
suggested that the presence of extensive degranulated mast cells in resting conditions 
might promote a chronic inflammatory environment in aged mesentery (Chatterjee 
and Gashev, 2012). Conversely, a study on human rectal biopsy reported a reduction 
in mast cell density in the aged population (Dunlop et al., 2004). It is unknown why 
this study is contrary to our data.  It may be attributed to regional (ileum, colon vs. 
rectum) or methodological differences (whole-thickness specimen vs. biopsy).  
Another study did not find dramatic difference in mast cell density quantified from 
jejunal biopsy between aged (>70) and younger group (20-50) (Arranz et al., 1992). 
However, their criteria for screening suitable experimental objects was that the final 
diagnose was of functional gastrointestinal symptoms or of a minor clinical problem 
without evidence of immunological, infectious, neoplastic, or allergic disease. It is 
possible that mast cells were abnormal on those patients of functional GI disorders. 
 
Some studies have proposed that increased circulating levels of pro-inflammatory 
cytokines including interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-alpha and 
IL-12, IFN-alpha/beta up-regulate the inflammatory response in the elderly, and 
promote a low-grade chronic systemic pro-inflammatory state (Fagiolo et al., 1993; 
Franceschi et al., 1995; Bruunsgaard and Pedersen, 2003; Csiszar et al., 2003; Giunta, 
2008). This low-grade inflammatory state may be associated with enhanced immune 
cell infiltration including mast cells. 
 
                                                                                                                       Chapter 3 
 86 
Effects of ageing on density of sensory nerves in human colon 
SP is present at extrinsic primary sensory afferents innervating the GI tract (Holzer, 
1998; Chang et al., 1996). Although a proportion of SP positive myenteric neurons 
are excitatory motor neurons (Costa et al., 1996), the majority of SP positive neurons 
in the submucosa are sensory neurons (Bornstein et al., 1989). As such, SP is widely 
used as a marker for sensory nerve fibers (Miller et al., 2000; Sulaiman et al., 2001; 
Arnold et al., 2012).  
 
SP-positive nerve fibers ramify throughout the laminar propria to form a dense 
network underneath the epithelium in human colonic mucosa (Keast et al., 1985). 
This distribution pattern facilitates their function to detect external stimulation, 
collect signal from other cells (e.g., EC cells, mast cells) and interact with them.   
 
As introduced in the beginning of this chapter, a number of studies revealed a 
significant loss of enteric neurons in the elderly. Furthermore, the ganglionic areas 
were found decreased in the submucosal plexus in association with reduced neuropil 
spaces (Phillips et al., 2007; Phillips and Powley, 2007). Normally neurons within 
the ganglion are surrounded by small interstices of neuropil composed of axons, 
dendrites and glia cells. Based on the evidence of collapsed ganglia with loss of 
neuropil, it can be inferred that the nerve fibers that innervate or project from the 
ganglia might be reduced. A supporting evidence has revealed that the density of SP-
positive nerve fibers is decreased in the circular muscle of aged guinea-pig colon 
(Peck et al., 2009). In addition, a decrease in SP level has been described in the DRG 
neurons of aged rat (Bergman et al., 1996). 
 
In agreement with these studies, our data indicates that SP density tends to decrease 
in the mucosa of aged human colon. Reduction of sensory innervation may result in 
impaired initiation of motility reflex and consequently delayed or diminished 
motility, which might contribute to the prevalence of constipation in the elderly.  
 
Effect of ageing on the close association between mast cells and sensory nerves  
Mast cells have been reported in close proximity to SP positive afferent nerve fibers 
in a variety of rodent organs (Stead et al., 1987; Dimitriadou et al., 1997) and in 
human skin (Naukkarinen et al., 1996), bile duct (Gulubova and Vlaykova, 2004) 
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and IBS colon (Pang et al., 1996). Our data confirmed this association in the colonic 
mucosa of non-diseased specimens from cancer patients.  
 
The close anatomical connections between mast cell and SP facilitate their 
communications. SP can induce degranulation of mast cells and release of histamine, 
tryptase and serotonin (Shanahan et al., 1985; Repke and Bienert, 1987), which in 
turn, activate afferent nerve through corresponding receptors on the terminals 
(Corvera et al., 1999; Nozdrachev et al., 1999; Breunig et al., 2007). These bi-
directional interactions might form a positive feedback loop and amplify 
inflammatory responses. Evidences have revealed a significant correlation between 
abdominal pain and the association of mast cells and nerves in IBS patients (Barbara 
et al., 2004b). 
 
The effects of ageing on the close morphological association between mast cells and 
nerves haven’t been investigated. This study revealed an increased proportion of 
mast cells in close apposition to SP afferent nerves with advanced age. Although we 
reported an increased density of mast cells with ageing, that is not likely to be the 
main cause of the enhanced mast cell-SP association. The first reason is that we 
analyzed the relative distribution as a percentage instead of absolute number. 
Increased number of mast cells may not necessarily change the distribution pattern. 
Additionally, in our flipped control, the mast cell-SP association is completely 
broken, indicating that the pattern is not random.  It has been identified that both 
mast cells and neurons express the same adhesion molecule, named synaptic cell 
adhesion molecule (SynCAM), which is believed to be responsible for the 
connection between mast cells and nerves (Biederer et al., 2002; Ito and Oonuma, 
2006). 
 
The elevated anatomical mast cell-SP associations may be consistent with the low-
grade pro-inflammatory state in the elderly. Since closer associations increase the 
severity of abdominal pain in IBS, whether it is the case in the elderly will be further 
discussed later by comparison of the alterations in IBS and ageing.   
 
In comparison with mast cells, EC cells are not closely apposed to afferent nerves.  
Although EC cells are able to shift along the epithelium from the crypt to the top and 
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finally peel off in the lumen, they are restricted in the epithelium. Even though SP in 
the laminar propria might approach the base of epithelium, the grade of apposition is 
difficult to reach nanometer level.  
 
Effect of ageing on gene expression of TRP channels in human colonic mucosa 
Our data demonstrate that presence of TRPA1, TRPC4, TRPC6, TRPM2, TRPM4, 
TRPM8, TPH1 and CgA mRNA in the mucosa of human ileum and colon. Among 
these genes, TRPA1, TRPM4 and CgA are highly expressed, comparing with others.  
We examined the differences in gene expression between ileum and colon. Colonic 
mucosa showed a lower expression in TRPA1, TRPM2 and TRPV1 but a higher 
expression of TRPC4 and TRPC6 than ileum. 
 
Specimens were classified into aged group (≥65) and non-aged group (<65) to 
calculate fold changes (aged vs. non-aged) of gene expression. As a result, only 
TRPC4 showed a significant up-regulation in the aged bowel with a fold change 
more than 2, although correlation test between the relative gene expression (1/2ΔCt) of 
TRPC4 and age did not reveal any significance. The involvements of TRPC4 in the 
regulation of visceral contractility have been extensively studied (Walker et al., 2002; 
Lee et al., 2005; Boesmans et al., 2011); in addition, a recent study on TRPC4-knockout 
rat demonstrated that it’s also implicated in visceral pain sensation (Westlund et al., 
2014). Since TRPC4 plays multiple roles in the GI physiology, the interpretation of up-
regulation of TRPC4 in the elderly requires further investigation. 
 
Ageing and IBS  
As introduced in previous chapters, IBS is a common gastrointestinal disorder 
characterized by abdominal pain, bloating and disturbed defecation. The 
etiopathogenesis underlying IBS has not been fully understood. One of the 
hypotheses is end organ visceral hypersensitivity mediated by mast cell and EC cells. 
In comparison with many previous reports, current study notes some interesting 
similarities between aged bowel and IBS bowel, such as increased EC cells, mast 
cells and enhanced mast cell-nerve apposition.  
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Table 3.3 Summary of changes in EC cells and mast cells in IBS patients 
Region Gender 
(M: F) 
Clinical subtype Findings Magnitude 
of change 
Reference 
EC cells 
Ileum 
17:21 IBS-C +IBS-D No change  (Wang et al., 2007) 
9:16 IBS-D No change  (Park et al., 2006a) 
Colon 
7:18 IBS-C +IBS-D Increase 51% (Cremon et al., 2011) 
5:2 IBS-D No change  (Kim et al., 2010) 
7:3 IBS-D Increase 64% (Bian et al., 2009) 
9:16 IBS-D No change  (Park et al., 2006a) 
Mast cells 
Ileum 
17:21 IBS-C +IBS-D Increase 25% (Wang et al., 2007) 
10:8 IBS-D Increase 30% (Park et al., 2006b) 
4:16 IBS-C +IBS-D Increase 243% (Weston et al., 1993) 
Colon 
 IBS-D Increase 68% (Sohn et al., 2014a) 
9:16 IBS-C +IBS-D Increase 45% (Coeffier et al., 2010) 
5:2 IBS-D No change  (Kim et al., 2010) 
7:3 IBS-D Increase 94% (Bian et al., 2009) 
4:7 IBS-C +IBS-D Increase 164% (Buhner et al., 2009) 
13:35 IBS-C +IBS-D Increase 116% (Cremon et al., 2009) 
3:20 IBS Increase 38% (Akbar et al., 2008) 
10:8 IBS-D Increase 28% (Park et al., 2006b) 
13:31 IBS Increase 179% (Barbara et al., 2004b) 
2:12 IBS No change  (O'Sullivan et al., 2000) 
 
To examine if the magnitude of increase in EC cells and mast cells with advanced 
age was pathophysiologically significant, their magnitude of change in IBS was 
roughly calculated based on literature (table 3.3).  The average increasing rates of EC 
cells and mast cells in IBS were 58% and 94% respectively. To make a comparison, 
the current study divided human specimens into aged (>65) and non-aged group 
(<65). The increasing rate by ageing for EC cells and mast cells were about 31% and 
80%, which were comparable to the rates in IBS. 
 
It has been proposed that the hypersensitivity in IBS might be attributed to a low-
grade inflammation present in IBS bowel (Barbara et al., 2002; Spiller, 2003), 
evidenced by increased number of T cells (Spiller et al., 2000; Chadwick et al., 2002; 
Tornblom et al., 2002) and increased proinflammatory cytokines such as IL-1β, IL-6, 
IL-8 and TNF-α (Dinan et al., 2006; Liebregts et al., 2007). In line with IBS, ageing 
is associated with increased circulating levels of pro-inflammatory cytokines 
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including IL-1, IL-6, TNF-α and IL-12, IFN- α/β, which promote a low-grade 
chronic systemic pro-inflammatory state in the elderly (Fagiolo et al., 1993; 
Franceschi et al., 1995; Bruunsgaard and Pedersen, 2003; Csiszar et al., 2003; Giunta, 
2008). 
 
In line with the low-grade inflammation in IBS, increased mast cells have been 
frequently reported in IBS bowel. Although conflicting results exist, as summarized 
in a review, 29 in 40 studies reported increases in mast cells with only one reporting 
a decrease (Matricon et al., 2012). In agreement with the majority, our data reveal 
that mast cells increase with advanced age. The causes of increased mast cells in IBS 
patients remain unknown. It has been suggested previous episodes of infectious 
enteritis (Gwee et al., 1999) and food allergies (Smout et al., 2000) might contribute 
independently or in combination. Whether the age-related increases in mast cells are 
accelerated by previous inflammatory events requires further investigation. 
  
A study has reported a significant correlation between abdominal pain and vicinity of 
mast cells to nerves in IBS patients (Barbara et al., 2004b). Similarly, we found 
closer anatomical associations between mast cells and sensory nerve fibers in the 
elderly. 
 
It is very controversial whether EC cells are augmented in IBS bowel. About half of 
previous studies have reported increases in EC cell, while the rest found no change 
(Matricon et al., 2012). This study revealed an increase of EC cells in the ileum and 
female colon with age, but not in the male colon. Since our data suggest that EC cell 
distribution depends on age, gender and region, the conflicting reports in IBS might 
be owing to ignorance of age or gender related differences.  
 
These similarities between IBS and ageing suggest that they might share some 
common mechanisms. However, it has been shown that IBS is less prevalent in aged 
population and the severity of pain is decreased (Kay, 1994; Wilson et al., 2004; 
Tang et al., 2012). A difference between our data on age-related changes and IBS-
related changes might explain this contradiction. Numerous studies have reported an 
increase in SP in IBS bowel (Mazumdar and Das, 1992; Dong et al., 2004; Sohn et 
al., 2014b); whereas, our data suggest an age-related decrease of SP positive sensory 
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nerve fibers. Since IBS is characterized as abdominal pain and discomfort, reduction 
of sensory innervation is likely to attenuate these sensation-based symptoms. 
 
It is unknown whether the reduction of SP nerve fibers contributes to the increase of 
mast cells. Capsaicin or dihydrocapsaicin treatment that depletes peptidergic nerve 
fibers results in an increase in mast cells in neonatal rat dura mater (Dimitriadou et 
al., 1997) and neonatal sheep lung (Ramirez-Romero et al., 2000). A possible 
explanation is that one or more mediators released from afferent C-fibers might have 
a negative regulative effect on mast cell proliferation. Alternatively, as a 
compensative mechanism, reduction of sensory innervation results in augmented 
mast cells to maintain the sensory input from the immune system to the nervous 
system.  
 
Mechanisms underlying ageing process in the GI tract, especially factors that 
promote ageing, are poorly understood. Diet habit is believed to play an essential 
role. Caloric restriction that is known to extend lifespan in rodents and other species 
has been demonstrated to prevent neurons loss in myenteric plexus of aged rat 
(Cowen, 2002). Further investigations are required to address these mechanisms. 
 
Limitations 
Studies on human specimens must confront variations in the patient age, gender, 
genetic background, medical history and so on. This variability is difficult to control 
by the researcher. An elegant review has discussed some basic principles in 
functional studies with human specimens, such as influence of disease, choice of 
control, timing of experiment, influence from surgical process, age/gender related 
variability and sample size (Sanger et al., 2013). Considering these factors might 
minimize variations. 
 
One limitation of the current study is that inadequate clinical information was 
available, such as the genetic background, medical history and other gastrointestinal 
symptoms. For example, it was unknown if the patients were suffering from 
abdominal pain and changes in stools, which would suggest IBS. Since a lot of 
evidence has revealed altered densities of mast cell, EC cells and SP in IBS patient, 
ignorance of this information might influence the evaluation of age-related changes 
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in those cells.  It is unclear whether the diseases of patients or the treatment they 
received could affect our observation. Although these “safe margins” were 
morphologically normal, it could not be assured that the changes that we observed in 
the elderly were pure effect of ageing. The huge variability in human specimens was 
difficult to control. When investigating the age-related alterations, we tried to control 
the gender and region. However, this was only feasible if there were a large number 
of tissue supplies. 
 
In the introduction and discussion above, a number of conflicting and controversial 
results in the literature have been frequently mentioned. Ageing is a very 
complicated and comprehensive process. A variety of factors might contribute to this 
confliction, such as experimental models, co-morbidities, sampling strategies, 
experimental techniques and analysis methods.  
 
Differences in experimental models including species, strains and different regions 
of the GI tract might account for most of the contradictory results obtained from 
different models. It has been noted that a large number of species differences do exist 
and knowledge obtained from one model sometimes translates poorly to another. In 
addition, nutrition might influences the ageing patterns as well, which is supported 
by the evidence that caloric restriction diet prevented neuronal loss in the myenteric 
plexus of aged rat ileum (Cowen et al., 2000). Perhaps other maintenance or 
environmental factors can potentially affect the patterns of ageing in the 
gastrointestinal innervation. Ageing study on human specimens is more complicated 
and difficult. In addition to genetic varieties, differences in living environments, 
ways of life, especially eating habits would largely affect the health conditions and 
further influence the patterns of ageing in the GI tract. Moreover, many diseases are 
more common in the aged population, such as cardiopulmonary disorders, 
degenerative disorder of the CNS, rheumatoid arthritis and degenerative joint disease, 
and the therapy aiming to treat them may directly or indirectly influence GI 
physiology. Last but not least, access to human specimens, especially “health” 
objects is very limited.  
 
Experimental techniques might influence the results. An obvious example is different 
choice of markers, which might have different sensitivity and selectivity, leading to 
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variable labeling. Another possible example is that most studies that quantify certain 
type of cells in the elderly often employ immunohistochemistry or chemical staining. 
The results of cell labeling could be influenced by changes in tissue permeability to 
staining agents that might be one of the effects of ageing. In this case, these labeling 
techniques cannot truly reflect the changes of cells induced by age.  
 
Another limitation in our study is that we sampled through a series of consecutive 
sections of a three-dimensional specimen when we analyzed the spatial relationship 
between mast cells and nerves. The problem is that nerve fibers and mast cells might 
overlay with each other or at different depth within the section, which preclude the 
measurement of the three-dimensional distances. Considering the fact that the 
thickness of the section is smaller than the diameter of mast cell, this limitation 
should be tiny. However, a powerful stereological technique would definitely be 
more reliable for this type of studies. 
 
In addition to sampling and technique, comparisons between specimens varying in 
age are still based on analysis methods, which is crucial for interpreting the raw data. 
Some animal studies proposed that as animals grow, changes in organ size and 
surface area might result in a dilution of the density of neurons or other elements 
interested; to address this dilution, they developed a age-specific correction factor, 
which was the ratio of cross-sectional areas of samples in different age groups 
(Gabella, 1989; Cowen et al., 2000; Phillips et al., 2003; Phillips and Powley, 2007). 
The purpose of this normalization is that they tried to conclude a neuronal loss in 
aged animals. If they use the term neuronal loss instead of decreased density, they 
have to validate that the reduction they observed are not due to increase of organ size. 
In our study, the density of examined targets is simply expressed as number of cells 
per unit area.  
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4.1 Introduction 
Significance of human afferent recording 
Abdominal pain is a common character of many gastrointestinal disorders. Some of 
these disorders are defined as functional GI disorders, such as IBS, on the basis of 
unexplained recurrent pain in association with other GI symptoms. The prevalence of 
IBS reported by many epidemiological studies is quite variable due to diverse 
diagnostic criteria. It is widely accepted that an estimated prevalence rate in 
industrialized countries is about 10-15% (Maxion-Bergemann et al., 2006; Spiller et 
al., 2007). Although IBS is not a life-threatening disease, it consumes a large 
proportion of healthcare resource and thus imposes a substantial economic burden on 
its sufferers and the society (Fullerton, 1998; Hulisz, 2004; Maxion-Bergemann et al., 
2006). 
 
IBS is associated with a large unmet medical need, which can be attributed to poor 
understanding of the underlying pathophysiology of this disorder. Since IBS is 
defined as a functional bowel disorder, lack of marked pathological alterations make 
it difficult to build a mirrorlike animal model. Instead, animal models of visceral 
hypersensitivity have been developed based on the observations of hypersensitivity 
to colorectal distension in a large proportion of IBS patients (Whitehead et al., 1990; 
Verne et al., 2001; Dong et al., 2004). Studies on these models have developed some 
potential treatments for abdominal pain. For example, alosetron, a 5-HT3 receptor 
antagonist, has been shown to inhibit the response to colorectal distension in the 
rodents (Scott et al., 1994; Clayton et al., 1996; Kozlowski et al., 2000). In 2000, 
alosetron was approved for marketing to release symptoms of abdominal pain in IBS 
patients; however, it was withdrawn from the market 9 months later owing to serious 
life-threatening adverse effects including ischaemic colitis and severe constipation 
accompanied with 7 death cases (U.S. Food and Drug Administration, 2002). 
Although alosetron was reintroduced in 2002, it was restricted to treat women with 
diarrhea-predominate IBS. In addition, Some other drugs failed to show efficacy 
against abdominal pain in IBS clinical trials, such as talnetant (NK3 receptor 
antagonist), GW876008 (corticotropin-releasing factor-1 receptor antagonist) and 
AZD7371 (5-HT1A receptor antagonist)(Drossman et al., 2008; Camilleri, 2010), in 
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spite of promising data from animal studies (Fioramonti et al., 2003; Schwetz et al., 
2004; Lindstrom et al., 2009). 
 
These translational failures highlight a demand for more thorough research on human 
directly. Indeed, a large number of studies using biopsies and supernatant from IBS 
patients have revealed the alterations in the immune infiltration (Spiller et al., 2000; 
Chadwick et al., 2002; Tornblom et al., 2002; Barbara et al., 2004b; Cremon et al., 
2009), chemical environment (Barbara et al., 2004b; Dinan et al., 2006; Liebregts et 
al., 2007; Cremon et al., 2011), innervation patterns and receptor expression (Akbar 
et al., 2008) in IBS bowel. Furthermore, studies on human enteric neurons have 
provided evidence on hypersensitivity involving mast cells (Breunig et al., 2007; 
Buhner et al., 2009). Nevertheless, these studies are limited to intrinsic nervous 
system at the level of single cell type.  
 
Studies on human visceral afferent signaling have been limited to in vivo studies 
based on symptom reporting or brain imaging. For example, colorectal distention in 
humans using a barostat device is a useful method to investigate the visceral 
mechanosensitivity in IBS patients. However, it is limited by subjective perception 
and thus may be not reliable. In addition, artificially evoked visceral pain may not 
truly reflect the pathophysiology of spontaneous pain in IBS (Bulmer and Grundy, 
2011). Although these techniques have improved our understanding of visceral pain 
signaling in humans, they are less capable to provide deep insight into the underlying 
mechanisms compared with in vitro models at the level of end organ.  
 
Although in vitro recordings of sensory afferent nerve activity from the rodent GI 
tract have been well established, the application of such recordings on human bowel 
has been a blank area in the literature. Until recently, our group and another group 
reported independent preliminary data on afferent recording from isolated human 
bowel (Jiang et al., 2011; Peiris et al., 2011). This will allow directly mirroring the 
studies that have been performed in animal models addressing mechanisms 
underlying visceral pain. Human visceral afferent recording has enormous advantage 
over animal model in the light of avoiding translational problems that have been 
discussed above. Another remarkable advantage of this in vitro human model is the 
                                                                                                                   Chapter 4 
 97 
ability to test the efficacy of drugs against visceral pain or other symptoms, which 
will greatly reduce the risks of in vivo trials in patients or healthy volunteers.   
 
Afferent subtypes determined by mechanosensitivity 
Afferents can be classified according to their terminal distribution and sensitivity to 
different stimuli. A classification method has been established on flat sheet 
preparations of rodent GI tract to facilitate studies on specific afferent 
subpopulations (Lynn and Blackshaw, 1999; Brierley et al., 2004). As summarized in 
table 4.1, spinal afferents innervating mouse colon can be classified into five distinct 
classes based on their sensitivity to three types of mechanical stimuli: probing, 
mucosal stroking and stretch. All mechanosensitive afferents are able to response to 
probing, allowing accurate locating of their receptive fields. In addition to probing, 
mucosal afferents are also responsive to light mucosal stroking without disturbance 
to underneath layers. Muscular afferents are defined by their ability to respond 
readily to circumferential stretch of the tissue. Serosal and mesenteric afferents are 
identified by sensitivity to probing on serosa or mesentery respectively and lack of 
response to mucosal stroking and stretch. Additionally, muscular/ mucosal afferents 
are sensitive to all three distinct stimuli. It remains unknown whether afferents 
innervating human bowel are consist of similar subpopulations.   
 
Table 4.1 Afferent subtypes determined by mechanosensitivity on mouse colon 
Summarized from (Brierley et al., 2004) 
Stimuli Probing Stretch Mucosa stroking 
Mesenteric ✔   
Serosal ✔   
Muscular ✔ ✔  
Mucosal ✔  ✔ 
Muscular/ mucosal ✔ ✔ ✔ 
 
 
Mediators and ion channels involved in hypersensitivity 
It has been demonstrated that supernatants derived from IBS biopsies significantly 
elevate the excitability of rat visceral afferents (Barbara et al., 2007) and human 
enteric neurons (Buhner et al., 2009), which is attributed to increased levels of 5-HT 
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(via 5-HT3 receptor), histamine (via H1-H3 receptor) and proteases (via PAR2 
receptor) in IBS supernatants. Furthermore, supernatants from hypersensitive IBS 
patients induced a greater response on guinea pig submucosal neurons compared 
with non-hypersensitive IBS biopsies (Buhner et al., 2011). 
 
Therapeutic treatments for visceral pain have been developed under two strategies. 
One approach is to prevent the effects of mediators that elicit pain or sensitize 
nociceptive pathways by modulating their synthesis and release or by blocking their 
target receptors. The other approach is to suppress the signaling within the 
nociceptive pathways directly. A number of mediators including 5-HT, histamine 
and proteases have been shown to contribute to the hypersensitivity in IBS, whereas 
it is unclear which subpopulation of afferents interact with these mediators or which 
ion channels are responsible for transducing noxious stimuli and transmitting 
nociceptive signals to the CNS. TRP channels have been shown to serve as direct 
transducer for noxious stimuli including heat, cold, acidity and mechanical pressure 
(Basbaum et al., 2009). Thereinto, TRPV1 has been given the most attention. Studies 
on TRPV1 knockout mice have revealed attenuated jejunal afferent response to 
noxious distension (Rong et al., 2004). Additionally, in animal models of visceral 
hypersensitivity, a TRPV1 antagonist attenuated the visceromotor response to 
colorectal distension (Miranda et al., 2007; Winston et al., 2007). Increasing 
evidence has suggested that TRPA1 might be another candidate based on the 
attenuation effects of TRPA1 antagonist on hypersensitivity induced by mast cell 
activation (Yu et al., 2009), bradykinin (Yu and Ouyang, 2009) and diabetes (Wei et 
al., 2009). On the other hand, TRPA1 agonists allylisothiocyanate (AITC) and 
cinnamaldehyde have been demonstrated to induce mechanical hypersensitivity of 
serosal afferents to probing in mouse colon (Brierley et al., 2009).   
 
Bradykinin is one of the chemical stimuli most physiologically relevant to tissue 
injury, and has been revealed to be an important mediator in signaling of pain 
(Mizumura et al., 1990; Shin et al., 2002). In addition, bradykinin has been 
demonstrated to induce mechanical hypersensitivity in mice colon (Brierley et al., 
2005; Brierley et al., 2009) and guinea pig esophagus (Yu and Ouyang, 2009) via 
bradykinin receptor B2. In flat sheet preparations of mouse colon, bradykinin 
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induced mechanical hypersensitivity to probing is absent in TRPA1 knockout mice 
(Brierley et al., 2009).  
 
Ageing and human bowel afferent sensitivity 
The incidence of motility or transit problems is increasing with age (Jost, 1997; 
O'Mahony et al., 2002; Hays and Roberts, 2006; Norton, 2006). Since detection of 
intraluminal content is a precondition to initiate motor reflexes, impaired afferent 
sensitivity might contribute to the reduced motility in the elderly. However, it is 
largely unknown whether the afferent sensitivity in aged human bowel is impaired or 
not. 
 
 
Objectives 
This study aimed to investigate the mechanical and chemical sensitivity of afferent 
nerves innervating human bowel using a recent established in vitro recording model. 
Objectives include: 
1) to identify afferent subtypes by mechanosensitivity; 
2) to examine chemical sensitivity of identified afferent subpopulations to 
capsaicin, AITC, bradykinin, 5-HT and histamine; 
3) to test the effects of AITC and bradykinin on mechanosensitivity; 
4) to examine the influence of ageing on afferent sensitivity. 
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4.2 Experimental protocol and analysis 
Sources and collection of human bowel specimens were described in chapter 2. 
Within two years, 50 specimens were used for afferent recording; thereinto, 5 were 
excluded due to limited mesentery. As illustrated in figure 4.1, these specimens were 
obtained from patients of various age groups (varying from 24 to 88) and covered 
most regions of the lower GI tract (from ileum to rectum), among which sigmoid 
colon and ileum were the most abundant sources.  
 
As illustrated in figure 2.2, full-thickness tissue was pinned flat with the mucosa 
uppermost in an organ bath, which was perfused with Krebs buffer at 34 °C. Nerve 
bundles were identified from the attached mesentery and sucked into a glass 
electrode. Afferent activity was recorded as described in section 2.4. 
 
 
Figure 4.1 Age and region distribution of human bowel specimens used for afferent 
recording. (A) A pie chart showing the proportion of different regional sources of 
specimens. Sigmoid colon and ileum accounted for about one third of total 
specimens respectively. (B) Age and region information was plotted for each 
specimen. 
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After nerve activity stabilized, the mechanosensitive hotspot was identified by 
systematical probing using the blunt end of glassware. Once identified, the 
mechanosensitivity was examined by applying three distinct types of stimuli. 
Probing was applied on the hotspot with calibrated von Frey hair (4g, 10g and 60g 
force; each probing applied at least 5 times for a period of 2 seconds with a 3-second 
interval). Similarly, fine mucosal stroking was applied on the receptive field with 
calibrated von-Frey hair (1g or 4g force). In addition to probing and stroking, stretch 
was applied circumferentially and longitudinally using forceps.  
 
Following mechanical stimulation, a variety of chemical stimuli were applied 
directly onto the receptive fields using a pipette, including bradykinin (10 µM), 
capsaicin (0.1~10 µM), AITC (10~1000 µM), 5-HT (10~100 µM) and histamine 
(10~300 µM). Volume of capsaicin applied was 0.2 ml, while volume of the other 
drugs was 1 ml. The total volume of the organ bath was about 60 ml. During the 
application of drug, the perfusion pump was left on so that the drug could be washed 
out quickly. Time interval between two drugs was at least 10 minutes. 
 
Data were analyzed offline using Spike 2 software. In the case that activities of 
multiple units were recorded from the same nerve bundle, single unit analysis was 
performed to discriminate activities of each unit. Data were expressed as mean 
afferent discharge frequency ± SEM.    
                                                                                                                   Chapter 4 
 102 
4.3 Success rate of recording 
The overall success rate of human afferent recording in current study is 45% (20 in 
45 specimens). Success here was defined as nerve activities recorded. Among the 20 
successful recordings, 8 specimens were responsive to the stimuli applied, whereas 
the remaining 12 either did not show prominent responses or stopped firing before 
application of any stimuli. Figure 4.2B illustrated the possible correlation between 
success rate and the age and region of specimens. Descending colon appeared to 
have a higher chance of successful recording, whereas ascending and transverse 
colon showed the least chance. Age seemed to have no effects on the success rate of 
recording.   
 
Figure 4.2 Success rates of recording and its correlation with the age and region of 
specimens. (A) A pie chart shows that 45% recording were successful, which is defined as 
nerve signal recorded. Among these recordings, only 8 in 20 were responsive. (B) 
Correlation between success rate and the age and region of specimens. Red dots indicate 
responsive recordings, and green dots label non-responsive recordings with spontaneous 
nerve activities. 
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4.3 Afferent subtypes determined by mechanosensitivity 
As introduced above, afferents can be classified based on their responses to three 
kinds of mechanical stimuli: probing, mucosal stroking and stretch. Representative 
traces of afferent responses to these stimuli were shown in figure 4.3. Spontaneous 
burst firing might be a character of certain nerve subtype, and thus was noted as well. 
 
As summarized in table 4.2, about 29% (10 in 34) of identified units innervating 
human bowel were mechanosensitive afferents, whereas 71% (24 in 34) were 
mechanically-insensitive afferents (or silent afferents). Among the mechanically-
sensitive units, four types of afferents were identified: mesenteric, serosal, muscular 
and mucosal afferent. Serosal afferents were the most abundant class, accounting for 
50% (5 in 10) of total mechanosensitive units. The other subtypes were relatively 
scarce. Spontaneous burst firing appeared to be a common character shared by 
various afferent subtypes. 
 
Figure 4.3 Sample traces to show spontaneous burst firing (A) and afferent responses to 
probing (B), stretch (C) and mucosal stroking (D).  Upper channels in each trace showed 
the nerve activities, and lower channel displayed corresponding firing frequency. Age, 
gender and region of the sources of these specimens were 58-female ileum (A), 77-male 
ascending colon (B), 77-male ascending colon (C) and 42-male sigmoid colon (D). 
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Table 4.2 Afferent subtypes identified in human bowel 
 
Classification  Number of units 
Spontaneous 
burst firing  Probing 
Mucosal 
stroking Stretch 
Mesenteric 
afferent 2 Yes Yes No No 
Serosal afferent  5 1: Yes   4: No  Yes No No 
Muscular 
afferent  2 1: Yes   1: No  Yes No Yes 
Mucosal afferent  1 Yes Yes Yes No 
Unclassified 24 7: Yes   17: No No No No 
 
 
Afferent discharges in response to graded probings (4g, 10g and 60g) were 
dramatically increased in a serosal afferent (figure 4.4A). However, repeated probing 
with constant force resulted in gradually decreased afferent responses (figure 4.4B). 
This might be due to either adaptation or desensitization.  
 
 
Figure 4.4 Sample traces to show afferent responses to graded probing force (A) and 
adaptation in repeated probing (B) on a serosal afferent. (A) Probing with increased 
force (4g, 10g and 60g) was applied with calibrated von Frey hair. Each probing lasted for 2 
seconds with a 3-second time interval from another. Graded probing resulted in increased 
afferent discharges. (B) Afferent responses to repeated probing (10g) were gradually 
decreased. Upper channels showed the nerve activities, and lower channel displayed 
corresponding firing frequency. Age, gender and region of the source of this specimen were 
67-female sigmoid colon. 
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4.4 Chemical sensitivity 
A variety of chemical stimuli were applied directly onto the receptive fields 
identified by probing. Our results demonstrated that bradykinin (10 µM), capsaicin 
(0.3~1 µM), AITC (300 µM) and 5-HT (10 µM) were able to trigger afferent 
responses in human bowel. Single unit analysis was performed to discriminate 
responsive units and non-responsive units. Representative traces to show these 
responses were displayed in figure 4.5.  
 
 
 
Figure 4.5 Representative traces to show afferent response to 10 µM bradykinin (A), 1 
µM capsaicin (B), 300 µM AITC (C) and 10 µM 5-HT (D). Top channels (green 
waveform) displayed raw nerve activities. The middle channels showed discriminated 
activities of responsive units (in purple) and non-responsive units (in blue) separated by 
single unit analysis. Bottom channels displayed firing frequency of the responsive units only. 
Age, gender and region of the sources of these specimens were 42-male sigmoid colon (A), 
77-male ascending colon (B), 42-male sigmoid colon (C) and 77-male ascending colon (D). 
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Characterisations of chemosensitive afferents were summarized in table 4.3. The 
most potent chemical stimulus in this study was bradykinin, which triggered marked 
afferent discharges from 4 in 17 examined units (those 4 units from different 
experiments). Bradykinin sensitive units were composed of two subpopulations: one 
was mechanosensitive serosal afferent associated with co-response to AITC, whereas 
the other was mechanically-insensitive unit without co-response to AITC. 2 in 24 
units (those 2 units from different experiments) were capsaicin sensitive, including 
one muscular afferent and one serosal afferent. AITC induced increased afferent 
discharge from 2 out of 19 units (those 2 units from different experiments), both of 
which were mechanosensitive serosal afferent with co-response to bradykinin but 
without co-response to capsaicin. Only 1 in 8 units was responsive to 5-HT, and it 
was a muscular afferent that was capsaicin sensitive. 
 
Table 4.3 Characterization of chemosensitive units 
 
Drug Responsive proportion 
Unit 
Number 
Co-response to 
 Burst Probing Mucosal stroking Stretch 
Afferent 
subtype  BK CAP AITC 5-HT 
BK 
10µM 
4/17 
 
2 - No Yes 1: no 1: NT No Yes No No 
Serosal 
afferent 
2 - No No NT No No No No Silent afferent 
CAP 
1 µM 
2/24 
 
1 NT - NT Yes No Yes No Yes Muscular afferent 
1 No - No NT Yes Yes No No Serosal afferent 
AITC 
300 µM 2/19 2 Yes No - 
1: no 
1: NT No Yes No No 
Serosal 
afferent 
5-HT 
10 µM 1/8 1 NT Yes NT - No Yes No Yes 
Muscular 
afferent 
 
BK: bradykinin, burst: spontaneous burst firing, CAP: capsaicin, NT: not tested, -: not applicable. 
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Afferent discharges in response to bradykinin were compared among three sigmoid 
colon obtained from patients of different ages. Based on these three recording, 
afferent responses to bradykinin in the elderly appeared to be blunted and possibly 
delayed (figure 4.6).  
 
 
Figure 4.6 Afferent responses to bradykinin were decreased with advanced age in 
human sigmoid colon. Representative responses to 10 µM bradykinin in sigmoid colon 
from 42 years old (A), 55 years old (B), and 67 years old (C) patients. Bottom channels 
displayed firing frequency of the responsive units only.  (D) Response profile revealed that 
bradykinin induced afferent discharges were blunted and delayed in the elderly. 
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4.5 Hypersensitivity induced by bradykinin and AITC 
Effects of bradykinin treatment on mechanosensitivity were investigated by 
comparing afferent responses to probing after BK treatment with control. Based on 
one recording, afferent discharges in response to probing after bradykinin treatment 
were greater than control (18.9 ± 5.2 vs. 9.5 ± 2.3, figure 4.7C). Despite a 2-fold 
augment, it was not statistically significant (P =0.13), which was due to the large 
variations in treatment group.  As revealed in the representative trace (figure 4.7B), 
the first three probing responses were markedly increased in comparison with control, 
whereas the following three responses were greatly reduced due to either adaptation 
or desensitization.  
 
 
Figure 4.7 Afferent responses to probing might be augmented by bradykinin treatment. 
Representative traces showed afferent discharge induced by probing with 60g von Frey hair 
before (A) and immediately after (B) bradykinin response. 6 probing were applied for both 
groups. (C) Afferent discharge in response to probing after bradykinin treatment was greater 
than control (18.9 ± 5.2, N=6 vs. 9.5 ± 2.3, N=6), although this was not statistically 
significant (P =0.13, unpaired t-test). Data were obtained from one recording experiment on 
a 67-female sigmoid colon. 
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Similar to bradykinin, based on one recording, AITC treatment significantly 
enhanced afferent discharges induced by probing (12.4 ± 1.7, N=6 vs. 5.9 ± 0.6, N=6, 
P <0.01, unpaired t-test). It was noteworthy that AITC itself did not cause any 
change of afferent discharge. 
 
Figure 4.8 Afferent responses to probing are elevated by AITC treatment. Sample traces 
showed afferent discharge triggered by probing with 10g von Frey hair before (A) and 10 
minutes after (B) AITC application. 6 probing were applied for both groups. (C) Afferent 
discharge in response to probing after AITC treatment was significantly greater than control 
(12.4 ± 1.7, N=6 vs. 5.9 ± 0.6, N=6, P <0.01, unpaired t-test). Data were obtained from one 
recording experiment on a 67-female sigmoid colon. 
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4.6 Discussion 
Afferent subtypes determined by mechanosensitivity 
This study identified four subtypes of afferents innervating human bowel including 
mesenteric, serosal, muscular and mucosal afferents, based on their sensitivity to 
probing, stretch and mucosal stroking. In combination with recently published 
preliminary data from our group (Jiang et al., 2011), 15 mechanosensitive units can 
be classified into five subtypes: serosal (46%), muscular (27%), mesenteric (13%), 
mucosal (7%) and muscular/ mucosal (7%) afferent. Although the number of 
classified unit is relative small, to our knowledge, this is the first report about 
classification of human bowel afferent. The other group who also managed to record 
nerve activities from isolated human bowel set up preparations in a different way by 
pinning colon flat with serosal side up, which did not allow application of mucosal 
stroking and thus identification of afferent subtypes (Peiris et al., 2011). 
 
Similar studies have been performed on flat sheet preparations of mouse colon; 
however, such studies on mice allow discrimination of lumbar splanchnic nerves and 
pelvic nerves, and indeed these two pathways have been shown to contain distinct 
populations of mechanosensitive afferents (Brierley et al., 2004; Feng and Gebhart, 
2011). Our in vitro recording model on isolated human bowel doesn’t allow 
identification of nerve pathways, as the nerve recording sites are extremely close to 
the gut wall. Since the specimens which we record from cover the most regions of 
lower GI tract from ileum to rectum, afferents identified might belong to lumber 
splanchnic, pelvic or even vagal pathways. As such, direct comparison to studies on 
mouse is not reliable. However, there is one obvious similarity in the proportion of 
serosal afferent in total mechanosensitive units. Based on two studies on mouse 
colon, serosal afferents are usually the most abundant subtypes, occupying 47% or 
36% in lumbar splanchnic afferents and 37% or 33% in pelvic pathways (Brierley et 
al., 2004; Feng and Gebhart, 2011). In line with these reports, our data indicate that 
50% of mechanosensitive afferents innervating human bowel are serosal afferent. 
One of the limitations with this classification system is the lack of specific 
stimulation for submucosal, therefore it is possible that some of the units classified as 
serosal afferents actually terminate in the submucosa. 
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It is noteworthy that we found a high proportion of mechanical insensitive afferents 
(71%) innervating human lower GI tract. A study employing an electrical search 
strategy has revealed that about 23% of the pelvic afferents innervating mouse 
colorectum are normally mechanically insensitive (silent afferents), 71% of which 
are able to acquire mechanosensitivity after application of inflammatory soup to their 
receptive fields; whereas 33% of lumbar splanchnic afferents are mechanically- 
insensitive units, only 23% of which acquire mechanosensitivity after exposure to 
inflammatory soup (Feng and Gebhart, 2011). Our data indicate a much higher 
proportion of silent afferents. This might be attributed to species-related difference 
between human and mouse, considering the huge distinction in terms of the size of 
bowel. Another possibility is that some of these unclassified units might belong to 
mesenteric afferents. Considering the thickness and flexibility of human mesentery, 
probing on mesentery was often associated with high risks of losing the nerve, as 
such some of the specimens did not allow systematical application of probing on 
their mesentery.   
 
Based on limited data, we observed some characteristics of serosal afferent 
mechanosensitivity. In agreement with animal studies (Brierley et al., 2004), afferent 
discharges in response to probing with graded von Frey hair force (4g, 10g and 60g) 
were markedly increased. In addition, their responses to repeated consecutive 
probing adapted very fast.  
 
Chemical sensitivity 
Chemical sensitivity of visceral afferents innervating human bowel is nearly blank in 
the literature. Our recently published report has shown evidence of afferent response 
to capsaicin in human colon (Jiang et al., 2011). The other preliminary report on 
human visceral recording has revealed a robust increase in afferent discharge on 
human appendix elicited by capsaicin (10 µM) and inflammatory soup (PGE2 10 µM, 
histamine 10 µM, serotonin 1 µM, ATP 5 µM, adenosine 1mM and bradykinin 1 µM) 
(Peiris et al., 2011). In addition to capsaicin, this current study is the first one to 
provide direct evidence that afferent discharges could be elicited by bradykinin (10 
µM), AITC (300 µM) and 5-HT (10 µM) in isolated human ileum and colon.  
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Bradykinin is one of the most potent algogenic substances released from tissue injury 
and inflammation (Couture et al., 2001). A study using flat sheet preparations of 
mouse colon has reported that bradykinin elicits afferent discharges in 66% of 
lumbar splanchnic nerves, among which 10 in 27 are mechanically-insensitive 
afferents recruited during the application of bradykinin; conversely, only 2 in 19 
pelvic nerve afferents respond to bradykinin and both are mechanically sensitive 
(Brierley et al., 2005). 
 
In this study bradykinin was the most effective chemical stimulus that trigger marked 
afferent discharges from 4 in 17 tested units. Among the 4 responsive units, two units 
were mechanosensitive serosal afferents accompanied with the ability to co-response 
to AITC, whereas the other two were mechanically-insensitive units without co-
response to AITC. The two silent afferents did not acquire mechanosensitivity after 
responses to bradykinin. A study addressing mouse colorectal silent afferents has 
revealed that 71% of the silent pelvic afferents are able to acquire mechanosensitivity 
after application of inflammatory soup to their receptive fields; whereas only 23% of 
silent lumbar splanchnic afferents acquire mechanosensitivity after exposure to 
inflammatory soup (Feng and Gebhart, 2011). On the other hand, AITC induced 
increased afferent discharges from 2 out of 19 units, both of which were 
mechanosensitive serosal afferent with co-response to bradykinin. Previous studies 
have demonstrated that bradykinin is able to activate TRPA1 indirectly via 
bradykinin receptor 2 (B2), which is modulated by phospholipase C (PLC) and 
protein kinase A (PKA) pathways (Bandell et al., 2004; Bautista et al., 2006; Wang 
et al., 2008). In association with these studies, our data suggested that TRPA1 might 
be expressed in a subpopulation of B2 receptor-expressing afferents. Neither 
bradykinin sensitive nor AITC sensitive afferents co-responded to capsaicin, which 
is contrary to previous reports suggesting that TRPA1 is exclusively expressed in a 
subpopulation of TRPV1-present afferents (Story et al., 2003; Kobayashi et al., 2005; 
Bautista et al., 2005). However, some functional studies revealed that a proportion of 
mustard oil-sensitive neurons did not response to capsaicin (Kwan et al., 2006; 
Hjerling-Leffler et al., 2007). It is possible that some TRPV1 channels that are co-
expressed with TRPA1 are not functionally active. 
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In flat sheet preparations of mouse colon, afferent responses to probing are 
significantly increased after the chemosensory response to bradykinin (Brierley et al., 
2005; Brierley et al., 2009). Similarly, TRPA1 agonists AITC and cinnamaldehyde 
induce mechanical hypersensitivity of serosal afferents to probing (Brierley et al., 
2009). In agreements with these studies, we observed a short-term mechanical 
sensitization of serosal afferent to probing by bradykinin and AITC, in spite of fast 
adaptation to repeated probing. AITC treatment increased mechanosensitivity to 
probing whereas AITC itself did not elicit afferent discharges, which is consistent 
with mouse studies (Brierley et al., 2009). One possible explanation is that AITC 
activated TRPA1 on non-neuronal cells, such as EC cells, which release mediators to 
depolarize or sensitize afferent nerves. 
 
Studies on mouse showed that 14 in 40 serosal afferents respond to capsaicin, and 
mechanosensitivity was significantly reduced after chemical response to capsaicin 
(Brierley et al., 2009). Current study only identified 2 (out of 24) capsaicin sensitive 
units, including one muscular afferent and one serosal afferent. The effects of 
capsaicin on mechanosensitivity were not tested. Only 1 in 8 units was responsive to 
5-HT, and it was a muscular afferent that was capsaicin sensitive. Limited 
comparable data about serotonin sensitivity in flat sheet animal models can be seen, 
as it is often collectively applied with other mediators as inflammatory soup.  
 
In the current study, chemical stimuli were topically administrated onto the receptive 
field with a pipette.  Thus the concentration of drug hitting the receptor might be 
lower than stated due to diffusion. In addition, manual application of drug reduced 
the accuracy. However, considering the size of human specimen and organ bath, 
perfusion into the bath brought more limitations, such as large consumption of drug, 
difficulty in washing out, delayed response and potential indirect effects. 
  
Ageing on afferent sensitivity  
Efforts have been made to examine the influence of ageing on human bowel afferent 
sensitivity. However, since human bowel specimens were obtained from various 
regions (ileum, colon and rectum) of patients within different age groups (from 24 to 
88) and of both genders, so many variables required a large number of successful 
recordings to make variable-controlled comparisons. In addition, afferents classified 
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into different subtypes (serosal, mesenteric, muscular, mucosal and muscular/ 
mucosal) might be not comparable directly.  
 
Based on very limited data, afferent discharges in response to bradykinin in human 
sigmoid colon appeared to be blunted in the elderly, which is consistent with our 
unpublished data on mouse. This indicates an attenuated sensitivity to inflammatory 
events in the elderly. The underlying mechanisms are not fully understood. Our 
studies on mice have identified some possible contributors, such as reduced primary 
innervation with advanced age (chapter 6). Whether this applies to human requires 
further investigation. In addition, changes in the expression of bradykinin receptor 
and some secondary messengers in bradykinin signaling pathway might contribute to 
the reduced afferent response to bradykinin. 
 
Success rate 
Current study managed to record afferent nerve activities from 45% of human bowel 
specimens, which is higher than a 15% success rate in our preliminary report (Jiang 
et al., 2011) and similar to 48% of the other group (Peiris et al., 2011). All these 
studies are greatly limited by the low success rate, reflecting the inherent difficulties 
of in vitro recording on isolated human bowel. The difficulties might be owing to 
short tissue supply, low specimen viability, adverse surgical influence and technical 
problems. However, accurate causes for the failure are not clear.  
 
It is suggested that some factors could affect functional studies with human tissues, 
such as the type of surgery (laparoscopic or open), ischaemia time, time of 
equilibration in the organ bath and possible influence by drugs given during surgery 
(Sanger et al., 2013). We tried to find out the possible influence of surgery (type of 
surgery, surgeon, ischaemia time and use of cauterization) when possible. Based on 
limited information from a small proportion of cases, it seemed that these factors 
were not decisive.  Although it is possible that these factors might influence the 
chance of successful recording, there is not sufficient information to make 
systematical analysis. We were not aware about the drugs given during the surgery. 
Overcoming of these limitations might help to figure out potential ways of increasing 
success rate. We did not found any obvious influences by time of equilibration, 
diagnosis of patients, transferring time from theatre to organ bath and preparation 
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setup. In addition, there was no obvious correlation between success rate and the 
ages of patients. Regarding to the region, descending colon appeared to have a higher 
probability for successful recording, whereas ascending and transverse colon showed 
the least chance. It is likely that the success rate of human bowel recording is 
determined by summation of a variety of factors.  
 
Even though nerve activities were successfully recorded, 60% of these specimens did 
not show any significant response to mechanical and chemical stimuli applied. This 
might be due to a smaller proportion of sensory afferents in the nerve bundles 
identified comparing with efferent or a substantial proportion of mechanically-
insensitive units. It is difficult to apply chemical stimuli if the receptive fields are not 
identified, as the huge size of organ bath consumes too much drugs and time to wash 
out. Another reason might be that many specimens did not allow systematical 
probing, which is associated with high risk of losing the nerve.   
 
A prominent difference between human and mouse afferent recording is the “level” 
of recording sites, which refers to the distance away from the terminals and the 
volume of afferent fibers. In a typical recording on mouse jejunum, recording site is 
far away from the gut wall and usually about 10-15 afferent units can be recorded. 
Whereas in human specimens, recording sites might be very close to the gut wall 
considering the relative size of human bowel, and typically only 1 or 2 units can be 
identified. This difference decreases the chance to get responsive units in human 
bowel. 
 
Despite obvious technical challenges, this human in vitro afferent recording model at 
the peripheral afferent level has enormous advantages, such as avoiding translational 
failures, test of compounds for clinical use and better understanding of the 
mechanisms underlying human bowel disorders. 
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Interplay between EC cells, mast cells 
and TRPA1 in afferent signaling from 
mouse intestine  
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5.1 Introduction 
Inflammation is a normal biological response to harmful stimuli, such as pathogens, 
tissue injury or irritants, which activate neuronal, immune and epithelial cells to 
initiate protective and healing process. In response to harmful stimuli, a variety of 
cells in the damaged area release inflammatory mediators including bradykinin, 
prostaglandins, ATP, adenosine, leukotrienes, histamine, proteases, tumor necrosis 
factor-α, interleukin-1β and glutamate, some of which activate a subpopulation of 
primary afferents that release inflammatory neuropeptides such as substance P, 
CGRP and neurokinin A. 
 
The link between TRPA1 and inflammatory pain was first indicated by the 
observation that AITC (mustard oil), an inducer of neurogenic inflammation and 
hypersensitivity, is a specific agonist of TRPA1 (Jordt et al., 2004). Further evidence 
has revealed that activation of TRPA1 elicits acute nociceptive behavior in mice, 
followed by neurogenic inflammation and marked hypersensitivity to thermal and 
mechanical stimuli, which is absent in TRPA1 knockout animals (Bandell et al., 
2004; Bautista et al., 2006). 
 
In addition to generating nociceptive sensation, TRPA1 expressing afferents release 
neuropeptides to communicate with other cell types and modulate inflammatory 
response. In animal model of colitis induced by TNBS and DSS, activation of 
TRPA1 elicits marked release of SP and CGRP; furthermore, SP knockout mice are 
protected from colitis, while CGRP mutants show a more severe course of TNBS 
colitis, indicating a proinflammatory effect for SP and a protective role for CGRP 
(Engel et al., 2011). This is in agreement with observations that pharmacologic block 
of the SP receptor using a neurokinin 1 antagonist significantly attenuates TNBS and 
DSS colitis (Di Sebastiano et al., 1999; Stucchi et al., 2000); on the other hand, 
treatment with a CGRP receptor antagonist augments the severity of inflammation 
(Reinshagen et al., 1998), and exogenous administration of CGRP markedly 
ameliorates TNB colitis (Evangelista and Tramontana, 1993). Interestingly, 
CGRP/SP double-knockout mice are completely protected against TNBS colitis, 
suggesting that the proinflammatory effect of SP is predominant over the protective 
effect of CGRP (Engel et al., 2011). Moreover, activation of neurokinin 1 (NK1) 
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receptors contributes to somatic hypergesia and stress-induced visceral hyperalgesia 
(Mantyh et al., 1997; Bradesi et al., 2006). 
 
TRPA1 and mast cells 
Some neuropeptides released by TRPA1 activation promote communications 
between nerves and mast cells. SP can induce degranulation of mast cells 
accompanied with release of histamine, tryptase and serotonin (Shanahan et al., 1985; 
Repke and Bienert, 1987), which in turn, activate afferent nerve through 
corresponding receptors on the terminals (Corvera et al., 1999; Nozdrachev et al., 
1999; Breunig et al., 2007). These bi-directional interactions might form a positive 
feedback loop to amplify inflammatory responses. 
 
As IBS patients display a lower pain threshold to stimulation in colon-rectum 
(Sinhamahapatra et al., 2001; Dong et al., 2004) and also skin (Verne et al., 2001), 
mast cell induced hypersensitivity has been thought the most likely mechanism 
accounting for the recurrent pain and discomfort in IBS patients. As introduced in 
previous chapters, many independent lines of evidence have provided support for this 
mechanism. However, it hasn’t been fully understood what mediators from mast 
cells and what subtypes of afferents nerves are involved. 
 
Intracolonic administration of protease-activated receptor-activating peptide (PAR2-
AP) augments visceromotor responses to graded colorectal distension (Cattaruzza et 
al., 2010). PAR2-AP can induce mechanical hypersensitivity of vagal afferents to 
esophageal distension, which is inhibited by TRPA1 antagonist (Yu et al., 2009). 
These observations suggest that protease released from mast cells might sensitize 
TRPA1 expressing afferent nerves through PAR2 receptors. In addition to protease, 
evidence has implicated histamine in the interaction between TRPA1 and mast cells 
(Andrade et al., 2008; Hox et al., 2012). 
 
TRPA1 and EC cells  
TRPA1 expression has been described in both myenteric neurons (Penuelas et al., 
2007; Poole et al., 2011) and extrinsic neurons innervating mouse intestine (Brierley 
et al., 2009). Most interestingly, it has been demonstrated that TRPA1 is highly 
expressed in EC cells, and activation of TRPA1 significantly increases serotonin 
                                                                                                                    Chapter 5 
 119 
release from enriched rat EC cell fraction, a rat endocrine cell line RIN14B (Nozawa 
et al., 2009) and a human pancreatic endocrine cell line QGP-1 (Doihara et al., 2009). 
This observation provides a crucial link between TRPA1 and serotonergic signaling. 
Serotonin, as the major transmitter molecule within the GI tract, plays an essential 
role in the orchestration of motility and secretion reflexes to facilitate intestinal 
transition and digestion under physiological conditions and in the initiation of 
inappropriate secretomotor activity and sensation under pathophysiological state, 
such as nausea or pain. 
 
Serotonin can act on a number of G-protein coupled receptors as well as one ligand-
gated channel known as 5-HT3, which has been extensively studied in the context of 
sensory signaling. Serotonin directly activates nodose ganglion neurons (Peters et al., 
1993) and DRG neurons (Todorovic et al., 1997) via 5-HT3 receptor. In addition, 
serotonin excites human enteric neurons via 5-HT3 receptors, which may comprise 
both 5-HT3A and 5-HT3B subunits (Michel et al., 2005). 5-HT3B subunit has been 
shown to be a major determinant of receptor function (Davies et al., 1999). 
 
A recent study on TPH1 deficient mouse has observed a much slower propulsion 
with larger faecal pellets as well as reduced colonic migrating motor complexes and 
reduced responses to intraluminal balloon distension (Heredia et al., 2013). 
Additionally, the spontaneous afferent activity in small intestine is attenuated by 5-
HT3 antagonist granisetron (Hillsley et al., 1998). These observations suggest an 
essential role of mucosal 5-HT in normal gastrointestinal motor reflexes and 
mechanosensitivity.  
 
In addition to physiological activities, serotonin is also implicated in pathogenesis of 
multiple GI disorders. Study on rat model of inflammatory pain has revealed an 
antinociceptive role of 5-HT3 receptor antagonist ondansetron (Butkevich et al., 
2007). Intrathecally administered 2-methyl-5-HT produced antinociception against 
formalin-induced inflammatory pain in neonatal rat (Giordano, 1997). In clinic, 5-
HT3 receptor antagonists represent a class of antiemetics that are commonly used on 
cancer patients undergoing chemotherapy and radiotherapy. Moreover, 5-HT3 
receptor antagonists are effective in relieving symptoms in patients with diarrhoea-
predominant IBS (Camilleri et al., 2001) 
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Since TRPA1 is present on EC cells, which is the major source of 5-HT within the 
gut, TRPA1 might be implicated in the various physiological and pathological 
process mediated by 5-HT.  
 
Bradykinin 
Bradykinin, one of the most potent algogenic substances released from tissue injury 
and inflammation (Couture et al., 2001; Bandell et al., 2004), elicits acute pain 
through immediate excitation of nociceptors, followed by a lasting sensitization to 
mechanical and thermal stimulations (Dray and Perkins, 1993). Many studies have 
addressed the mechanism underlying bradykinin-induced hyperalgesia. It has been 
revealed that bradykinin sensitizes TRPV1 through B2 receptor and PLC pathway 
(Chuang et al., 2001), whereas some evidence has implied that this pathway is not 
predominant based on the observation that afferent response to bradykinin in TRPV1 
knockout mice is not altered (Rong et al., 2004). However, studies on TRPA1 
deficient mice have reported a significant attenuation in bradykinin induced 
nociceptors excitation and pain hypersensitivity (Bautista et al., 2006; Kwan et al., 
2006). 
 
Similar to TRPA1, Bradykinin receptor 2 (B2) is expressed in a subpopulation of 
TRPV1-expressing nociceptors (Kasai et al., 1998). Bradykinin activates 78% of 
cinnamaldehyde-responsive rat DRG neurons (Bandell et al., 2004). AITC activates 
31.67% of rat DRG neurons and 65.22% of bradykinin-responsive neurons (Wang et 
al., 2008). 97% of mouse trigeminal neurons that exhibit large response to 
bradykinin are mustard oil sensitive (Bautista et al., 2006). These independent lines 
of evidence suggest a large overlap of TRPA1 expression and bradykinin receptor 
expression in primary sensory neurons. Based on heterologous-expression studies, 
TRPA1 might be functionally coupled to B2 receptor, as suggested by the acute 
current response to bradykinin on cells expressing both TRPA1 and B2 receptors 
(Bandell et al., 2004). However, another in vitro recording study has revealed that 
TRPA1 antagonist does not affect BK-evoked discharges in nodose and jugular C 
fibers (Yu and Ouyang, 2009). In addition, afferent response to bradykinin is not 
altered in TRPA1 knockout mouse colon (Brierley et al., 2009), making it still 
controversial whether bradykinin can activate TRPA1. 
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Figure 5.1 A schematic graph illustrating functional interactions between bradykinin 
receptors, TRPA1 and TRPV1 (Bautista et al., 2006). Binding of bradykinin to its 
corresponding G protein-coupled receptors on primary afferents activates phospholipase C 
(PLC), which results in the hydrolysis of membrane phosphatidylinositol bisphosphate 
(PIP2), activation of protein kinase C (PKC), and release of calcium from intracellular stores. 
Consequently, TRPV1 is sensitized and open. TRPA1 might open in response to both 
calcium release from intracellular stores and calcium influx via TRPV1. 
 
 
TRPA1 and TRPV1 
TRPA1 and TRPV1 channels both belong to the TRP superfamily and share some 
structural similarity. Increasing evidence has suggested that TRPA1 and TRPV1 
interlink with each other to a considerable extent, especially in the context of pain 
and neurogenic inflammation. TRPA1 has been shown to be exclusively expressed in 
a subpopulation of unmyelinated, peptidergic nociceptors that also express TRPV1 
(Story et al., 2003; Kobayashi et al., 2005; Bautista et al., 2005), although some 
functional studies have argued that a proportion of mustard oil-sensitive neurons did 
not response to capsaicin (Kwan et al., 2006; Hjerling-Leffler et al., 2007). Due to 
co-expression of TRPV1/A1 in intestinal afferents, activation of either channel 
results in similar downstream effects, such as neuropeptide release and hyperalgesia. 
It has been shown that afferent responses to capsaicin tend to increase in TRPA1 
knockout mouse colon (Brierley et al., 2009).  
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Objectives 
Preliminary data from our group has shown that AITC induces increase in afferent 
discharge from mesenteric afferents innervating mouse jejunum in a dose dependent 
manner (Jiang et al., 2012). This chapter further addressed following objectives: 
 
1) to examine the involvement of bradykinin in TRPA1 signaling; 
2) to assess the mechanical hypersensitivity induced by AITC and 
bradykinin; 
3) to examine the effect of 5-HT3 receptor antagonist on TRPA1 signaling; 
4) to examine the effect of mast cell stabilizer on TRPA1 signaling; 
5) to test the effect of TRPA1 agonist AITC on intestinal motility; 
6) to evaluate TRPA1 signaling on TRPV1 knockout mice.  
 
 
                                                                                                                    Chapter 5 
 123 
5.2 Experimental protocol and analysis 
Extracellular recording on mouse jejunum was performed as described in chapter 2. 
Once the nerve activities were stabilized, a number of distensions were applied at an 
interval of 15~20 minutes. Prior to the commencement of any protocol, at lease three 
reproducible responses to distension were achieved. 
 
Afferent response to AITC and bradykinin 
AITC working solution (final volume at 20 ml) was diluted from fresh-made stock 
(10 mM) with Krebs and perfused into the organ both (volume at about 9 ml) at a 
rate of 10 ml/min. To investigate the dose-dependent responses to AITC, a range of 
concentrations (100 µM, 300 µM and 1mM) were applied orderly with an interval at 
20 minutes. 
 
Bradykinin stock (10 mM) was diluted to 10 µM working solution with Krebs. 1 ml 
working solution was administered into a corner of the organ bath (about 9 ml) using 
a pipette to make the final concentration at 1 µM. 
 
Effects of antagonists or inhibitors on TRPA1 signaling 
Control experiments were performed by applying two repeated doses of AITC or 
bradykinin with time intervals at about 40 minutes. In treatment groups, HC-030031 
(30 µM), granisetron (10 µM) or cromolyn (100 µM) were perfused into organ bath 
10~15 minutes prior to the second application of agonists so that Krebs in the bath 
was replaced by antagonist solution. Time interval between applications of agonists 
was consistent with control. After responses to agonists finished, antagonist solution 
was washed out by fresh Krebs.  
 
TRPA1 and contractility  
Mouse jejunum segments were set up and nerve activities were recorded in the same 
way as routine afferent recording. To assess the contractility of the jejunal 
preparation, the tissue was slightly distended to 5 mmHg. The infusion pump was 
then closed, whereas the connection to the pressure transducer was maintained to 
allow the real-time detection of the intraluminal pressure that was used to reflect the 
contractility. After the pressure stabilized, AITC (300 µM) were perfused into the 
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organ bath consistently. To examine the effect of 5-HT3 antagonist on AITC induced 
contraction, granisetron (30 µM) was perfused into organ bath 10~15 minutes prior 
to the second application of AITC. At the end of each experiment, 1 µM carbachol 
was applied as a positive control. The contractions induced by AITC were calculated 
as the peak intraluminal pressure subtracted by baseline pressure within 30 second 
bins. These changes in pressure induced by AITC were normalized against 
carbachol-induced contractions. 
 
TRPA1 signaling in TRPV1 knockout mice 
TRPA1 signaling induced by AITC in TRPV1 knockout mice was assessed and 
compared with their wildtype littermates. All experimental procedures were 
consistent with that on normal wildtype mice. 
 
Single unit analysis 
Afferent units were classified into low threshold (LT), wide dynamic range (WDR) 
and high threshold (HT) based on their response profile to graded pressure. An 
objective classification method that introduced a parameter referred to as LT% was 
described previously (Raybould, 1998). LT% is the ratio of the afferent discharges at 
20 mmHg in the response at 50 mmHg. A value around 40% indicates a linear 
increase in afferent discharges in response to ramp distension. <15% was used as the 
criteria for the HT and >55% for the LT. However, these criteria were too strict for 
high threshold units. In this study, units with a threshold>5 mmHg were classified 
into high threshold units.  
 
Data analysis 
Data are presented as frequency of afferent discharges (number of action potentials 
per second). All data are expressed as mean ± SEM from the N values, where N 
refers to the number of animals or preparations. 
 
The changes in afferent discharges in response to AITC or bradykinin were analyzed 
in two ways, peak response and response time course. Peak response was quantified 
as maximum firing frequency in a 30-second bin subtracted by baseline frequency 
before the application of drugs. To compare two or more peak responses, student’s t-
test or one-way ANOVA were performed. P value <0.05 was considered as 
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significant. Response profile showing the time course of changes in mean firing 
frequency was obtained from XY View measurements of Spike 2. Two-way 
ANOVA was used to compare two or more groups of changes over time. 
 
The afferent response to ramp distension was plotted as increase in afferent firing 
frequency against increase in intraluminal pressure from 0 to 60 mmHg. Data were 
extracted using a script. To analyze whether distension responses were significantly 
changed, two-way ANOVA with Sidak multiple comparisons test was used. 
 
Some representative images of afferent recording are shown in this and next chapter. 
Unless otherwise stated, the three channels as shown in the below image display 
nerve activities, pressure and firing frequency, respectively. 
 
 
Nerve 
activity 
Pressure 
Discharge 
frequency 
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5.3 TRPA1 signaling induced by AITC and bradykinin 
Perfusion of AITC into organ bath consistently induced increase in afferent 
discharge from mesenteric afferents innervating mouse jejunum. These afferent 
responses were mediated via TRPA1, as they were significantly attenuated by HC-
030031, a selective TRPA1 antagonist (P<0.01, figure5.2 D&E). By discrimination 
of different afferent subtypes, low threshold (LT) units, wide dynamic range (WDR) 
units and high threshold (HT) units were all implicated in AITC induced TRPA1 
signaling, and LT afferents appeared to contribute more than HT (figure 5.2F). In 
addition, HC-030031 appeared to be effective on all three subpopulations, although 
only WDR and HT units achieved significance (figure 5.2G).  
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Figure 5.2 AITC induced afferent response was mediated by TRPA1. (A) Sample trace 
to show afferent response to 300 µM AITC was attenuated by TRPA1 antagonist HC-
030031 (30 µM). (B&C) Repeated application of 300 µM AITC induced reproducible peak 
responses (61.1±11.2 vs. 57.8±9.3 vs.54.5±9.1, P=0.895, N=8, one-way ANOVA) and 
response profiles (P=0.854, two-way ANOVA). (D&E) Response profile to 300 µM AITC 
was blunted by HC-030031 (P< 0.05, two-way ANOVA) with a reduced peak response 
(61.9±8.4 vs. 33.3±4.8, P<0.01, paired t-test), N=6. (F) Response profiles of different 
afferent subtypes to 300 µM AITC, P= 0.396, N=6 two-way ANOVA. (G) Peak response of 
high threshold (6.5±1.9 vs. 3.4±1.2, P<0.05) and wide dynamic range (14.2±3.6 vs. 8.1±2.5, 
P<0.01) units were significantly attenuated by HC-030031, P=0.151 for low threshold units 
(14.3±5.2 vs. 8.8±2.8). N=6, paired t-test. 
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Bradykinin (1 µM) triggered potent afferent response from jejunal afferent nerves. 
These responses were significantly inhibited by HC-030031 (P<0.01, figure 5.3B), 
suggesting TRPA1 activation was involved. Similar to AITC, bradykinin evoked all 
three afferent subpopulations, and LT units contributed more than HT (P<0.05, 
figure 5.3D). Inhibition of HC-030031 on bradykinin response was not selective for 
any afferent subpopulation (figure 5.3E).  
 
At a rough estimate, more than 80% and 90% units participated afferent signaling 
induced by AITC and bradykinin, respectively. The ratio between direct activation 
and secondary activation was not clear. 
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Figure 5.3 Bradykinin induced afferent discharges involved TRPA1 activation. (A) 
Representative trace to show afferent response to bradykinin (1 µM) was attenuated by HC-
030031 (30 µM). (B) Peak responses to BK were significantly attenuated by HC-030031 
from 88.1±11.9 to 64.1±8.0, P<0.01, N=5, paired t-test. (C) Response profile to BK, BK 
with HC-030031 and washout. BK vs. BK+HC-030031, P= 0.053, N=5, two-way ANOVA. 
P<0.05 at time points of 20 and 30 seconds. (D) Response profile of different afferent 
subtypes in response to BK, P= 0.101 for all. LT vs. HT, P<0.05, two-way ANOVA. (E) 
Peak responses of different afferent subtypes to BK. P= 0.212, 0.062 and 0.076 for low 
threshold (45.5±15.3 vs.38.9±11.8), wide dynamic range (22.7±5.5 vs. 13.4±2.4) and high 
threshold units (6.3±2.2 vs. 4.2±1.5), N= 5, paired t-test.  
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To investigate if AITC and bradykinin induce hypersensitivity to mechanical stimuli 
in this in vitro recording model, afferent responses to ramp distension before and 
after the application of AITC or bradykinin were analyzed. As a result, no obvious 
mechanical sensitization caused by AITC (300 µM) or BK (1 µM) was observed for 
total firing (figure 5.4 & 5.5). After further discrimination of different afferent 
subtypes, there were no significant alterations for low threshold, wide dynamic range 
and high threshold units as well.  
 
 
Figure 5.4 Effects of AITC on afferent responses to ramp distension. (A) Total afferent 
responses to ramp distension up to 60 mmHg before and after AITC treatment (300 µM) did 
not show any dramatic difference. P= 0.817. (B-D) No significant alterations were observed 
for low threshold units (P= 0.478), wide dynamic range units (P= 0.812) and high threshold 
units (P= 0.854). N= 10 for each group, two-way ANOVA. 
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Figure 5.5 Effects of bradykinin on afferent response to ramp distension. (A) Total 
afferent response to ramp distension up to 60 mmHg was not significantly changed by 
bradykinin treatment (1 µM), P= 0.795. (B-D) No significant changes were observed for low 
threshold units (P= 0.987), wide dynamic range (P= 0.866) and high threshold units (P= 
0.716). N= 10 for each group, two-way ANOVA. 
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5.4 Effect of granisetron on TRPA1 signaling 
As shown in figure 5.6, the increase in afferent discharge in repsonse to AITC (300 
µM) was significantly attenuated by granisetron (10 µM), a selective 5-HT3 receptor 
antagonist, indicating that serotonin was implicated in AITC-induced TRPA1 
signaling. Single unit analysis revealed that responses of LT, WDR and HT all 
appeared to be inhibited by granisetron, although WDR and HT were not statistically 
significant. 
 
The washout response to AITC did not recover, which might be due to insufficient 
washing time.  
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Figure 5.6 Granisetron attenuated afferent response to AITC. (A) A representative trace 
to show that afferent response to 300 µM AITC was attenuated by 10 µM granisetron. (B) 
Peak afferent discharge in response to 300 µM AITC was significantly reduced by 
granisetron from 68.5±7.7 to 39.7±6.1, P<0.05, N=7, paired t-test. (C) Time course of the 
response to AITC with or without granisetron. Granisetron significantly blunted afferent 
response to AITC, P<0.05, two-way ANOVA. (C) Response of all afferent subpopulations 
appeared to be reduced by granisetron, whereas only low threshold units achieved 
significance, 18.0±2.4 vs. 13.3±3.3, P<0.05. WDR: 18.7±5.1 vs. 10.1±1.9, P= 0.115; HT: 
14.3±2.5 vs. 6.6±1.5, P= 0.089, paired t-test. 
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5.5 Effect of cromolyn on TRPA1 signaling 
As shown in figure 5.7, the increase in afferent discharge in repsonse to AITC (300 
µM) was significantly attenuated by mast cell stabilizer cromolyn sodium (100 µM), 
suggesting that mast cells might be involved in AITC-induced TRPA1 signaling. 
Similarly, single unit analysis did not find prominent selectivity for cromolyn’s 
inhibition effect on LT, WDR and HT units, although only WDR units were 
statistically significant. 
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Figure 5.7 Cromolyn inhibited afferent response to AITC. (A) Example recording trace 
to show the inhibition of cromolyn sodium (100 µM) on AITC (300 µM) induced afferent 
discharges. (B) Peak afferent response to AITC was significantly attenuated by cromolyn, 
64.9±6.4 vs. 50.1±6.4, P<0.01, N=6, paired t-test. (C) Response profile to AITC was blunted 
by cromolyn, P= 0.619, two-way ANONVA. (D) Responses of all three subpopulations 
appeared to be inhibited by cromolyn, while only wide dynamic range units reached 
significant level, 26.1±4.2 vs. 18.3±2.9, P<0.01. LT: 18.8±4.7 vs. 15.2±3.0, P=0.154; HT: 
8.3±2.9 vs. 5.5±2.4, P= 0.051, N=6, paired t-test. 
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5.6 TRPA1 and contractility 
Although interfered by spontaneous contractions sometimes, in most jejunum 
preparations, AITC (300 µM) elicited prominent increases in intraluminal pressure  
which reflected increased contractile activity. This observation suggested that AITC 
induced TRPA1 signaling comprised indirect activation secondary to contraction. In 
addition, AITC induced contractions were abolished by 5-HT3 receptor antagonist 
granisetron (figure 5.8), indicating that these contractions were evoked through a 5-
HT3 receptor mediated pathway.   
  
 
Figure 5.8 AITC elicited contractions of mouse jejunum through a 5-HT3 pathway. (A) 
Sample recording trace to show AITC induced contractions and the inhibition of granisetron 
on this contraction. (B) AITC (300 µM) induced contraction were significantly suppressed 
by granisetron (30 µM), 107.3±22.8 vs. 19.2±2.2, P<0.05, N=5, paired t-test. Data were 
expressed as relative contraction normalized by 1 µM carbachol. 
B AITC-induced contraction
AITC AITC+granisetron   Washout
0
50
100
150
R
ela
tiv
e c
on
tr
ac
tio
n 
%
*
A 
N
er
ve
 
ac
tiv
ity
 
80
µ
V
 
 
Pr
es
su
re
 
5m
m
H
g 
Fi
rin
g 
fr
eq
ue
nc
y 
50
 s
pi
ke
/s
 
AITC AITC Granisetron 
50s 
                                                                                                                    Chapter 5 
 137 
5.7 TRPA1 signaling in TRPV1 knockout mice 
To assess TRPA1 signaling in the absence of TRPV1, afferent responses to AITC in 
the TRPV1 knockout mice were examined and compared with their wild type 
littermates. Jejunal mesenteric afferents displayed augmented responses to 100 µM, 
300 µM and 1 mM AITC in the knockout mice, although only peak response to 300 
µM achieved significance (P<0.05). Time courses of response shown in figure 5.9 
revealed that TRPV1 knockout mice had a shorter latency time before afferent 
discharges rose up.  
 
Figure 5.9 TRPA1 signaling in the TRPV1 knockout mice was augmented. (A) Peak 
responses to 100 µM, 300 µM and 1 mM AITC inTRPV1 knockout mice and wildtype 
littermates. WT vs. KO, 100 µM AITC: 40.6±6.9 vs. 64.2±16.6, P= 0.195; 300 µM: 58.5±5.9 
vs. 89.3±9.4, P< 0.05; 1 mM: 71.3±8.1 vs. 96.4±6.7, P= 0.059; N=6 for WT, N=5 for KO, 
unpaired t-test. (B-D) Time course of response to 100 µM, 300 µM and 1 mM AITC in 
TRPV1 WT and KO mice. P< 0.01 for 300 µM, P<0.05 for 1mM, P= 0.119 for 100 µM, 
two-way ANOVA. 
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5.8 Discussion 
This study employed in vitro afferent recording to assess TRPA1 sensory signaling at 
the level of a segment of mouse small intestine. Main findings were summarized as 
follows: 
 1) afferent responses to AITC and bradykinin were mediated by TRPA1; 
 2) 5-HT3 receptor antagonist granisetron attenuated TRPA1 signaling; 
 3) mast cell stabilizer cromolyn attenuated TRPA1 signaling; 
 4) AITC elicited contractile activities were inhibited by granisetron; 
 5) TRPA1 signaling was augmented in TRPV1 knockout mice. 
 
 
TRPA1 signaling induced by AITC and bradykinin 
Increases in afferent discharge elicited by TRPA1 agonist AITC were significantly 
inhibited by a selective TRPA1 antagonist, HC-030031. By discrimination of 
individual afferent units, more than 80% of afferents were implicated in TRPA1 
signaling, and low threshold units contributed more than high threshold units. 
However, different from wide dynamic range and high threshold units, low threshold 
afferents were not significantly inhibited by HC-030031.  
 
As introduced in the introduction of this chapter, it is controversial whether 
bradykinin can activate TRPA1. This study demonstrated that bradykinin induced 
increase in afferent discharge was significantly attenuated by TRPA1 antagonist HC-
030031. This is in agreement with the observation that TRPA1 knockout mice 
exhibit a reduced nociceptive behavior to subcutaneous bradykinin (Kwan et al., 
2006).  
 
Our preliminary data indicated that AITC did not induce any change in 
mechanosensitivity (Jiang et al., 2012). This study further discriminated different 
afferent subpopulations, and no significant alteration was observed for all three 
afferent subtypes. This is in agreement with a study on guinea pig that AITC (1 mM) 
perfusion for 30 minutes did not change esophageal distension-evoked vagal nerve 
action potentials (Yu and Ouyang, 2009). It has been demonstrated on mouse colonic 
flat sheet preparations that TRPA1 agonist AITC (40 µM) or cinnamaldehyde (100 
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µM) potentiate mechanosensitivity to probing in mesenteric, serosal and mucosal 
afferents instead of muscular afferents characterized by their responses to stretch 
(Brierley et al., 2009).  The type of mechanical stimulation might account for this 
disagreement. 
 
In line with AITC, bradykinin (1 µM) did not significantly sensitize afferent 
responses to ramp distension, which is not consistent with some evidence in the 
literature. Bradykinin (1 µM) has been shown to induce a slight sensitization to 
probing in splanchnic afferents but not pelvic afferents (Brierley et al., 2005). 
Perfusion of bradykinin (10 µM) for 30 minutes significantly augments vagal nerve 
response to esophageal distention in guinea pig. Bradykinin injection into mouse paw 
causes hypersensitivity to mechanical stimuli by measuring plantar withdrawal 
response 2 hours after injection(Kwan et al., 2006). In addition, a study has 
suggested that bradykinin at low doses (20 nM) doesn’t activate TRPA1 but sensitize 
this channel to agonist stimulation through PLC and PKA (protein kinase A) 
pathways (Wang et al., 2008). Hence the concentration of bradykinin, incubation 
time and target afferent subpopulation might produce variable results. 
 
Effects of granisetron on TRPA1 signaling 
The current study demonstrated that TRPA1 sensory signaling induced by AITC was 
significantly attenuated by 5-HT3 antagonist granisetron, which provided functional 
evidence that serotonin was implicated in TRPA1 signaling. Unpublished data from 
our group have demonstrated that AITC induced increased serotonin release from 
mouse jejunum preparations and BON cells (human EC cell model), which was in 
agreement with studies on enriched rat EC cells and rat endocrine cell line RIN14B 
(Nozawa et al., 2009). Combining these observations suggests that EC cells play an 
important role in the amplification of TRPA1 signaling following 5-HT release. As 
such, TRPA1 signaling might not only transmit nociceptive signals to the CNS but 
also mediate inflammatory response by the interaction between afferent nerves and 
non-neuronal cells. 
 
Increasing evidence has demonstrated the important role of TRPA1 in visceral 
inflammation and pain (Lapointe and Altier, 2011; Bautista et al., 2012). Considering 
the antinociceptive role of 5-HT3 receptor antagonists on a rat model of 
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inflammatory pain (Butkevich et al., 2007) and the relieving effect of 5-HT3 receptor 
antagonists in patients with diarrhoea-predominant IBS (Camilleri et al., 2001), it is 
likely that TRPA1 is the central molecular responsible for the pain and discomfort in 
IBS. Consequently, TRPA1 might be a promising pharmacological target in treating 
functional bowel disorders such as IBS. Indeed, a recent study has suggested that 
ASP7663, a novel TRPA1 agonist, can improve the symptoms in an animal model of 
constipation (Kojima et al., 2013). 
 
Rodent mast cells also contain 5-HT. It is possible that a proportion of released 
serotonin in TRPA1 signaling is originated from mast cells. However, serotonin 
antibody revealed intensive immunoreactivities in EC cells of mouse intestine, 
whereas no mast cells were labeled. As such, serotonin released from mast cells 
might be marginal. 
 
TRPA1 and contractility 
In the small intestine, afferent discharges triggered by 5-HT are composed of a direct 
excitation through 5-HT3 receptors and an indirect action through increased motility, 
which is likely to arise from 5-HT receptors on enteric neurons and muscles (Hillsley 
et al., 1998). Evidence has shown that serotonin released from EC cells activates 
enteric nerves system to control gastrointestinal motility and secretion (Yamano and 
Miyata, 1996; Gershon, 2003). A very recent study on TPH1 deficient mouse has 
observed a much slower propulsion with larger faecal pellets as well as reduced 
responses to intraluminal balloon distension, suggesting an essential role mucosal 5-
HT in gastrointestinal motility (Heredia et al., 2013). Since literature and our 
unpublished data have demonstrated AITC’s ability to induce serotonin release, 
whether AITC could induce gastrointestinal contractions was determined on isolate 
mouse jejunum. Despite interference from spontaneous contractions, AITC induced 
prominent contractions in most preparations, and granisetron abolished these 
contractions, indicating a 5-HT3 receptor-mediated mechanism. This is in agreement 
with a study on guinea pig isolated ileum, showing that AITC induces contractions in 
a dose-dependent manner and these contractions are inhibited by ruthenium red and 
5-HT3 antagonist ramosetron (Nozawa et al., 2009). 
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However, it remains controversial whether TRPA1 agonist can elicit contractions of 
isolated intestine. Evidence has shown that AITC dose-dependently induced 
contractions in mouse proximal and distal colon, whereas in the jejunum and ileum 
AITC elicits only small contractions (Penuelas et al., 2007). Nevertheless, a study 
has suggested that cinnamaldehyde has no effect on mouse duodenum and ileum, but 
inhibits contractility in the colon, which might be attributed to co-expression of 
TRPA1 with inhibitory motor neurons (Poole et al., 2011). As such, it is possible that 
TRPA1 signaling orchestrates a bidirectional modulation on the motility through 
multiply pathways. 
 
Effects of cromolyn on TRPA1 signaling 
Mast cells can release a variety of mediators to orchestrate allergic and inflammatory 
responses, such as histamine, protease, serotonin and TNF-α. Intracolonic 
administration of protease-activated receptor-activating peptide (PAR2-AP) 
augments visceromotor responses to graded colorectal distension (Cattaruzza et al., 
2010). Activation of mast cells by antigen or perfusion of PAR2-AP both can induce 
mechanical hypersensitivity of vagal afferents to esophageal distension, which is 
inhibited by TRPA1 antagonist; furthermore, TRPA1 is highly co-expressed with 
PAR2 receptors (Yu et al., 2009). PAR2 activation potentiates TRPA1 currents 
evoked by AITC or cinnamaldehyde in DRG neurons and HEK293 cells transfected 
with TRPA1 (Dai et al., 2007). These observations suggest that protease released 
from mast cells might sensitize TRPA1 expressing afferent nerves through PAR2 
receptor that is coupled with TRPA1. In addition to protease, TRPA1 has been 
suggested an essential downstream pathway in histamine-dependent itch (Wilson et 
al., 2011). Pre-evacuation of mast cell mediators or histamine receptor H1 antagonist 
pyrilamine significantly inhibit AITC induced nociception in mice (Andrade et al., 
2008). 
 
Current study demonstrated that TRPA1 signaling induced by AITC was 
significantly attenuated by cromolyn sodium, a mast cell stabilizer, suggesting that 
mast cells might be involved in TRPA1 signaling. Cromolyn sodium has been used 
in clinic to treat asthma for more than 30 years. Inhalation of cromolyn by patients 
with allergic asthma blocks allergen-induced bronchospasm, presumably by 
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suppressing the release of mediators from mast cells, as supported by the drug’s 
inhibition effect on the degranulation of rat peritoneal mast cells in response to 
challenge with IgE and specific antigen (Kusner et al., 1973). In addition to IgE 
dependent activation, evidence has shown that cromolyn (100 µM) significantly 
inhibits mast cell degranulation induced by a variety of stimuli such as substance P, 
thapsigargin, ionomycin and compound48/80; however, its specificity and efficacy 
have been controversial, especially in the mouse (Oka et al., 2012; Weng et al., 
2012). Hence further studies are required to validate this observation. 
 
TRPA1 signaling in TRPV1 knockout mice 
Interestingly, our afferent recording data indicated that TRPA1 signaling in the 
TRPV1 knockout mice was significantly augmented. This may be a longtime 
consequence of compensative mechanisms. Loss of TRPV1 results in a deficiency in 
nociceptive signaling, and TRPA1 is up regulated to compensate this deficiency. 
Alternatively, other non-neuronal cell types might adapt to up-regulate 
communications with afferent nerves. 
 
In line with our observation, afferent responses to capsaicin tend to increase in 
TRPA1 knockout mouse colon (Brierley et al., 2009). Conversely, another study has 
suggested that there is no significant change in capsaicin sensitivity in TRPA1 
mutant neurons, and similarly no prominent alteration of mustard oil sensitivity in 
TRPV1-deficient neurons (Bautista et al., 2006). This study may be not contradicted 
with our observation, since our in vitro recording comprises the contribution of non-
neuronal cells. For example, EC cell might be up-regulated in the knockout mice 
with enhanced serotonin release to amplify sensory signaling. The exact mechanisms 
underlying this observation require further investigations. 
 
Deconstruction of TRPA1 signaling pathways 
A study employed microarray hybridization and laser-capture microdissection to 
compare gene expression profiles of DRG and NG neurons projecting to mouse 
viscera, and revealed that DRG neurons had much higher expressions of TRPA1 but 
much lower expressions of 5-HT3A and 5-HT3B receptors, compared with nodose 
neurons (Peeters et al., 2006). Interestingly, a recent study on animal model of 
constipation has revealed that ASP7663, a novel TRPA1 agonist, significantly 
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improves loperamide (opioid receptor agonist)-induced constipation, and this effect 
can be reversed by either pretreatment with TPRA1 antagonist or vagotomy (Kojima 
et al., 2013). This suggests that physiological motor reflexes are mainly mediated via 
vagus nerve, possibly through serotonin release and 5-HT3 receptors on vagal nerve 
terminals. It is widely accepted that vagal afferents only have low threshold units and 
regulate normal physiological activities, whereas spinal afferents comprise both low 
and high threshold units to detect noxious stimuli. The current study observed that 
more than 80% of afferent units participating AITC induced TRPA1 signaling, which 
maybe consist of direct activation of spinal afferents through TRPA1 and indirect 
activation on vagal afferents through 5-HT3 following 5-HT release. This is 
consistent with afferent sorting result that response of low threshold units to AITC 
was significantly inhibited by 5-HT3 antagonist, whereas high threshold units were 
not.  This pattern is relative, as TRPA1 and 5-HT3 are present on both DRG and NG 
neurons. 
 
In addition to primary sensory neurons and EC cells, TRPA1 is expressed in 
myenteric ganglia where it localizes to inhibitory motorneurons, descending 
interneurons, cholinergic neurons and intrinsic primary afferent neurons (Poole et al., 
2011), suggesting that the modulation effects of TRPA1 signaling could  be diverse. 
The above study has provided functional evidence that AITC can activate myenteric 
neurons directly. This chapter described the possible pathways involved in TRPA1 
signaling (figure 5.11). AITC directly excite extrinsic and intrinsic neurons to elicit 
afferent discharge as well as to modulate motor and secretion reflexes. Activation of 
TRPA1 on EC cells results in 5-HT release, which also either directly depolarizes 
extrinsic afferents or act on enteric neurons to regulate motility. Altered motility or 
secretion provides feedback to extrinsic afferents. Activation of afferent nerves 
releases neuropeptides, which can degranulate mast cells; mediators released from 
mast cells, in turn, depolarize or sensitize afferent nerves.  
 
The interaction between EC cells, mast cells and TRPA1 modulates afferent 
sensitvity to noxious stimuli or inflammatory mediators. Imbalanced interaction 
might result in inapropriate sensitivity, such as hypersensitivity, a hall marker for 
IBS. As such, TRPA1 is a potential therapeutic target for treating funtional bowl 
disorders associated with abdominal pain. 
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Figure 5.11 Schematic illustration of TRPA1 signaling pathways induced by AITC. 
AITC could directly activate TRPA1 on extrinsic afferents to elicit afferent discharge. 
Activation of TRPA1 on EC cells results in 5-HT release, which on one hand target on 5-HT 
receptors on extrinsic afferent to depolarize primary neurons, and on the other hand act on 
enteric neurons to initiate contractions and secretions. AITC activation on the intrinsic 
neurons excites or inhibits motilities and secretions, which provides feedback to extrinsic 
afferents. Activation of afferent nerves might release neuropeptides to degranulate mast cells, 
and mediators released from mast cells in turn depolarize or sensitize afferent nerves. MC: 
mast cells. 
 
The distribution of TRPA1 protein within the gut wall remains controversial. TRPA1 
immunoreactivities have been shown colocalized with CGRP in afferent endings 
throughout different layers of mouse colon (Brierley et al., 2009). Another study has 
reported that TRPA1 is detected not only in enteric ganglia but also uniformly in 
surface epithelial cells in the mucosa at a low level (Poole et al., 2011). In situ 
hybridization on rat and human duodenum has shown that TRPA1 mRNA is 
restricted to epithelial cells with frequent colocalization with serotonin 
immunoreactivities (Nozawa et al., 2009). Efforts were made to locate TRPA1 on the 
gut wall using immunohistochemistry. However, due to the lack of reliable TRPA1 
antibodies, no conclusive data were achieved. As such, whether TRPA1 proteins are 
present in EC cells and whether TRPA1-expressing afferent nerves are closely 
apposed to mast cells require further investigations. 
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6.1 Introduction 
As introduced in section 1.7 and 3.1, a variety of age-related changes occur in the GI 
tract. In terms of nervous system, a large number of studies have reported a reduction 
in myenteric neurons in aged intestine of rat (Santer and Baker, 1988), guinea pig 
(Gabella, 1989; Peck et al., 2009), mice (El-Salhy et al., 1999) and human (de Souza 
et al., 1993; Gomes et al., 1997; Bernard et al., 2009). Similar to myenteric plexus, 
neuron loss in submucosal plexus with advanced age has been found in rat (Phillips 
et al., 2007) and mouse (El-Salhy et al., 1999). In addition to intrinsic neurons, 
sympathetic innervations within the gut wall display some signs of 
neurodegeneration with advanced age, as indicated by the presence of observable 
swollen axons and decreased expression of tyrosine hydroxylase; similar swollen 
varicosities are observed in the sensory terminals of vagal innervation, whereas 
spinal afferents are not dramatically affected by senescence (Phillips and Powley, 
2007). Some studies have described decreases in the size or number of primary 
neurons in the nodose ganglia and DRGs (Vega et al., 1993), whereas other studies 
did not observe a significant change (Soltanpour et al., 1996; Bergman and Ulfhake, 
1998). In addition, changes in neuropeptides and neurotrophin receptors have been 
described in DRGs of aged rat, such as increased NPY and galanin as well as 
decreased CGRP and SP (Bergman et al., 1996). 
 
In addition to morphological changes, some functional studies have described 
alterations in the sensitivity of aged GI tract. Intraesophageal balloon distension on 
human subjects have revealed an increased pain threshold with advanced age (Lasch 
et al., 1997). In line with this study, rectal sensory thresholds have been found 
significantly higher in aged subjects. (Lagier et al., 1999). 
 
It is poorly understood whether the expressions and functions of TRP channels are 
influenced by advanced age. It has been revealed that TRPV1 mRNA is not changed 
in aged mouse DRG whereas TRPV1 protein appeared to be reduced in the DRG and 
peripheral nerves (Wang et al., 2006; Wang and Albers, 2009). Another study 
reported an increased expression of TRPV1 in human epidermis of elderly subjects 
(Lee et al., 2009). Regarding to TRPA1, it is largely unknown whether its expression 
and function in the GI tract are altered by ageing. 
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As demonstrated in chapter 5, EC cells and serotonin played an important role in the 
amplification of TRPA1 signaling. Consequently, the alteration of EC cells density 
or serotonin release with advanced age might change TRPA1 signaling. EC cell has 
been found increased in rat stomach during ageing (Khomeriki, 1989). A study 
employing chromatographic analysis found an increase in the synthesis and release 
of serotonin in aged mouse distal ileum (Parmar et al., 2012). A study on human 
duodenum found that serotonin positive cells tend to increase with age (Sandstrom 
and El-Salhy, 1999). Conversely, staining for somatostatin and chromogranin, 
markers for EC cells, did not reveal any change in aged rat colon (Sweet et al., 1996); 
moreover, EC cells in the guinea pig distal colon are spared from the influence of 
ageing (Wade et al., 2003). In addition, serotonin receptors measured by positron 
tomography in the living human brain decline with advanced age (Wong et al., 1984). 
However, it is largely unknown if 5-HT receptor expressions in the primary sensory 
neurons or cells within the gut wall are influenced by ageing. 
 
Hypothesis and objectives 
This chapter hypothesized that TRPA1 signaling was attenuated in the intestine of 
aged mice, and this attenuation might be attributed to reduced sensory innervation, 
down regulation of TRPA1 or 5-HT3 receptors, reduced EC cells or serotonin release 
and impaired sensitivity of sensory neurons. 
 
Parallel studies were performed on aged mice (24 months) and control (3 months), 
aiming to investigate potential age-related changes in    
1) mechanosensitivity of jejunal innervation; 
2) TRPA1 signaling induced by AITC and bradykinin; 
3) expression of TRPA1 and 5-HT3 receptors in DRG and jejunum; 
4) density of EC cells in the jejunum; 
5) TRPA1 mediated calcium signaling in primary sensory neurons. 
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6.2 Experimental protocol and analysis 
Afferent recording  
Extracellular recording on jejunal segments from 24 months old mouse was 
performed as described in section 2.4 and 5.2. All experimental procedures and 
analysis methods were consistent with adult mice. Student’s t-test or two-way 
ANOVA were used to compare the peak response or time course of response 
between 3 and 24 months old mice. 
 
Changes of gene expression in aged mice 
RNA was isolated from jejunal segments (whole-thickness) and DRG neurons of 3 
and 24 months old mice. RNA isolation, reverse transcription and quantitive real-
time PCR were performed as described in section 2.5. Probes for genes encoding 
TRPA1, 5-HT3A and 5HT3B were commercially available from Integrated DNA 
Technologies. Data analysis was described in section 2.5 and 3.2. Probe sequences 
for mouse GAPDH and TRPA1 were as follow. 
Genes Accession No.  Sequence  
Expected Band  
Size (bp) 
TRPA1 NM_177781 Forward 5' ACCATCGTGTATCCAAATAGACC 3' 91 
  Reverse 5' GTACTTCTTGTCGTGTTTCTTGC 3'  GAPDH NM_008084 Forward 5' AATGGTGAAGGTCGGTGTG 3' 150 
  Reverse 5' GTGGAGTCATACTGGAACATGTAG 3'   
 
Quantification of EC cells density in mouse jejunum 
Jejunum segments were fixed in 4% PFA, embedded in OCT and sectioned in a 
cryostat as described in section 2.3. EC cells were labeled by a polyclonal rabbit anti 
serotonin antibody (1:50, AbD Serotec, AHP522) and visualized by a goat anti-rabbit 
secondary antibody conjugated with Cyanine 3 (Cy3, 1:400, Jakson 
ImmunoResearch, 111-165-144). 
 
10 random images were acquired from one tissue under 20 times objective for offline 
quantification. EC cells density was calculated as number of EC cells divided by the 
area of mucosa. EC cells were counted blindly, and area of mucosa was measured 
using ImageJ software.  
 
                                                                                                                   Chapter 6 
 149 
Calcium imaging 
Dissociation, culture and preparation of mouse DRG (T7-L2) and nodose ganglion 
was performed as described in section 2.6.  
 
Prior to application of AITC (30 or 300 µM) or bradykinin (1 µM), 5-minute baseline 
intensity was recorded. Drug diluted in HEPES buffer was perfused into recording 
chamber by gravity for 1 minute and then washed out by HEPES. At the end of each 
experiment, 5 µM ionomycin was applied for 1 minute as a positive control. 
 
Intracellular calcium concentration was indicated by the ratio of emission 
fluorescence under 340 nm and 380 nm excitation light. Raw data exported to Excel 
were emission fluorescent intensities at a series of time points. Ratio between 340 
nm and 380 nm channels was calculated prior or to any analysis. A time window 
covering a period of baseline activity and the response profile of the drug was 
selected for analysis. Changes of calcium concentration in response to a drug were 
calculated as the net difference between baseline ratio (minimum value within the 
time window) and the peak ratio (maximum value within the time window) during 
drug application. Data were expressed as mean±SE. 
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6.3 Mechanical sensitivity in aged mouse 
To investigate if mechanosensitivity in aged mouse intestine was impaired, afferent 
recording was performed on jejunal preparations from 3 and 24 months old mice. 
Ramp distension up to 60 mmHg produced a biphasic increase in afferent discharges, 
corresponding to the activation of low threshold and high threshold afferents. In 
comparison with adult mice, total afferent responses to distension were significantly 
reduced in the 24 months old mice (P<0.01, figure 6.1B). By further discrimination 
of different afferent subtypes, this reduction was selective for low threshold units 
(P<0.01, figure 6.1C).  This is consistent with the quantification of the number of 
units per nerve bundle, which revealed that average number of low threshold units 
detected by recording was significantly decreased (4.5±0.4 vs. 2.7±0.5, P<0.01, 
figure 6.3B). 
 
The total number of units per nerve bundle was significantly reduced in aged mice 
(11.8±0.4 vs. 8.8±0.5, P<0.001). LT units were the major contributor to this 
reduction, whereas HT units were unchanged. WDR units might be decreased, but 
not statistically significant. In addition, the proportions of different afferent subtypes 
were altered in aged mice. As shown in the pie charts (figure 6.2A), proportion of LT 
was decreased from 35.7% to 28.5%, whereas HT was increased from 27.6% to 
36.8%. Besides, WDR units remain unchanged, and mechano-insensitive units were 
slightly decreased. 
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Figure 6.1 Afferent responses to ramp distension were attenuated in aged mouse. (A) 
Sample traces of afferent recording to compare responses to distension up to 60 mmHg in 
aged and control mice. (B-E) Comparison of increase in afferent discharge in response to 
distension in 24 and 3 months old mice. P<0.01 for total units, P<0.01 for LT units, P= 0.345 
for WDR, P= 0.435 for HT. N= 10 for both groups, two-way ANOVA.  
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Figure 6.2 Number of low threshold afferents was decreased in aged mouse. (A) Pie 
charts to show the percentage of afferent subtypes in control and aged mice. LT, WDR, HT 
and non-mechanosensitive units account for 35.7%, 30.1%, 27.6% and 6.6% of total units in 
3 months old mice, 28.5%, 30.6%, 36.8% and 4.2% in 24 months old animals. (B) 
Quantification of average number of units per nerve bundle innervating a segment of 
jejunum from aged and control mice. 3 months vs. 24 months: 11.8±0.4 vs. 8.8±0.5, P<0.001 
for total; 4.5±0.4 vs. 2.7±0.5, P<0.01 for low threshold units; 3.8±0.4 vs. 2.8 ±0.4, P= 0.078 
for wide dynamic range; 3.5±0.3 vs. 3.3±0.4, P= 0.717 for high threshold; 0.8±0.5 vs. 
0.4±0.3, P= 0.127 for non-mechanosensitive units. N= 37 for 3 months old mice, N= 16 for 
24 months group. 
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6.4 TRPA1 signaling in aged mouse 
In comparison with adult mice, changes in afferent discharge in response to AITC at 
a range of concentrations were all significantly attenuated in aged mouse jejunum 
(P<0.05 for 100 and 300 µM, P< 0.01 for 1mM, figure 6.3). By discrimination of 
activities from different afferent subtypes, low threshold and wide dynamic range 
units were responsible for this age-related attenuation, whereas high threshold units 
were spared (figure 6.4). This is consistent with the attenuation of 
mechanosensitivity and reduced number of low threshold units per nerve bundle. 
 
In line with the attenuation in AITC-induced TRPA1 signaling, afferent response to 
bradykinin was significantly decreased (P<0.05, figure 6.5) in aged mice. LT and 
WDR appeared to be responsible for this attenuation. 
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Figure 6. 3 Increases in afferent discharge in response to AITC were attenuated in aged 
mice. (A) Example recording trace to show afferent responses to AITC in 3 and 24 months 
old mice. (B) Peak responses to 100 µM, 300 µM and 1 mM AITC in 24 months old mice 
were all significantly reduced, comparing with 3 months group. 3 months vs. 24 months, 100 
µM AITC: 19.9±63.6 vs. 6.8±3.4, P<0.05; 300 µM: 47.2±10.2 vs. 15.7±5.9, P<0.05; 1 mM: 
74.9±7.3 vs. 28.8±9.7, P<0.01; N=5 for both groups, unpaired t-test. (C-E) Time course of 
increase in afferent discharge in response to AITC in aged and control mice, P<0.05 for 100 
µM AITC, P<0.01 for 300 µM and 1 mM AITC, two-way ANOVA. 
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Figure 6.4 Low threshold and wide dynamic range units contributed to the age-related 
attenuation of afferent responses to AITC. (A) Total afferent responses to 100 µM, 300 
µM and 1 mM AITC were attenuated in the 24 months old mice. (B) Responses of low 
threshold units to 100 µM, 300 µM and 1 mM AITC were all significantly reduced in aged 
mice, 3 months vs. 24 months, 100 µM AITC: 10.7±3.1 vs. 1.0±0.8, P<0.05; 300 µM: 
14.1±3.2 vs. 3.7±1.5, P<0.05; 1 mM: 21.1±4.3 vs. 7.6±3.8, P<0.01; N=5 for both groups, 
unpaired t-test. P<0.05. (C) Wide dynamic range units displayed a similar pattern, whereas 
only response to 1 mM AITC achieved significance (23.3±7.7 vs. 3.5±1.1, P<0.05). P= 0.212 
and 0.061 for 100 µM (3.6±2.0 vs. 0.8±0.5) and 300 µM (13.5±5.3 vs. 1.9±0.5). (D) No 
significant reductions were observed in high threshold units. P= 0.477, 0.667 and 0.166 for 
100 µM (1.0±1.0 vs. 1.9±0.8), 300 µM (6.5±1.8 vs. 5.4±1.7) and 1 mM AITC (14.2±3.5 vs. 
7.6±2.7). N=5 for both groups, unpaired t-test. 
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Figure 6.5 Afferent responses to bradykinin were significantly reduced in aged mice. (A) 
Example traces of afferent responses to bradykinin in 3 and 24 months old mice. (B) 
Response profile to 1 µM bradykinin in 3 and 24 months old mice. P<0.05, N=5, two-way 
ANOVA. (C) Peak responses of total units and subpopulations to 1 µM bradykinin. Total 
response was significantly attenuated in 24 months mice (54.3±8.4), comparing with 3 
months group (88.1±11.9), P<0.05. P= 0.167, 0.186 and 0.086 for LT (45.5±15.3 
vs.19.1±8.3), WDR (22.7±5.5 vs. 13.5±3.2) and HT (6.3±2.2 vs. 13.9±3.2). N=5 for both 
groups, unpaired t-test. 
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6.5 Gene expression of TRPA1 and 5-HT3  
One of the hypotheses for the attenuation of TRPA1 signaling in the aged mice is 
reduced expression in corresponding genes, such as genes that encode TRPA1 and 5-
HT3 receptors. Quantitive PCR was performed to compare the gene expression of 
TRPA1, 5HT3A and 5HT3B in 3 and 24 months old mice.  
 
Relative gene expression (1/2ΔCt) reflects the percentage of tested gene expression in 
the housekeeping gene expression (GAPDH in this study). Overall, all examined 
genes were highly expressed in the DRG, comparing with jejunum (revealed by the 
difference in scale in figure 6.6A&B), which might be due to that only a small 
proportion of cell types in the jejunum expressed these genes. Furthermore, TRPA1 
expression appeared to be higher than 5HT3A and 5HT3B in both DRG and jejunum 
segment.  
 
Comparison of the relative gene expression between aged mice and control did not 
reveal any significant alteration. Fold change of TRPA1 and 5-HT3A were not 
significant in both DRG and jejunum. 5-HT3B expressions were not changed in the 
DRG, but decreased in the jejunum with a significant fold change (-2.11, figure 6.6).   
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Figure 6.6 Changes in the expression of TRPA1 and 5-HT3 receptor in the aged mouse. 
Comparison of relative gene expression (1/2ΔCt) of TRPA1 and 5-HT3 receptors in the DRG 
(A) and jejunum (B) from aged mice and control. DRG: P=0.182, 0.362 and 0.767 for 
TRPA1 (N=5), 5-HT3A (N=4) and 5HT3B (N=4); Jejunum: P= 0.245, 0.795 and 0.296 for 
TRPA1 (N=10), 5-HT3A (N=7) and 5HT3B (N=7), unpaired t-test. (C) Fold changes of gene 
expression in 24 months mice compared with 3 months group. Fold changes for TRPA1 in 
DRG (1.58±0.80, N=5) and jejunum (-1.42±0.80, N= 10) were not significant. Expression of 
5-HT3A in DRG (1.21±0.87, N= 4) and jejunum (-1.02±0.57, N= 7) were not significantly 
changed. 5-HT3B expressions was unaltered in DRG (-1.06±0.89, N=4), but significantly 
down regulated in jejunum (-2.11±0.63, N=7). Gene expression of 5-HT3 was investigated 
by L. Nocchi and C. Keating. 
Jejunum
TRPA1 5-HT3A 5HT3B
0.000
0.002
0.004
0.006
0.008
0.010
R
ela
tiv
e g
en
e e
xp
re
ss
io
n 
1/
2Δ
Ct
3 months  
24 months 
Fold change by age
DRG Jejunum
-4
-2
0
2
4
Fo
ld
 ch
an
ge
TRPA1
5HT3A
5HT3B
*
DRG
TRPA1 5-HT3A 5HT3B
0.0
0.1
0.2
0.3
R
ela
tiv
e g
en
e e
xp
re
ss
io
n 
1/
2Δ
Ct
3 months  
24 months 
Jejunum
TRPA1 5-HT3A 5HT3B
0.0000
0.0001
0.0002
0.0003
R
ela
tiv
e g
en
e e
xp
re
ss
io
n 
1/
2Δ
Ct
3 months  
24 months 
 
A B 
C 
                                                                                                                   Chapter 6 
 159 
6.5 Changes of EC cell density in aged mouse intestine 
EC cells, labeled by an anti-serotonin antibody, were located in the epithelium of 
mucosa in mouse jejunum. The conical distribution of serotonin was similar to 
human EC cells. Densities of EC cells were quantified blindly on jejunal sections of 
3 and 24 months old mice. As a result, EC cells were significantly increased in aged 
mouse jejunum (P<0.01, figure 6.7B).  
 
 
 
Figure 6.7 EC cell density in the jejunum was augmented in the aged mice. (A) Lateral 
view of an EC cell in the epithelium of a villus. (B) Density of EC cells were significantly 
increased in the jejunum of 24 months old mice, 26.3±1.5 vs. 36.5±2.1, P<0.01, N=5 for 3 
months, N=7 for 24 months, unpaired t-test. EC cell density is calculated as number of EC 
cells per mm2 of mucosa. (C and D) Representative staining of EC cells in the jejunum from 
3 and 24 months old mice. Scale bar= 50 µm. 
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6.7 Effect of granisetron on TRPA1 signaling in aged mouse 
It has been previously demonstrated that TRPA1 signaling was attenuated by 5-HT3 
receptor antagonist granisetron in the adult mice. Parallel experiments were 
performed on aged mice. Unlike in adult mice, granisetron failed to block afferent 
response to AITC significantly (figure 6.8A). The inhibition efficiency of granisetron 
was significantly decreased in the aged mice (60.0±4.2% vs. 33.4±10.6%, P<0.05). 
This is consistent with the reduced expression of 5-HT3 receptor in aged jejunum. All 
three afferent subtypes in aged group appeared to show a lower inhibition by 
granisetron (figure 6.8B). 
 
  
Figure 6.8 Inhibition of TRPA1 signaling by granisetron was lost in the aged mice. (A) 
Comparison of the effect of granisetron on peak response to AITC in the jejunum from 3 and 
24 months old mice. In adult mice, afferent responses to 300 µM AITC were significantly 
reduced from 59.5±11.0 to 23.6±5.2, P<0.01, N=7, paired t-test. In aged mice, this effect was 
not significant, 33.0±9.9 vs. 19.0±3.2, P= 0.124, N=5, paired t-test. (B) Inhibition effect of 
granisetron on TRPA1 signaling of total units and subpopulations. For total afferents, the 
inhibition of granisetron was significantly decreased in the elderly, 60.0±4.2% vs. 
33.4±10.6%, P<0.05; P= 0.664 (46.9±9.7 vs. 38.8±15.9), 0.242 (67.3±4.5 vs. 45.1±13.8) and 
0.457 (68.6±11.6 vs. 52.4±17.9) for LT, WDR and HT. N=7 and 5 for 3 and 24 months 
group, unpaired t-test. Inhibition effect referred to the percentage of afferent discharges 
blocked by granisetron.  
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6.8 TRPA1 mediated calcium signal in aged DRG and NG 
Afferent recording is capable of evaluating the sensory signaling at an integrated 
level. To exclude influence of non-neuronal cells and examine TRPA1 signaling of 
primary sensory neurons directly, calcium imaging on cultured DRG and NG 
neurons were performed in aged and control mice in parallel.   
 
About 52.1% and 64.6% of DRG neurons from control mice were responsive to 30 
and 300 µM AITC, and these proportions were not altered in the aged mice (50.9% 
and 62.5%). 35.1% of adult DRG neurons responded to 1 µM bradykinin, whereas 
this probability was only 6.9% in aged DRG (P= 0.08, figure 6.9C). In comparison 
with DRG, a much smaller proportion of nodose neurons were responsive to AITC 
(P<0.05). As such, the responsive proportions were quite variable between aged and 
control nodose neurons. 
 
Relative increases of Ca2+ in response to AITC and bradykinin were not significantly 
altered in the aged DRG and NG (figure 6.9D). 
 
Calcium imaging on DRGs from both aged and control mice was performed at room 
temperature in parallel. It has been suggested that temperature doesn’t significantly 
affect the response to TRPA1 agonist cinnamaldehyde, based on the comparison 
between the cinnamaldehyde concentration for half-maximal activation of TRPA1-
expressing cells at 23°C and 35°C (Bandell et al., 2004).  
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Figure 6.9 Calcium imaging of DRG and NG neurons from aged and adult mice. (A) an 
representative image to show DRG neurons labeled by fura-2. (B) Example trace to show 
increase of Ca2+ in response to AITC and ionomycin. (C) Responsive proportions to 30 and 
300 µM AITC were 52.1% (N=6, n=141) and 64.6%  (N=6, n=111) in adult DRGs, and were 
not dramatically changed in the aged mice (50.9%, N=4, n=108 and 62.5%, N=4, n=245).  
Responsive proportion to bradykinin was much lower in the aged DRG (6.9% vs. 35.1%, P= 
0.08, N=6, n=107 for adult mice, N=4, n=107 for aged group). Responsive proportions to 30 
and 300 µM AITC were 4.2% (N=4, n=73) and 27.7% (N=4, n=64) in adult nodose and 
15.3% (N=4, n=37) and 10.4% (N=4, n=69) in aged nodose. Bradykinin responders occupied 
19.6% (N=4, n=49) in adult nodose and 31.8% (N=4, n=38) in aged nodose neurons. (D) 
Relative increase of Ca2+ (Ratio 340/380) in response to AITC and bradykinin. 3 months vs. 
24 months: DRG, 30 µM AITC, 0.095 vs. 0.081, P=0.659; DRG, 300 µM AITC, 0.133 vs. 
0.138, P= 0.891; DRG, bradykinin, 0.044 vs. 0.088, P= 0.430; NG, 30 µM AITC, 0.087 vs. 
0.042, P= 0.279; NG, 300 µM AITC, 0.109 vs. 0.153, P=0.637; NG, bradykinin, 0.054 vs. 
0.118, P= 0.308, unpaired t-test. N refers to the number of animal and n indicates number of 
cells. 
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6.9 Discussion 
Ageing and mechanosensitivity 
In vitro extracellular recording is capable of examining sensory signaling at the level 
of end organ. With this technique, the current study demonstrated that ageing is 
associated with attenuated mechanosensitivity in the small intestine of mice, and low 
threshold afferent components appeared the most susceptible to ageing. Furthermore, 
the number of functional low threshold afferents detected by recording was reduced 
in the nerve bundles supplying the small intestine of aged mice. 
 
One straightforward explanation is that some of the primary sensory neurons or their 
fibers declined with advanced age or lost their function due to possible structural 
deteriorations or loss of mechanosensitive receptors on their terminals. Some studies 
have described decreases in the size or number of primary sensory neurons in the 
nodose ganglia and DRGs (Vega et al., 1993), whereas contrary study did not 
observe a significant change in nodose ganglion of aged rat (Soltanpour et al., 1996). 
Another study reported a tiny decrease (12%) in the number of cervical and lumbar 
DRG neurons in aged rat and a significant cell body atrophy among myelinated 
primary afferents (Bergman and Ulfhake, 1998). Similarly, a down-regulation of 
neurofilaments accompanied with reduced cross-sectional area and circularity of 
myelinated fibers has been observed in aged rat DRG (Parhad et al., 1995). It has 
also been demonstrated that collateral sprouting of nociceptive axons is impaired by 
ageing in the rat (Kovacic et al., 2010).  
 
In addition, vagal sensory terminals innervating the myenteric plexus display 
markedly swollen varicosities in aged rat, and vagal free nerve endings in the villi 
contract into smaller plates of dystrophic neuritis; conversely, spinal afferents within 
the gut wall are not severely affected by ageing (Wade and Cowen, 2004). This more 
severe susceptibility to ageing induced deteriorations in vagal innervation is in 
agreement with the selective functional loss of low threshold units in aged mouse 
intestine observed in the current study, as it is widely accepted that low-threshold 
units might originate from both vagal and spinal afferents, whereas high-threshold 
units are exclusively of spinal origin.  
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The impaired mechanosensitivity is also likely due to the neuronal loss occurring in 
the enteric nervous system. As introduced previously, a large number of studies have 
described age related loss in enteric neurons. It has been suggested that enteric 
sensory neurons are particularly susceptible to neurodegeneration with age (Wade, 
2002; Wade and Cowen, 2004). Enteric neurons provide sensory output via 
viscerofugal afferents, which are often recorded in the mixed nerve bundles, and thus 
contribute to the sensory signaling. 
 
Another possibility is that some primary afferents respond to distention indirectly 
through the action of some transmitters, and reduction of those transmitters or their 
receptors might result in impaired sensitivity to distension. For example, stroking on 
the mucosa of human jejunum results in a significant increase in serotonin release 
(Kellum et al., 1999), which might directly excite primary sensory neurons through 
5-HT receptors on the afferents terminals (Peters et al., 1993; Klein et al., 2011). In 
addition, serotonin has been shown to induce contraction of guinea pig distal colon 
via 5-HT3 receptors in the enteric nervous system, which might involve the 
stimulation of acetylcholine and substance P release (Yamano and Miyata, 1996). 
This study has revealed down regulation of 5-HT3 receptors, which might contribute 
to the reduced mechanosensitivity.  
 
Ageing and TRPA1 signaling 
Similar to mechanical sensory signaling, TRPA1 signaling is a complicated pathway 
involving both extrinsic and intrinsic nervous system as well as non-neuronal cells. 
Mechanosensitivity in TRPA1 knockout mice is significantly impaired (Brierley et 
al., 2009), suggesting that they share some common pathways. As revealed in 
chapter 5, TRPA1 signaling comprises direct activation of TRPA1 on extrinsic 
afferents, indirect activation through 5-HT3 receptors on extrinsic afferents and 
signaling from enteric neurons following the effects of 5-HT. 
 
As far as we know, this study is the first one to report the influence of ageing on the 
gene expressions and functions of TRPA1 in mouse GI tract. Based on results from 
afferent recording, TRPA1 signaling induced by AITC and bradykinin was 
significantly attenuated at the level of peripheral afferent in aged mouse intestine. 
Furthermore, this attenuation was more dramatic in low threshold afferents in 
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comparison with high threshold components, which is consistent with the decrease in 
mechanosensitivity. As such, one of the explanations for this attenuation is age-
related decline in some low threshold primary sensory neurons, especially vagal 
afferents, considering their susceptibility in structural deterioration caused by ageing 
(Phillips and Powley, 2007).   
 
One of the hypotheses for the attenuation of TRPA1 signaling with advanced age is 
reduced expression in corresponding genes, such as genes that encode TRPA1 and 5-
HT3 receptors. Quantitive PCR was performed to compare the gene expression of 
TRPA1, 5HT3A and 5HT3B in 3 and 24 months old mice. Expressions of TRPA1 and 
5-HT3A were not significantly changed in both DRG and jejunum. 5-HT3B 
expressions were not changed in the DRG, but decreased in the jejunum with a 
significant fold change (-2.11).  These data indicate that no significant change was 
found at the level of primary sensory neurons, whereas 5-HT3 receptors in the cells 
within the gut wall were declined with advanced age. In agreement with this 
observation, our unpublished data have demonstrated that peak afferent responses to 
superfusion of 2-Me-5-HT, a selective 5-HT3 agonist, were significantly reduced in 
the small intestine of 18 and 24 months old mice. In addition, 5-HT3 receptor 
antagonist granisetron significantly inhibited TRPA1 signaling in the adult mice, 
whereas its inhibitory effect was reduced in the aged mice, which was consistent 
with the decrease in 5-HT3 receptors. Moreover, microarray hybridization study on 
DRG and NG neurons supplying mouse jejunum has revealed that gene expressions 
of 5-HT3A and 5-HT3B in nodose are much higher than DRG (Peeters et al., 2006). 
As such, the possible functional loss of low threshold vagal afferents in aged mice 
might be associated with reduction in total 5-HT3 receptors, which could also explain 
the reduced inhibition effect of granisetron.  
 
Interestingly, as the major source of 5-HT in the gut, EC cells were significantly 
increased in the jejunum of aged mice. It is possible that as 5-HT3 receptors declined 
with ageing process, EC cells were up-regulated to compensate the impaired 
signaling pathway mediated by 5-HT3 receptors. This is similar to the observation 
that serum levels of bradykinin are increased with advanced age, whereas the 
responsiveness of target cells is reduced (Perez et al., 2005). However, 5-HT release 
and reuptake in this ageing model remain to be assessed. 
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In vitro afferent recording facilitates investigation of integrated sensory signaling at 
the level of a segment of intestine, while calcium imaging on cultured DRG and NG 
neurons evaluates their sensitivity directly. AITC elicited increase in intracellular 
Ca2+ in about 64.6% of DRG neurons from adult mice, and this proportion was not 
dramatically altered in the aged mice (62.5%). The magnitude of calcium signaling 
induced by AITC was not significantly changed in the aged DRG. In comparison 
with DRG, a much smaller proportion of NG neurons were responsive to AITC, and 
thus the responsive proportions were quite variable. However, the magnitude of 
calcium response in aged NG was also preserved. These data suggested that TRPA1 
expressing primary sensory neurons were not prominently influenced by ageing, 
which was in line with the unaltered TRPA1 gene expression in aged DRG. 
 
The proportion of DRG neurons responding to bradykinin appeared to be decreased 
in aged animals. Whether bradykinin receptors on these neurons were reduced with 
ageing require further investigation. Nevertheless, bradykinin induced calcium 
increases were not significantly changed by ageing. Conversely, a study has reported 
that calcium increase in response to bradykinin is significantly attenuated in 
senescent fibroblast cells (Muramoto et al., 2011), which may be not directly 
comparable with current study.  
 
To sum up, this chapter revealed a significant attenuation in the mechanosensitivity 
and TRPA1 signaling in aged mouse intestine, and low threshold afferents were most 
susceptible to ageing. Functional loss of some low threshold afferents in aged mice 
contributed to this attenuation. TRPA1 expressions in primary sensory neurons and 
jejunum segments were not significantly changed with ageing, which was in 
agreement with unaltered calcium signaling induced by TRPA1 agonist on aged 
DRG and NG neurons. Although EC cells were found increased in aged jejunum, its 
compensatory effect might be masked by the reduction of 5-HT3 receptors within the 
gut wall. 
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This thesis addressed the sensory functions of the GI tract with an emphasis on the 
interaction between afferents nerves and other cell types such as EC cells and mast 
cells, and also investigated the influence of ageing on these interactions. 
 
Understanding the mechanisms underlying diseases is the ultimate objective of most 
research in life science, including the current study. As one of the most common GI 
disorders, the pathogenesis of IBS hasn’t been fully understood. IBS is a functional 
bowel disorder characterized by chronic abdominal pain, discomfort, bloating and 
alteration of bowel habits. Prevalence rates of IBS usually range from 5% to 20%, 
but vary between countries and depend on the diagnostic criteria used (Spiller et al., 
2007). This rate is about 10.5% in the UK; moreover, IBS accounts for 20~50% of 
referrals to gastroenterology clinics and thus is a substantial burden on primary 
healthcare services (Wilson et al., 2004). One of the theories accounting for the 
pathogenesis of IBS is visceral hypersensitivity based on the observation that IBS 
patients have a lower pain threshold to colorectal distension or electrical stimuli 
(Whitehead et al., 1990; Sinhamahapatra et al., 2001; Verne et al., 2001; Dong et al., 
2004).  
 
Increasing evidence has suggested an important role of mast cells and EC cells in 
IBS hypersensitivity. Despite of many discrepant reports, increased mast cells and 
EC cells are often associated with IBS (Barbara et al., 2004b; Lee et al., 2008; 
Cremon et al., 2011; Matricon et al., 2012). More importantly, the severity of 
abdominal pain in IBS patients has been found positively correlated with serotonin 
release (Cremon et al., 2011) and anatomical mast cell-nerve association (Barbara et 
al., 2004b). Moreover, TNBS induced visceral hypersensitivity is abolished in mast 
cell deficient rats (Ohashi et al., 2008). Treatment with mast cell stabilizer, disodium 
cromoglycate, improves the symptoms in a large proportion of IBS-D patients (Leri 
et al., 1997). 5-HT3 receptor antagonists are effective in relieving symptoms in 
patients with diarrhoea-predominant IBS (Camilleri et al., 2001), whereas 5-HT4 
agonists improve symptoms in constipated IBS patients due to prokinetic effects 
(Novick et al., 2002). In addition, mucosal supernatants from IBS patients 
significantly increased afferent firing recorded from rat jejunal nerves (Barbara et al., 
2007), which could be blunted by 5-HT3 receptor antagonist granisetron (Cremon et 
al., 2011). 
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A large number of studies have provided evidence on the interaction between nerves 
and mast cells, including close anatomical association and functional crosstalk. 
However, what mediators from mast cells are involved in hypersensitivity and 
especially what subtypes of afferent nerves are depolarized or sensitized by those 
mediators require further investigation. Some members of TRP channels are possible 
candidates due to their role in nociception. Increasing evidence has revealed the 
important role of TRPA1 in visceral inflammation and pain (Lapointe and Altier, 
2011; Bautista et al., 2012). 
 
Activation of TRPA1 elicits acute nociceptive behavior in mice, followed by 
neurogenic inflammation and marked hypersensitivity to thermal and mechanical 
stimuli (Bandell et al., 2004; Bautista et al., 2006). Pharmacological blockage or 
genetic knockout of TRPA1 significantly attenuates hypersensitivity to mechanical 
and thermal stimuli (Bautista et al., 2006; Kwan et al., 2006). Therefore, TRPA1 
might be the key molecule responsible for the pain and discomfort in IBS patients.  
 
TRPA1 mediated sensory signaling in mouse small intestine 
Although TRPA1 signaling might be a possible determinant of abdominal pain, it 
hasn’t been thoroughly investigated at the level of peripheral afferent nerves. This 
study employed in vitro afferent recording to assess peripheral TRPA1 signaling 
induced by TRPA1 agonist and the potential involvement of EC cells and mast cells.    
  
TRPA1 agonist AITC elicited increase in afferent discharge in a dose dependent 
manner. AITC induced afferent response was significantly attenuated by 5-HT3 
receptor antagonist granisetron, which provided a functional link between serotonin 
and TRPA1 mediated sensory signaling. Unpublished data from our group have 
demonstrated that AITC induced increased serotonin release from mouse jejunum 
preparations and BON cells (human EC cell model), which was in agreement with a 
study on enriched rat EC cells and rat endocrine cell line RIN14B (Nozawa et al., 
2009). The above study also demonstrated that TRPA1 was highly expressed in EC 
cells. Although rodent mast cells also contain 5-HT, in this context, serotonin 
released from mast cells might be marginal, based on our observation that serotonin 
immunoreactivities were not detectable in mast cells. Combination of these data 
indicated that EC cells amplify TRPA1 signaling by 5-HT release.  
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Afferent response to AITC was also inhibited by cyomolyn, a mast cell stabilizer, 
suggesting that mast cells might play a similar role in the amplification of TRPA1 
signaling. Activation of mast cells by antigen or perfuse of PAR2-AP both can 
induce mechanical hypersensitivity of vagal afferents to esophageal distension, 
which is inhibited by TRPA1 antagonist (Yu et al., 2009). In addition to protease, 
pre-evacuation of mast cell mediators or histamine receptor H1 antagonist pyrilamine 
significantly inhibit AITC induced nociception in mice (Andrade et al., 2008). These 
observations suggest that protease or histamine released from mast cells might 
sensitize TRPA1 expressing afferent nerves.  
 
Current study demonstrated that AITC induced increased motility in mouse jejunum 
through 5-HT3 receptors. Since activation of TRPA1 on EC cells increased 5-HT 
release, this is in agreement with a recent study on TPH1 deficient mice that exhibit a 
much slower propulsion as well as reduced responses to intraluminal balloon 
distension (Heredia et al., 2013). Nevertheless, it has been shown that activation of 
TRPA1 inhibits contractility in mouse colon, which might be attributed to co-
expression of TRPA1 with inhibitory motor neurons (Poole et al., 2011), These 
observations suggest that the modulation effects of TRPA1 signaling on GI motility 
could  be diverse. 
 
Combination of current study and recent publications can reveal the complicated 
pathways of TRPA1 mediated signaling recorded from primary afferent nerves 
innervating a segment of jejunum. As illustrated in figure 5.11, TRPA1 signaling 
induced by AITC comprises direct activation of TRPA1 on extrinsic afferents, 
indirect activation of 5-HT3 receptors on extrinsic afferents following 5-HT release 
from EC cells and indirect signals evoked by contractions, which are either induced 
by action of 5-HT on enteric neurons or by activation of TRPA1 expressed on enteric 
neurons. In addition, communications between mast cells and afferents might result 
in depolarization or sensitization of afferent nerves. Since TRPA1 mediated sensory 
signaling is such a complicated network including the amplification and modulation 
by mast cells and EC cells, abnormal or imbalanced interactions might result in 
hypersensitivity, a hall marker for IBS. As such, TRPA1 is a promising 
pharmacological target for IBS or other bowel disorders. A recent study has 
                                                                                                                    Chapter 7 
 171 
suggested that ASP7663, a novel TRPA1 agonist, can improve the symptoms in 
animal model of constipation (Kojima et al., 2013). 
 
Influence of ageing on sensory functions in the GI tract 
This study identified some age-related changes involving the sensory functions of the 
GI tract in both human and mouse models. In humans, EC cells and mast cells 
appeared to be increased with advanced age, whereas sensory afferent nerves labeled 
by SP were decreased. In addition, the close anatomical association between 
afferents and mast cells were enhanced in the elderly. RT-PCR did not reveal any 
change with ageing in the expression of TRPA1 and TPH1 in the mucosa of human 
bowel. 
 
Interestingly, ageing and IBS share some common alterations, for example, IBS is 
often associated with increased EC cells, mast cells and enhanced mast cell- nerve 
association. However, one striking difference is that SP has been shown increased in 
IBS bowel (Mazumdar and Das, 1992; Dong et al., 2004; Sohn et al., 2014b), 
whereas we observed reduced SP positive sensory afferents with ageing. This might 
explain that IBS is less prevalent in aged population and the severity of pain is 
decreased (Kay, 1994; Wilson et al., 2004; Tang et al., 2012). As previously 
discussed, peptidergic TRPA1 afferents might be responsible for the abdominal pain 
in IBS. Therefore, the less prevalence of IBS in the elderly might be attributed to 
attenuated TRPA1 signaling.  
 
Hence, this study examined peripheral TRPA1 signaling in aged mouse intestine. As 
a result, AITC or bradykinin-induced TRPA1 signaling was significantly attenuated 
in aged mouse. After discrimination of individual afferent units by spike sorting, this 
attenuation was found more dramatic on low threshold units, which was consistent 
with the decrease in mechanosensitivity with ageing. Reduction in the number of 
functional distension-sensitive low threshold units detected by recording might 
account for this attenuation. Gene expressions of TRPA1 and 5-HT3A were not 
changed in both DRG and jejunum. Expressions of 5-HT3B subunits were not altered 
in aged DRG, but decreased in aged jejunum. In agreement with this observation, our 
unpublished data have demonstrated that peak afferent responses to superfusion of 2-
Me-5-HT, a selective 5-HT3 agonist, were significantly reduced in the small intestine 
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of 18 and 24 months old mice. In addition, 5-HT3 receptor antagonist granisetron 
significantly inhibited TRPA1 signaling in the adult mice, whereas its inhibitory 
effect was reduced in the aged mice, which was consistent with the decrease in 5-
HT3 receptors. Interestingly, as the major source of 5-HT in the gut, EC cells were 
significantly increased in the jejunum of aged mice. It is possible that as 5-HT3 
receptors declined with ageing process, EC cells were up-regulated to compensate 
the impaired signaling pathway mediated by 5-HT3 receptors. In vitro afferent 
recording facilitates investigation of integrated sensory signaling at the level of a 
segment of intestine, while calcium imaging on cultured DRG and NG neurons 
evaluates their sensitivity directly. As a result, sensitivity of primary neurons to 
TRPA1 agonist was not significantly altered by ageing. 
 
If the attenuation of TRPA1 signaling in aged mice could be translated to humans, 
the less prevalence of IBS in the elderly might be attributed to impaired TRPA1 
signaling. This could be a key direction for future studies. 
 
Efforts were made to investigate potential age-related changes in the density of 
mouse intestinal mast cells by immunohistochemistry. Antibodies against mouse 
mast cell tryptase and CD34 occasionally revealed sporadic mast cells in the 
submucosa of intestine from both adult and aged mouse. The density of mast cells 
was too small to make a systematic quantification. A number of studies have shown 
that mast cells are dramatically increased after helminth-infection, while their data 
indicate that the density of mast cells in noninfected mice is fairly small (Friend et al., 
1996; Scudamore et al., 1997; Friend et al., 1998; De Jonge et al., 2002). In 
comparison with larger mammals, mice have fewer resident mast cells, as suggested 
by the observation that human and rat have substantial mast cells in the lung 
parenchyma, whereas mast cells in the mouse are located predominantly adjacent to 
the major airways (Miller and Pemberton, 2002). In addition, mouse mast cells 
comprise a variety of phonotypes: chymase (mMCP-1, -2 and -4), elastase (mMCP-5) 
and tryptase (mMCP-6 and -7). Certain markers can only detect a subpopulation of 
mast cells, which further decreases the chance to visualize mast cells.  
 
This study addressed the influence of “normal” ageing on the sensory function of the 
GI tract. However, some alterations in bowel functions in the elderly are likely to be 
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consequences of accumulative medical conditions or GI side effects of medications 
used to treat those conditions. These limitations require strict sampling strategy and 
cautious interpretation. 
 
Another limitation is that a senescence marker was not used in age-related gene 
expression study. Some quantitative indicators of senescence have been proposed, 
such as senescence-associated β-Galactosidase (Sen-β-Gal) and Ki67 (Lawless et al., 
2010). These markers would be a control to evaluate the degree of senescence in 
aged human or mouse specimens. However, it is also suggested that no marker or 
hallmark of senescence identified so far is entirely specific to the senescent state 
(Rodier and Campisi, 2011). 
 
 
In vitro afferent recording on human bowel  
Most of our knowledge about sensory functions of the GI tract was obtained form 
animal studies. However, some of the knowledge translates poorly to humans, which 
highlight the demand for more thorough research on human directly. In vitro afferent 
recording on human bowel is nearly blank in the literature; until recently, our group 
and another group reported independent preliminary data on afferent recording from 
isolated human bowel (Jiang et al., 2011; Peiris et al., 2011). This study further 
improved this in vitro recording model and increased success rate of recording. 
 
Current study examined mechanosensitivity and chemosensitivity on afferent nerves 
innervating human bowel. Based on the sensitivity to probing, stretch and mucosal 
stroking, 15 mechanosensitive units can be classified into five subtypes: serosal 
(46%), muscular (27%), mesenteric (13%), mucosal (7%) and muscular/ mucosal 
(7%) afferent. Afferent discharge induced by capsaicin has been shown in the two 
preliminary reports. In addition to capsaicin, this current study is the first one to 
provide direct evidence that afferent discharges could be elicited by bradykinin, 
AITC and 5-HT in isolated human ileum and colon.  
 
Based on limited data, afferent discharges in response to bradykinin in human 
sigmoid colon appeared to be blunted in the elderly, which is consistent with our 
observation on mouse. This indicates an attenuated sensitivity to inflammatory 
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events in the elderly. In addition, as our study on mouse jejunal afferent suggested 
that bradykinin induced afferent response is mediated via TR`PA1, this might imply 
a possible attenuation of TRPA1 signaling in aged human bowel. 
 
Lots of efforts have been made to improve the success rate for human afferent 
recording. Current study managed to record afferent nerve activities from 45% of 
human bowel specimens, which is higher than a 15% success rate in our preliminary 
report (Jiang et al., 2011) and similar to 48% of the other group (Peiris et al., 2011). 
All these studies are greatly limited by the low success rate, reflecting the inherent 
difficulties of extracellular recording on isolated human bowel. Despite technical 
challenges, this in vitro afferent recording model at the level of peripheral afferent 
has enormous advantages, such as avoiding translational failures, testing compounds 
for clinical use and better understanding of the mechanisms underlying human bowel 
disorders. 
 
The use of in vitro afferent recording to investigate sensory signaling 
Extracellular recording on in vitro preparations were used throughout this thesis. 
This technique is extremely robust, efficient and reliable. Peripheral sensitivity to 
mechanical and chemical stimuli could be examined straightforward and 
immediately. Pharmacological effects of agonist or antagonist on afferent discharge 
could be easily assessed.  
 
Many investigators have used in vivo models as they are assumed to closely resemble 
living tissue. However, there are a number of aspects making it difficult to interpret 
in vivo data. In vitro afferent recording employed in this study facilitates 
investigation of integrated sensory signaling at the level of a segment of intestine. Its 
prominent advantage over cellular and molecular studies is the inclusion of 
secondary effects of various cell types, and it thus better reflects the physiological 
process in organisms. Nevertheless, the advantage is disadvantage at the same time, 
because the summation of multiple mechanisms increases the difficulties in 
interpretation. As such, in addition to afferent recording, this thesis also employed 
histochemistry, immunohistochemistry, RT-PCR and calcium imaging. Combination 
of these techniques allows investigation of sensory signaling from different aspects 
and thus deconstruction of complicated mechanisms.         
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Future studies 
Similar to all courses of scientific research, there are still a number of undetermined 
issues arising from current study for future investigations. 
 
Whether attenuation of TRPA1 signaling in aged mice can be translated to humans 
remains to be investigated. Preliminary data on human bowel recording have shown 
a promising attenuation with ageing in bradykinin-induced afferent signaling. Gene 
expression of TRPA1 has been examined on mucosa of human bowel, while 
expression of 5-HT3 receptor would be an interesting target to test. This study 
quantified the changes in the density of EC cells with advanced age on both human 
and mouse specimens, whereas the influence of ageing on 5-HT release and reuptake 
remains to be assessed. 
 
Current study identified a functional loss of some low threshold afferents innervating 
mouse jejunum, which were possibly vagal afferents originated from nodose neurons, 
considering the susceptibility of vagal nerves in structural deterioration caused by 
ageing (Phillips and Powley, 2007). This hypothesis can be further tested by 
quantification of the low threshold units on vagotomized aged mice.  In addition, 
gene expressions for TRPA1 and 5-HT receptor on aged nodose remain to be 
examined. 
 
Since the specificity of cromolyn as a mast cell stabilizer is controversial, the 
involvements of mast cells in the TRPA1 signaling need further validation. As mast 
cells can release so many types of mediators and each mediator may act on a few 
subtypes of receptors, a comprehensive antagonist test would be difficult. Study on 
mast cell deficient mouse is an alternative way to examine the role of mast cells in 
TRPA1 involved signaling. 
 
This study also focused on 5-HT3 receptor, as it is highly expressed in primary 
sensory neurons innervating the GI tract. However, there are totally 7 subfamilies in 
5-HT receptors, in addition to 5-HT3, at least 5-HT2, 5-HT4 and 5-HT7 receptors are 
present in the GI tract. Since activation of TRPA1 on EC cells results in serotonin 
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release, which can act on corresponding 5-HT receptors. Whether those 5-HT 
receptors beside 5-HT3 are involved in TRPA1 signaling remains to be clarified.  
 
It is controversial if activation of TRPA1 induces mechanical hypersensitivity. In 
mouse model of in vitro recording, afferent response to ramp distension before and 
after AITC or bradykinin treatment were reproducible. However, based on limited 
data from human recording, AITC and bradykinin of the same concentration 
appeared to induce mechanosensitivity to probing. It requires further studies to 
explain this discrepancy. 
 
Many independent lines of evidence have supported the essential role of TRPA1 in 
visceral hypersensitivity and pathogenesis of IBS. It thus becomes a very promising 
target for the treatment of IBS. Examination of the pharmacological effects of 
TRPA1 agonists or antagonists on IBS symptoms or other bowel disorders would be 
very useful. 
 
Investigation of these issues would achieve a better understanding of the sensory 
functions of the GI tract and pathogenesis of GI-related disorders and ultimately 
promote development of specific and effective treatments. 
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